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ABSTRACT
Intraindividual Variability as a Predictor of Cognitive Decline in Elderly
by
Wendy S. Ramratan

Advisor: Dr. Laura A. Rabin
Mild cognitive impairment (MCI) is conceptualized as a transitional state between
normal aging and fully developed clinical features of dementia. The literature on MCI is notable
for varied measurement approaches and lack of stability in the diagnostic entity, with many
individuals remaining stable or reverting to normal cognitive status. Researchers agree that
multiple neuropsychological domains should be assessed to enhance the assessment and
prediction of cognitive decline. In addition, within-person assessments capture trajectories of
decline, which are better suited for understanding individual change than simple comparison to
group norms. The current study investigated the ability of within-person change on novel
experimental cognitive tasks, referred to as intraindividual variability (IIV), to enhance
characterization and prediction of MCI compared to traditional neuropsychological measures.
Participants were 426 older adults from the Einstein Aging Study, a longitudinal
community-based study, who were classified as healthy controls (HC) with no cognitive or
functional impairment at a baseline assessment (mean age=79.89, SD=5.05). Participants
completed a two-day testing battery that included standard (Free and Cued Selective Reminding
Task, Trail Making Test Part A, Trail Making Test Part B) and experimental (Cued-Recall
Retrieval Speed Task, Number Match Task, N-Back 2 Task) tests of episodic memory,
processing speed and executive function. For standard tasks we recorded the number of items
correct and/or time to task completion. For experimental tasks we recorded reaction time IIV
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and accuracy IIV. The outcome of interest was MCI, which was defined by two classification
approaches to prevent diagnostic circularity. Participant cognitive status was assessed annually
for up to 10 years following initial baseline testing.
Within-domain analyses aimed at characterizing future MCI status revealed that
participants who transitioned to MCI performed worse at baseline on the episodic memory
standard task and all experimental tasks; they also exhibited greater IIV on the episodic memory
experimental task. Within-domain analyses aimed at predicting future MCI status revealed that
baseline performance on the episodic memory standard task predicted future incident MCI and
baseline performance for the episodic memory experimental task predicted future incident MCI
when utilizing the alternate MCI criteria. Across-domain analyses aimed at predicting future
MCI status revealed that episodic memory and executive function standard tasks predicted
incident MCI better than experimental tasks. Across-domain time-dependent analyses revealed
that the episodic memory standard and experimental tasks and the executive function standard
task distinguished between individuals who transitioned to MCI within three years and HC.
However, this analysis was unable to distinguish between participants who transitioned to MCI
four or more years after initial testing.
Overall, results revealed that baseline differences on cognitive tasks present up to 10
years before MCI diagnosis. Episodic memory IIV classified transition of MCI for both
diagnostic MCI definitions. In addition, incident MCI can be predicted from baseline
performance on episodic memory standard and experimental tasks and on an executive function
standard task. These measures could be considered an early detection approach and should be
further examined to facilitate early diagnosis of MCI and related preclinical conditions.
Keywords: Intraindividual variability, mild cognitive impairment, aging, prediction of MCI
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Introduction
Cognitive Decline and the Elderly
Cognitive changes are a normal part of the aging process, though the trajectory of decline
differs for those with non-normative cognitive decline resulting from a neurodegenerative
process such as dementia. Alzheimer’s disease (AD) is the most common type of dementia
among the elderly, accounting for approximately 60-80% of all cases. The pathology of AD is
believed to begin many years before a clinical diagnosis leading to research focused on detecting
cognitive decline at its earliest stage. Studies have utilized multiple methodologies to examine
the prodromal stage of AD – mild cognitive impairment (MCI) – and the transition to AD.
Unfortunately, at the MCI stage, impairment may be too progressed to treat and researchers have
thus focused on healthy elderly to determine when non-normative changes first become evident.
The assessment of within-person cognitive change over time may be a specific and sensitive
marker of non-normative cognitive change, though research on this topic is inconclusive due, in
part, to the multiple methodologies and varying tests used to assess intra-individual change. At
present the field lacks consensus about how best to assess within-person change over time and
how to utilize this methodological approach to predict which cognitively healthy elderly
individuals will transition to MCI and AD. The current study addresses these important issues
through the assessment of within-person change using novel experimental cognitive tasks that
capture intraindividual variability in reaction time and task accuracy.

Alzheimer’s Disease Prevalence and Risk Factors
AD, the most common form of dementia, is the sixth leading cause of all deaths in the
United States and the fifth leading cause of death of those aged 65 and older (Alzheimer’s
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Association, 2016). One in every nine adults aged 65 or older carries a diagnosis of AD and the
estimated lifetime risk for developing AD ranges from 13-16% as age increases beyond 65
(Alzheimer’s Association, 2016). By the end of 2016 there will be approximately 5.7 million
older adults with AD (Alzheimer’s Association, 2016). Barring any monumental breakthroughs
in disease prevention or cure, it is estimated that within the next 10 years there will be 7.1
million people aged 65 or older with AD in the United States, representing a 37% increase in
prevalence compared to current rates (Alzheimer’s Association, 2016). Globally, there is an
estimated 46.7 million people aged 60 or older with dementia (Alzheimer’s Disease
International, 2015). Within 15 years, this value is predicted to have a 63% increase in
prevalence, so that by 2030, there will be an estimated 75 million people worldwide with
dementia (Alzheimer’s Disease International, 2015).
The greatest risk factor for developing AD is advancing age. Individuals between the
ages of 65 to 74 comprise 15% of the AD population compared to individuals ages 75 to 84 and
85 and older, who comprise roughly 44% and 37% of the AD population, respectively. Women
comprise approximately 63% of those with AD, which is likely due to the fact that on average,
women live longer than men and as previously noted, older age is the greatest risk factor for AD.
African-American and Hispanic individuals are more likely than Caucasian individuals to have
AD. Health conditions, such as cardiovascular disease and diabetes, which are associated with
an increased risk for AD, and are more prevalent within African-American and Hispanic
individuals, likely account for differences between ethnic groups. Globally, 58% of all people
with dementia have a lower socioeconomic status therefore indicating a higher risk of dementia
for those with a lower income. In addition, genetic factors increase the risk of developing AD—
for example, 40-65% of those diagnosed with AD carry one or two copies of the APOE 4 gene,
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indicating that while inheriting the gene increases the risk of AD, it does not guarantee that an
individual will develop AD (Alzheimer’s Association, 2016).

AD Diagnostic Criteria
The National Institute on Aging and the Alzheimer’s Association (NIA-AA) provide
recommendations for the clinical diagnosis (criteria) of all-cause dementia, which includes
cognitive or behavioral symptoms that interfere with daily activities, represent a decline from
previous functioning, and are not explained by delirium or major psychiatric disorder. Cognitive
impairment is detected and diagnosed through historical reports from patient and knowledgeable
informant(s) and objective cognitive assessment through bedside mental status examination or
neuropsychological tests. Cognitive and behavioral impairment must be present in at least two
of the following domains: acquisition and recall of new information, reasoning and handling of
new tasks, visuospatial abilities, language functions and changes in personality, behavior or
comportment (McKhann et al., 2011).
The NIA-AA also specifies criteria for the diagnosis of AD dementia including possible
AD dementia, which occurs when the clinical criteria for cognitive deficits (see above) are met
and there is a sudden onset of cognitive impairment or demonstrates insufficient objective
documentation of cognitive decline. A diagnosis of possible AD dementia can also be made
when there is a mixed etiological presentation that meets the clinical criteria of AD dementia but
also has evidence of features of other neurological on non-neurological medical issues that could
have a substantial effect on cognition. A diagnosis of possible AD dementia with
pathophysiological evidence does not eliminate the likelihood that other pathophysiological
conditions are also present (McKhann et al., 2011). The diagnosis for probable AD dementia
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includes the aforementioned criteria for dementia and also insidious onset, history of worsening
condition, the most prominent cognitive deficits have an amnestic or non-amnestic presentation,
and there is no evidence of any other medical or neurological disorder that could have an effect
on cognition (McKhann et al., 2011). A diagnosis of probable AD dementia is supported by the
presence of a causative genetic mutation (amyloid precursor protein, presenilin 1, or presenilin
2). Presence of biomarkers (total tau, phosphorylated tau or amyloid-β) may also increase
certainty of the probable AD dementia diagnosis, but are not advocated due to limited access and
information on the utility of these markers (McKhann et al., 2011). The criteria for diagnosis of
definite AD dementia include the clinical and cognitive criteria for AD dementia and
histopathological evidence obtained from a biopsy or autopsy (McKhann et al., 2011).
More recently, the Diagnosis and Statistical Manual of Mental Disorders, Fifth Edition
(DSM-V) characterized major neurocognitive disorder due to probable/possible AD (also
commonly referred to as Alzheimer's Dementia) where there is evidence of causative AD genetic
mutation from family history or genetic testing and/or decline in memory/learning and one other
cognitive domain; steadily progressive, gradual decline in cognition and absence of other
etiologies. Mild neurocognitive disorder due to probable AD is diagnosed if there is evidence of
causative AD genetic mutation from family history or genetic testing; mild neurocognitive
disorder due to possible AD is diagnosed if there is no evidence of causative AD genetic
mutation but there is decline in memory/learning; steadily progressive, gradual decline in
cognition and no evidence of mixed etiology (American Psychiatric Association, 2013).
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AD Neuropathology
The AD brain is characterized by the presence of extracellular amyloid plaques and
intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed
filaments (Alzheimer’s Association, 2016; Bloom, 2014). The soluble building blocks of these
structures are amyloid-β (Aβ) peptides for plaques and tau for tangles. The behavioral symptoms
of AD correlate with the accumulation of plaques and tangles, and they are a direct consequence
of the destruction of synapses that mediate memory and cognition (Bloom, 2014). Synaptic loss
can be caused by the failure of neurons to maintain functional axons and dendrites or by neuronal
death (Blumenfeld, 2002; Kolb & Whishaw, 2009; Petersen et al., 2001). Because soluble toxic
aggregates of Aβ and tau self-propagate and spread throughout the brain, therapeutic intervention
for AD requires early detection before plaques, tangles, and cognitive impairment become
evident (Bloom, 2014).
Jack and colleagues (2010) proposed a biomarker model of AD that suggests a temporal
cascade of onset AD pathology and clinical symptoms across the trajectory of cognitively normal
to MCI to AD (Figure 1). According to the model, as the clinical stage of the disease advances,
the presentation of biomarkers increase, with each biomarker presenting at different stages.
Therefore, AD can be viewed as an evolving process in which pathological changes in the brain
can present years before the onset of overt clinical symptoms. Biomarkers can be divided into
two categories: brain amyloid β plaque formation and neurodegeneration. Amyloid β (Aβ)
plaque formation can be measured by decreased cerebrospinal fluid levels of Aβ42 and by brain
PET Aβ imaging. Neurodegeneration is noted by neuronal damage (increased cerebrospinal
fluid tau), reduced brain metabolism (decreased Fluorodeoxyglucose uptake on PET) and
cerebral atrophy (Jack et al., 2010). According to Jack and colleagues (2010), the amyloid
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cascade hypothesis of AD states that AD begins with abnormal processing of the amyloid
precursor protein, which then leads to excessive production or reduced clearance, and
consequently plaque formation of Aβ in the brain. Recent research has led to an updated model
(Figure 2), which introduces differing profiles for low-risk versus high-risk individuals (Jack et
al., 2013).
Jack and colleagues (2013) observed that individuals who are high-risk differ along the
spectrum from those at low-risk. Individuals who are at high risk for cognitive impairment due
to AD pathophysiology may have more genetic risk alleles, lower cognitive reserve, or other comorbid brain pathologies, while low-risk individuals present with a protective genetic profile,
high cognitive reserve, and the absence of co-morbid brain pathologies; these individuals can
have substantial AD pathophysiology while still maintaining normal cognitive function (Jack et
al., 2013). Therefore, at a specific time point, individuals can present with the same AD
pathological burden, but because of their risk-status, display different cognitive profiles.
Specifically, a high-risk individual may display cognitive impairment while a low-risk individual
(examined at the same time) may present with normal cognition (Jack et al., 2013). It is
therefore imperative to utilize measures that detect subtle, cognitive impairment in order to
correctly classify all types of at-risk individuals.

Conceptualization and Characterization of Mild Cognitive Impairment
AD progresses slowly and begins years before the clinical manifestation of symptoms
(Alzheimer’s Association, 2016; McKhann et al., 2011). Brain changes associated with AD may
begin as early as 20 years before clinical symptoms actually appear. As noted above, AD is
characterized by deterioration in memory and other cognitive abilities (e.g., executive function,
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language) and changes in personality and behavior as a result of the neurodegenerative changes
(Alzheimer’s Association, 2016; Chantal, LaBelle, Bouchard, Braun, & Boulanger, 2002;
McKhann et al., 2011). As neuronal damage increases, individuals demonstrate increasing
cognitive decline, which eventually compromises every cognitive domain and all activities of
daily living (Alzheimer’s Association, 2016).
The prodromal phase of AD, which is characterized by a gradually progressive cognitive
decline, is believed to be the result of accumulation of AD pathology within the brain. Multiple
studies have examined this stage of AD, often referred to as mild cognitive impairment (MCI).
MCI is conceptualized as a transitional state between the cognitive changes of normal aging and
the fully developed clinical features of dementia (Morris, 2006; Petersen, 2007; Petersen et al.,
2014). But, the point at which the onset of decline begins is difficult to identify and therefore the
transition points from asymptomatic to symptomatic pre-dementia to dementia onset are also
difficult to distinguish. As a result, The NIA-AA introduced “mild cognitive impairment due to
AD” to characterize individuals along the MCI spectrum with primarily underlying AD
pathology. They recognized the need for core clinical criteria that would be broadly used by
healthcare professionals without the need for specialized tests or procedures as well as clinical
research criteria that incorporated the use of biomarkers for use in research settings.
According to Petersen (2007) and Albert and colleagues (2011), diagnosis of MCI is
made in individuals who are not demented, who have a cognitive complaint, cognitive
decline/impairment not normal for their age, and preservation of independence in functional
abilities. A combination of clinical, physiological, and neuropsychological measures may be
used to diagnose MCI, including a complete medical history, self-report assessment of daily
living activities, information from a close friend or relative, examination by a neurologist, mood
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evaluation, neuropsychological assessment, blood work, and in some cases neuroimaging (Albert
et al., 2011; Blumenfeld, 2002).
Studies of MCI have determined that there are multiple domains of cognition that can be
impaired (Albert et al., 2011). Petersen (2004) characterized subtypes based on the cognitive
domains of impairment (e.g., impairment in memory alone was characterized as amnestic MCIsingle domain). Individuals with amnestic MCI (aMCI) have a higher conversion rate to AD (1819%) compared to other non-amnestic MCI (naMCI) subtypes (5-10%) (Damien et al., 2013;
Fischer et al., 2007; Jungwirth, Zehetmayer, Hinterberger, Tragl & Fischer, 2012; Mitchell &
Shiri-Feshki, 2009; Tifratene, Robert, Metelkina, Pradier & Dartigues, 2015). Impairment in
memory and non-memory domains is characterized as amnestic MCI-multiple domain.
Individuals with this subtype have a higher likelihood of progressing to AD in addition to
vascular dementia (Petersen, 2004). Impairment in a single domain, which is not memory, is
characterized as non-amnestic MCI-single domain. Individuals with this subtype have a higher
likelihood of progressing to frontotemporal dementia and dementia with Lewy bodies.
Impairment in more than one non-memory domain is characterized as non-amnestic MCImultiple domain. Individuals within this subtype have a higher likelihood of progressing to
dementia with Lewy bodies and vascular dementia (Petersen, 2004).
Research criteria for MCI incorporate the presence of biomarkers (as mentioned
previously) associated with AD pathology. Albert and colleagues (2011) proposed a
hypothetical framework in which biomarkers may be used to increase diagnostic accuracy. Their
framework consisted of four levels in relation to biomarker presence/absence: high likelihood,
intermediate likelihood, low likelihood and uninformative. A high likelihood of MCI due to AD
requires the biomarker presence of Aβ and neuronal injury. An intermediate likelihood of MCI
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due to AD requires the biomarker presence of Aβ or neuronal injury. A low likelihood of MCI
due to AD requires the absence of Aβ and neuronal injury biomarkers. An uninformative
situation of MCI due to AD usually occurs when obtained biomarker information is
indeterminate, such that biomarker absence/presence is inconclusive. Interestingly, individuals
that fall within this category have the typical presentation of individuals who are at an increased
risk of progressing to AD. An uninformative situation of MCI due to AD also includes cases
where biomarkers were not tested such as in the core clinical criteria – which is still consistent
with the possibility that individuals with MCI have underlying AD pathology (Albert et al.,
2011). Recently, Vos and colleagues (2015) examined the proposed biomarker framework to
determine how accurately it assessed and predicted progression from MCI to AD and found the
refined model to have a greater sensitivity and specificity compared to prior criteria and therefore
recommend the implementation of such in clinical settings.
Mitchell and Shiri-Feshki (2009) found that in specialty settings (clinics, hospitals), rates
of conversion from MCI to dementia were 39.2%, and in the general population samples rates of
conversion were 21.9%. A review by Ward and colleagues (2012) found that the prevalence of
MCI ranged from 3% to 42% among international studies. Sachdev and colleagues (2015)
argued that this wide variation may be due to differences in the definition and methodology of
identifying MCI (e.g., studies vary widely in how they define and quantify objective cognitive
impairment on neuropsychological assessment). Sachdev and colleagues (2015) aimed to apply
a uniform diagnostic criterion, to produce more reliable estimations of MCI prevalence across
different geographical and ethnocultural regions. By applying more uniform criteria, which
utilized a broad spectrum of neuropsychological tests, they found that the prevalence of MCI
ranged from 6%-12%, which was greatly reduced from prior assessments. Moreover, prevalence
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of MCI increased with age but was unaffected by sex and prevalence of aMCI and naMCI was
2.0% and 3.9%, respectively. These values are more closely aligned with the worldwide
prevalence rates of AD and suggest that use of a full neuropsychological test battery leads to
more accurate diagnosis of MCI.

Neuropsychological Assessment
Here we focus on the core clinical criteria for MCI, which do not depend on the inclusion
of biomarker testing. MCI is typically diagnosed following neuropsychological assessment,
which involves an in-person evaluation of specific cognitive abilities such as episodic memory,
executive functioning, language/verbal ability, visuospatial skills, attention and processing speed
(Weintraub et al., 2012) and applying a cutoff (usually 1.5 or more standard deviations below
normative means on at least one measure. Episodic memory tasks generally tap how new
information is learned, stored, and retrieved (Derby et al., 2012; Weintraub et al., 2012).
Commonly used measures include list-learning tests such as the Free and Cued Selective
Reminding Task (Grober & Buschke, 1987) or story memory such as the Logical Memory
Subtests of the Wechsler Memory Scale (WMS–IV; Wechsler, 2009). Tests of executive
functioning tap higher-level cognitive abilities such as executing complex mental tasks that
require initiation, planning, sequencing, set-shifting, flexibility, sustained attention, resistance to
interference, and the manipulation of new information (Chan, Shum, Toulopoulou, & Chen,
2008; Weintraub et al., 2012). Commonly used tests include the Wisconsin Card Sort Test
(Heaton, Chelune, Talley, Kay, & Curtiss, 1993), Stroop Color-Word Test (Golden, 1978) and
Trail Making Test Part B (Army Individual Test Battery, 1944). Neuropsychological tests of
language and verbal ability tap general knowledge of facts, concepts, and the ability to name or
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report the meaning of words (Lezak, Howieson, Bigler, & Tranel, 2012; Weintraub et al., 2012).
The Boston Naming Test (Kaplan, Goodglass & Weintraub, 1983), for example, measures
confrontational word retrieval while category (Monsch et al., 1992) and letter fluency (Benton &
Hamsher, 1989) tests assess the ability to produce words under specific phonemic or semantic
constraints. Visuospatial tasks tap visual information processing skills (Weintraub et al., 2012)
such as the ability to draw a clock from memory and set the time correctly (i.e., Clock Drawing
Test, Shulman & Gold, 1993) or hands-on block assembly with provision of a visual model (e.g.,
Block Design, Wechsler, 2008). Tests of attention and processing speed tap into the ability to
focus and sustain attention and capture the time it takes to perceive information (typically
through visual and auditory channels), process information and/or formulate or enact a response
(Weintraub et al., 2012). Commonly used measures of attention and processing speed include
the Digit Span (auditory) and Digit Coding (visual) subtests from the Wechsler Adult
Intelligence Scale (WAIS–IV; Wechsler, 2008) and the Trail Making Test Part A (Army
Individual Test Battery, 1944).
The above neuropsychological tests are generally administered under standardized
laboratory conditions and require varying amounts of time to administer and score (Lezak et al.,
2012). As an alternative to lengthy evaluations that enable the characterization of specific
patterns of cognitive strengths and weaknesses, clinicians sometimes use brief assessment tools
such as the Mini Mental State Exam (MMSE; Folstein, Folstein & McHugh, 1975) and the
Blessed Information–Memory-Concentration test (BIMC; Blessed, Tomlinson & Roth, 1968) to
screen for cognitive disorders. The MMSE is a 30-item test that assesses orientation, registration
and recall of three words, attention and calculation, language, and constructional praxis and takes
about 10 minutes to administer. The BIMC is a 33-item test that assesses orientation, long-term
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memory (by assessing the ability to recollect information of both personal and non-personal
significance), recall, and concentration and also takes about 10 minutes to administer. Not
surprisingly, as measures of global cognition, the MMSE and BIMC are highly correlated (Thal,
Grundman & Golden, 1986).
The literature on MCI is notable for varied measurement approaches in terms of the way
objective and subjective memory are assessed and operationalized (including cutoffs for
impairment) and lack of stability in the diagnostic entity itself. In fact, research on MCI has
generally concluded that there is no “gold standard” test battery. Many individuals diagnosed
with MCI remain stable or revert to normal cognitive status on longitudinal follow-up (Baerresen
et al., 2015; Belleville, Gauthier, Lepage, Kergoat & Gilbert, 2014; Bondi et al., 2014; Bondi &
Smith, 2014; Forlenza, Diniz, Stella, Teixeira & Gattaz, 2013; Klekociuk, Summers, Vickers &
Summers, 2014; Petersen et al., 2014; Roberts et al., 2014). Moreover, due to the complex
nature of correctly classifying MCI, predicting the transition from normal cognitive function is
also difficult. Generally, researchers agree that multiple cognitive domains should be assessed to
enhance prediction of decline. As discussed in detail below, within-person change over time also
can be utilized to identify trajectories of decline as opposed to simple comparisons to group
norms (Baerresen et al., 2015; Belleville et al., 2014; Bondi et al., 2014; Bondi & Smith, 2014;
Forlenza et al., 2013; Klekociuk et al., 2014).

Preclinical AD
Bondi and colleagues (2008) described a preclinical AD condition that may be a stage
prior to MCI, which is characterized by subtle cognitive decline but not necessarily impairment.
They reviewed 91 studies of neuropsychological functioning and neuroimaging and found
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preclinical AD to be characterized by subtle deficits in a broad range of neuropsychological
domains (learning and memory, executive functioning, processing speed, attention and semantic
knowledge). A meta-analysis of 47 studies by Backman and colleagues (2005) found preclinical
deficits in global cognition, episodic memory, perceptual speed and executive function best
discriminated subjects who developed AD from those who remained non-demented. They
concluded that it would be beneficial to use a broad range of tests to improve the stability and
reliability of diagnosis. In addition, a study by Bennett and colleagues (2006) examining autopsy
results showed that MCI patients exhibit substantial AD pathology but preclinical AD patients
exhibit only minor AD pathology. This suggests that individuals with MCI may be closer to AD
than previously thought and that it may be beneficial to assess cognition even before clinical
manifestation of impairment at MCI develops. And, there may exist several potential markers of
a prodromal period of AD, in which specific cognitive and biomarker changes precede the
clinical manifestations (Bondi et al., 2008)
Chao and colleagues (2010) further investigated the possible preclinical AD stage
through examination of volumetric and metabolite differences in individuals characterized as
cognitively healthy, pre-MCI and MCI. Despite significant structural MRI differences that
differentiated between cognitively healthy and pre-MCI, there were no significant verbal
episodic memory, visual memory, semantic memory, executive function or MMSE differences
between pre-MCI and cognitively healthy subjects. Although the sample sizes for each group
were small, these findings lend support to the theory that changes in brain pathology can exist
before symptomatic/measurable cognitive changes are present (Chao et al., 2010).
Sperling and colleagues (2011) observed that individuals who had evidence of amyloid
accumulation on PET scans in early AD but who did not meet clinical criteria for MCI were at
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risk for progression to AD. These individuals demonstrated very subtle decline but did not meet
standardized criteria for MCI diagnosis and might be classified as “Not normal, not MCI”
(though they warrant inclusion under the rubric of preclinical AD). It is imperative to further
study these preclinical/prodromal stages of AD because they represent the initial emergence of
clinical impairment when individuals could benefit most from early intervention (Sperling et al.,
2011).
The NIA-AA recognized preclinical AD (pre-MCI) as an asymptomatic phase in which
individuals are classified as cognitively normal but have biomarkers associated with AD and
possible subtle cognitive decline which has not been quantified (Sperling et al., 2011). Edmonds
and colleagues (2015) aimed to define “subtle cognitive decline” and the association to
biomarker abnormalities. Within a group of cognitively normal participants, subtle cognitive
decline was defined as impaired scores in two out of the six neuropsychological measures (in
different domains) administered. Of the participants that displayed subtle cognitive decline, 75%
showed evidence for biomarker abnormalities (amyloidosis and/or neurodegeneration).
Interestingly, biomarker evidence of amyloidosis plus neurodegeneration or neurodegeneration
alone were the most common among individuals with subtle cognitive decline. These findings
suggest that most individuals did not follow the amyloid cascade hypothesis, which presents as
amyloidosis, followed by neurodegeneration, followed by subtle cognitive decline (Jack et al.,
2010; Jack et al., 2013). Instead, Edmonds and colleagues (2015) showed that
neurodegeneration and subtle cognitive decline can present concurrently without amyloidosis
and there are also individuals with subtle cognitive decline that have no biomarker presence but
still transition to MCI. Traditionally, subtle cognitive decline has been viewed as the last marker
to be affected in preclinical AD but that may be a result of insensitive measures that are unable to
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detect slight variations in cognition. More sensitive measures may be able to capture subtle
cognitive change and thus enhance the ability to fully characterize the preclinical stage of AD
and better predict transitions to MCI and AD.

Trajectory of Cognitive Decline
It is imperative to delineate the neuropsychological trajectory from normal cognitive
aging to MCI to dementia and variables that influence progression. Forlenza and colleagues
(2013) observed that impairments in memory (amnestic MCI-single domain) emerged as the
most common path to AD followed by impairments in memory and executive function (amnestic
MCI-multiple domain). Bondi and colleagues (2014) examined the diagnostic progression of
participants with MCI using conventional techniques and cluster analysis. Within the MCI
group, three impaired domains emerged from the cluster analyses: amnestic, dysexecutive/mixed
and language deficits. Using the development of AD as the external referent, 30.3% of MCI
participants progressed to AD and 4.2% reverted to cognitively normal. Using subgroups
defined by cluster analysis, 49% of the MCI group progressed to AD and less than 1% reverted
to cognitively normal, which indicates that groups defined by cluster analysis were classified
better than using conventional techniques. Although Bondi and colleagues (2014) had a group
of cognitively normal participants, they did not assess the outcomes of these individuals, such as
transitioning to MCI or remaining normal (i.e. stable). Therefore, we are unable to determine
how reliable the cluster analysis approach is when examining the progression from healthy to
MCI to AD, and how early impairment within those clusters manifest. Research examining
impairment in specific domains could lead to a more reliable, stable and possible earlier
diagnosis of MCI.
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Klekociuk and colleagues (2014) aimed to reduce false positive MCI diagnoses over
time. Participants were assessed at three different time points using varying neuropsychological
tests across different domains and were classified as either MCI or unimpaired. MCI and
unimpaired participants were monitored over time to assess whether they remained stable (i.e.
MCI to MCI or unimpaired to unimpaired) in their classification or changed classification (i.e.
MCI to unimpaired or unimpaired to MCI). Results showed that 80% of MCI and 88% of
unimpaired were correctly classified and the groups remained stable over time. These findings
suggest that tapping multiple cognitive domains is beneficial when attempting to reliably classify
and differentiate between MCI and unimpaired older adults (Klekociuk et al., 2014).
Tarnanas, Tsolaki, Nef, Müri, and Mosimann (2014) examined cognition using a virtualreality computer-based simulation that assessed executive function, prospective memory, and
reasoning. Computerized tests offer many advantages such as standardized formatting as well as
precise recording of accuracy and speed of responses. The authors utilized a computerized task
in addition to standard neuropsychological assessment to predict the progression of MCI to AD.
The computerized task strongly discriminated between MCI-progressor and MCI-stable and also
between MCI-progressor and healthy elderly; specifically MCI-progressor and MCI-stable
exhibited poorer executive function task performance compared to healthy elderly (Tarnanas et
al., 2014). The authors failed to utilize a time component in their study thus not allowing for
information about processing speed to be addressed. Using a computer-based
neuropsychological test in addition to speed of performance could optimize the early diagnosis
of AD compared to other techniques.
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Within-Person Assessments
Storandt, Grant, Miller and Morris (2006) examined individuals with MCI and preclinical
MCI (participants who were insufficiently impaired to meet MCI classification) across multiple
cognitive domains at different time periods to compare the rate of cognitive decline between
groups. They found that the rate of decline for the MCI group was faster than for the pre-MCI
group across all domains. Storandt and colleagues (2006) further proposed that individuals with
MCI represent an early stage of AD and those with preclinical MCI have subtle cognitive
changes detected through within-person (intraindividual) differences (accounting for why the
pre-MCI group declined slower than the MCI group). Perhaps the combination of early
biomarkers and clinical measures of cognitive decline over time may aid in diagnosing
progression to AD at the early onset of decline (Storandt, Grant, Miller, & Morris, 2006).
Serial evaluations that examine change over time can be used to establish whether
cognitive performance is impaired beyond what is expected for an individual given his or her
demographic characteristics (Albert et al., 2011). Within-person or intraindividual assessments
can be made over various time periods. Longitudinal studies often assess individuals annually.
At the other extreme, multiple assessments can be made during one testing session. By assessing
within person cognitive change, it may be possible to identify even earlier stages of cognitive
decline (Tarawneh & Holtzman, 2012). Intraindividual variability has been used to characterize
cognitive impairment in the elderly but has not been fully explored for its diagnostic capabilities.

Intraindividual Variability
Variability in one’s performance over short periods of time could indicate neural
dysfunction not typically assessed with traditional testing methods. Inconsistency in
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performance, for example, could be an early marker of loss of neural integrity, which is
represented by compromised regulation and coordination of neural networks (Macdonald, Li &
Backman, 2009). Exploring measures of intraindividual variability (IIV) in reaction time tasks
of sufficient complexity may facilitate identification of subclinical cognitive impairment before
decline across a broad range of cognitive domains become apparent. MacDonald and colleagues
(2009) proposed that increased IIV could reflect endogenous neural changes underlying
cognitive deficits. IIV measured over short time intervals, such as block-to-block fluctuations in
reaction time tasks, may represent endogenous sources that underlie cognitive variability and
therefore may capture aspects of neural functioning such as changes in the efficiency of
neurotransmitters previously concealed. Reduction in neurotransmitters may give rise to
increased neural noise and present as increased IIV in cognitive performance. In addition,
increased fluctuation in performance could indicate diminished stability of performance over
time resulting in maladaptive outcomes (MacDonald et al., 2009).
IIV can be defined as the variability or inconsistency of performance of a single person
across repeated blocks of a task during a single testing occasion (Gorus, De Raedt, Lambert,
Lemper, & Mets, 2008; Hultsch, MacDonald, Hunter, Levy-Bencheton, & Strauss, 2000). IIV
has also been characterized as variability of performance of a single person across different tasks
within a single testing session (Tractenberg & Pietrzak, 2011). There are multiple methods for
measuring IIV: (1) intraindividual standard deviation (i.e., computed standard deviation for items
or for standardized test scores per person; ISD), (2) coefficient of variation (i.e., standard
deviation divided by mean, either over all items or over standardized test scores; ICV), and (3)
level-independent variation (i.e., variability independent of an individual’s predicted mean score;
LIV) (Tractenberg & Pietrzak, 2011). These methods of measuring IIV are primarily used in the
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context of reaction time tasks that measure speed of performance as opposed to accuracy of
performance. IIV has shown some utility in differentiating between diagnostic groups (within
elderly populations), more so than conventional measures of accuracy alone (Bielak, Hultsch,
Strauss, MacDonald & Hunter, 2010a; Dixon et al., 2007; Ramratan et al., 2012). However, to
date, no single method of measuring IIV has been established as the optimal approach for
examining cognitive dysfunction within the elderly population (Bielak et al., 2010a; Dixon et al.,
2007; Ramratan et al., 2012; Tractenberg & Pietrzak, 2011).
Tractenberg and Pietrzak (2011) compared effect sizes on three different measures of IIV
(listed above) for the MMSE and Clock Drawing Test to effect sizes for the total score of these
tests. Effect sizes were based on 500 simulated observations for individuals characterized as
normal, MCI, or AD. For all group comparisons, there were greater IIV effect sizes for the
MMSE than the Clock Drawing test. In addition, stronger ISD effect sizes were present for the
Clock Drawing test while stronger ICV effect sizes for the MMSE were present. IIV was also
indicated to be a stronger predictor of change in Clinical Dementia Rating (a global clinical
measure that assesses overall cognitive functioning) scores. Stronger effect sizes were present
when evaluating IIV in the MMSE and Clock Drawing tests, indicating that IIV measures were
useful as an alternative performance summary (compared to total test scores). While this study
provided preliminary evidence that IIV measures can be used to provide information on test
performance, it did not specifically evaluate IIV measures for their ability to correctly classify
diagnostic group membership. Also, the tests used were not reaction time tasks; rather, they
were estimates of global cognition, a method not typically used in IIV assessment.
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IIV used to Distinguish Cognitive Outcome
Researchers commonly examine IIV using simple and complex multi-block reaction time
tasks among participants in various stages of cognitive decline, including multiple subtypes of
MCI, and mild dementia (Christensen et al., 2005; Dixon et al., 2007; Gorus et al., 2008; Hultsch
et al., 2000). In general, individuals with mild dementia or MCI (with or without amnestic
impairment) have displayed poorer accuracy, higher reaction times, and increased IIV on simple
and complex multi-block reaction time tasks (Christensen et al., 2005; Dixon et al., 2007; Gorus
et al., 2008; Hultsch et al., 2000). Researchers have also suggested that IIV on reaction time
tasks may enhance diagnostic accuracy or the ability to detect neuropathological changes before
rapid change across a range of cognitive domains becomes apparent (Christensen et al., 2005;
Dixon et al., 2007; Gorus et al., 2008; Hultsch et al., 2000).
Christensen et al. (2005) examined older adults (aged 60-64) who were cognitively
impaired compared to healthy older adults without cognitive impairment. The authors calculated
the mean independent variability for reaction time tasks and found greater IIV in the cognitively
impaired group compared to healthy controls, but increased IIV did not uniquely contribute to
diagnostic status. Also, group differences in reaction time tasks were more pronounced for the
simple task rather than the complex task, which was an unexpected finding given that increased
complexity typically correlates with poorer performance (Christensen et al., 2005). The complex
task was a slight variation of the simple task and thus may not have tapped into higher-order
functioning normally reserved for complex tasks. Therefore, performance in the simple task
would generate larger variability than the complex task due to the initial novelty of the task.
Dixon and colleagues (2007) further investigated levels of cognitive impairment (mild
versus moderate), assessing speed across five separate occasions utilizing three multi-block
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reaction time tasks. Cognitively impaired groups were slower and more variable (greater ISD)
than the non-impaired groups, with MCI-moderate more so than the MCI-mild subgroup.
Further, the researchers were able to use these measures to distinguish between the MCI and
non-impaired groups. The authors concluded that neurocognitive resources may be
compromised during the transition from normal aging to mild impairment and that greater IIV
may be indicative of compromised cognition (Dixon et al., 2007).
Gorus and colleagues (2008) found that individuals with AD had greater ICV compared
to aMCI and healthy controls regardless of task complexity, and those with aMCI had greater
ICV only when performing complex tasks—as compared to healthy elderly controls. This may
indicate that task complexity influences performance beyond simple reaction time measurements
(as noted in Christensen et al., 2005), and this should be considered when designing tasks for
aMCI individuals. Accuracy was also examined and was significantly higher for the aMCI and
cognitive healthy groups compared to those with AD, but there was no significant difference
between the aMCI and cognitively healthy groups; accuracy therefore did not contribute
meaningfully to group identification (Gorus et al., 2008).
Ramratan and colleagues (2012) utilized a novel technique to examine IIV withinsession. Using a computer-based repeated-blocks episodic memory task, the researchers
examined episodic memory in addition to reaction time, which was an improvement on extant
research that explored the two modals separately. As expected, the cognitively healthy elderly
group performed better than the aMCI group in terms of both greater accuracy and faster
processing. The researchers also used the unique approach of exploring trajectory of change
across blocks to measure IIV. By doing so, they found that although cognitively healthy elderly
and aMCI had similar trajectories of performance in accuracy, greater IIV in processing speed

22
across blocks in aMCI indicated that IIV in processing speed classified aMCI better than
traditional cognitive measures. The authors did not extend their findings to examine
performance across-session to see if the trajectory of performance was still present over longer
periods of time.

IIV Across-Domains
Allaire and Marsiske (2005) examined within-person IIV in cognitive tests across
multiple testing sessions in cognitively healthy older adults. The researchers investigated IIV
utilizing tests of inductive reasoning, processing speed and memory and found higher IIV to be
positively correlated only between memory and inductive reasoning. IIV across all cognitive
measures were not inter-related suggesting that IIV may not be a consistent phenomenon across
all domains. Allaire and Marsiske (2005) also found within-person performance across-sessions
exhibited low variability for all tasks, while mean level of performance increased across-sessions
for all measures. This suggests adaptive IIV in which there is improvement over time as a result
of repeated assessment and may reflect individuals’ active testing of new performance strategies
(Allaire & Marsiske, 2005). While this study introduced the idea of examining IIV across
different domains, only one test in each domain was examined, therefore not allowing for
generalizability. Additionally, the use of multiple testing occasions as a methodology provided
insight to performance over time, but since the testing was self-administered and not strictly
monitored by the researchers the quality of the data could be questioned.
Kalin and colleagues (2014) examined IIV in accuracy tests within-domain and acrossdomains in healthy controls, MCI and AD. To examine within-domain accuracy, the researchers
used scores from the Letter Fluency task, Stroop test, and Five Point test (a figural fluency task).
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To examine across-domain accuracy, the researchers used scores from the Digit Span, Word List
Learning and Category Fluency task. Results indicated that within-domain, ISD was greater in
the AD group compared to healthy controls, but there was no difference between the AD and
MCI groups. There was also slightly higher ISD in the MCI group compared to healthy controls.
Across-domain ISD was higher in the AD group compared to the MCI and healthy controls but
there was no difference between the healthy controls and MCI groups. These findings suggest
that even at the level of accuracy, differences between groups can be observed, but accuracy
alone is unable to distinguish changes between healthy controls and MCI.
Vaughan and colleagues (2013) investigated IIV across-domains and change in
performance over time to predict risk of MCI and incident dementia in individuals classified as
no impairment, MCI, and probable dementia. In the overall sample, there was no significant
difference in across-domain ISD between individuals with no impairment compared to MCI, but
significant differences were present between individuals with no impairment compared to
probable dementia. Change in performance over time differed significantly between individuals
with no impairment compared to MCI or probable dementia. After controlling for baseline
cognition, IIV across-domain was also predictive of incident dementia, but not MCI. Also,
change over time was predictive of MCI and probable dementia. The authors concluded that the
change in performance over time is particularly important in signaling the risk of incident
cognitive impairment, especially in the early stages (Vaughan et al., 2013).

IIV as a Predictor of Cognitive Outcome
Hultsch and colleagues (2000) used across-block IIV in reaction time tasks to predict
group membership between healthy older adults and older adults with possible/probable AD.
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The AD group had greater ISD and ICV in reaction time across blocks as compared to the
healthy group, but there were no significant difference between groups across multiple testing
sessions. The researchers did not examine accuracy across blocks but did examine accuracy
across-sessions for non-reaction time tasks and found no significant effects between groups.
They also noted that ISD in reaction time across-blocks most consistently predicted group
membership (Hultsch et al., 2000). It would be interesting to observe whether accuracy acrossblocks also differed between groups, thus facilitating the determination of learning and retention
patterns in various older adult subgroups and prediction of group membership.
Bielak and colleagues (2010a) examined IIV on reaction time tasks over multiple
sessions for cognitively impaired and non-impaired individuals. They found that ISD for all
reaction time tasks was able to predict cognitive status change, but only ISD on complex tasks
distinguished between groups. These findings suggested that higher-order cognitive processes
required to complete complex tasks are a reflection of the integrity of the neurological system
and may serve as a sensitive predictor of meaningful cognitive change (Bielak et al., 2010a).
Bielak, Hultsch, Strauss, MacDonald and Hunter (2010b) further investigated IIV acrosssessions to determine whether baseline IIV could be a predictor of subsequent cognitive decline.
Tests were administered annually for four years and evaluated to determine if significant change
in cognition or inconsistency in performance occurred. In general, greater baseline ISD was
associated with declining cognitive performance. Also, baseline ISD, specifically complex task
ISD, was related to later cognitive performance such that as ISD values increased, participants’
subsequent cognitive performance decreased. These findings suggest that baseline ISD acrosssession can be an independent predictor of the development of subsequent cognition decline in
the elderly.
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In conclusion, there is a strong need to improve upon the quantitative assessment of
prodromal AD stages such as MCI and possible pre-MCI conditions. The extant literature
suggests that IIV may be a valuable and sensitive measure to distinguish among cognitively
unimpaired and impaired older adults. Also, research with IIV has demonstrated some strength
in predicting cognitive decline. Within-session and across-domain testing measures have both
provided useful information in characterizing cognition in the elderly. Further research is
required, however, to clarify the role of IIV in cognitive impairment and decline in the elderly.
Ideally, IIV can be used to distinguish early changes that conventional neuropsychological tests
have been unable to capture. To measure the efficacy of IIV as a predictor of cognitive decline
in the elderly, it is necessary to execute a study that utilizes the IIV measure to its full potential.

Current Study
The current research investigated the role of IIV in the prediction of neurodegenerative
cognitive impairment. IIV is thought to be an indicator of neurological integrity where increased
fluctuation in performance may be indicative of brain disturbance or compromised neurological
mechanisms (Bielak et al., 2010a; Hultsch et al., 2000). Short-term fluctuations in performance
could be a marker for long-term cognitive change and potential decline (Bielak et al., 2010b).
Thus, IIV may serve an important role in identifying older adults who are at the greatest risk for
future cognitive decline (Sugarman et al., 2014). Recently, a study by Roalf and colleagues
(2016) examined global neurocognitive performance in addition to across-domain IIV and found
the combination of variables to significantly improved diagnostic classification of MCI
compared to utilizing global neurocognitive performance alone. They suggested that IIV may
reflect domain specific deterioration of cognitive performance and inconsistency across domains
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may be an important signal of overall deterioration of the neural system. Sugarman and
colleagues (2014) examined within-domain IIV in relation to neuropsychological performance
and also found that the combination of IIV and neuropsychological scores improved the
prediction of cognitive decline. In fact, IIV variables alone were able to predict cognitive
decline better than traditional measures alone and could therefore serve as a prognostic indicator
of future cognitive decline (Sugarman et al., 2014). IIV could then be useful if incorporated
within cognitive assessments aimed at detecting subtle changes in performance in older adults
with overall “intact” cognitive functioning and preserved activities of daily living.
For the current study, we examined IIV using two different methods: across multiple
blocks within one testing session (within-session) and within-session across-domains, to examine
the effectiveness of these two methods for early detection in a sample of community-dwelling
older adults who were non-demented at baseline. The primary hypothesis was that IIV withinsession would be a stronger predictor of cognitive impairment than conventional
neuropsychological tests. It was further hypothesized that within-session across-domain
variability would enhance understanding of how cognitive decline manifests in a healthy
population. Additionally, IIV within-session will aid in early detection of cognitive impairment
compared to traditional neuropsychological tests.

Study Rationale & Aims
Overall Objective: To determine whether experimental task intraindividual
variability measures have greater efficacy at characterizing and predicting future MCI
group status than conventional standard task measures. Given the prevalence of AD,
research has focused on developing methods to detect and treat the disease at its earliest point.
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Research described above has shown that there is no “gold standard” for assessing MCI and
determining who will decline from normal cognition to MCI and subsequent AD based on
traditional cognitive tests. A possible alternative to standard tests are tasks that examine
variability in performance over time, which permit the evaluation of change over short periods of
time between cognitively impaired and non-impaired groups. Increases in intraindividual
variability co-vary with cognitive changes occurring within a short period of time therefore
intraindividual variability may be sensitive to even subtle changes of cognitive decline (Bielak et
al. 2010a; Bielak et al., 2010b). Therefore, this type of assessment could enhance detection of
subtle cognitive impairment and prediction of future cognitive decline.
Preliminary analyses to determine whether within-domain baseline experimental
task measures (each block) compared to the within-domain baseline standard task measure
characterized future MCI group status. Prior studies have shown that differences between
MCI and HC groups exist at baseline. We need to first establish that there are baseline
differences between future MCI and HC groups on experimental and standard tasks. We
hypothesized that within each cognitive domain (episodic memory, processing speed, executive
function), future MCI participants would exhibit poorer performance at baseline for the
experimental and standard tasks. We also hypothesized that the experimental task measures (at
each block) would be better at discriminating between future MCI and HC groups compared to
the standard task measure.
Preliminary analyses to determine whether within-domain baseline experimental
task measures (across-block) characterized future MCI group status. Research has shown
that performance on multi-block tasks can be used to monitor change over time (Ramratan et al.,
2012; Tarnanas et al., 2014). Change over time, or trajectory of performance, can be used to
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discriminate between cognitively impaired and non-impaired groups as well. We therefore need
to establish that there is some change of performance over time for the experimental tasks. We
hypothesized within each cognitive domain (episodic memory, processing speed, executive
function), future MCI participants would exhibit poorer across-block performance at baseline.
We also hypothesized that the experimental task measures across-block would be able to
discriminate between future MCI and HC groups.
Aim I: Determine whether within-domain baseline experimental task
intraindividual variability measures compared to the within-domain baseline standard task
measure characterized future MCI group status. Multiple studies have shown that
intraindividual variability can be used to distinguish between impaired and cognitively healthy
groups (Christensen et al., 2005; Dixon et al., 2007; Gorus et al., 2008; Hultsch et al., 2000), but
there has been limited success examining the ability of intraindividual variability to characterize
future cognitive impairment, which may be due to insufficient task complexity that can capture
subtle changes in cognition. We hypothesized that within each cognitive domain (episodic
memory, processing speed, executive function), future MCI participants would exhibit greater
intraindividual variability at baseline for experimental task variability measures. We also
hypothesized that experimental task intraindividual variability measures would be better at
discriminating between MCI and HC groups compared to the standard task measure.
Aim II: Determine whether within-domain baseline experimental task
intraindividual variability measures compared to the within-domain baseline standard task
measure predicted future MCI group status. Prior studies (Bielak et al., 2010a; Hultsch et al.,
2000) have shown that intraindividual variability in reaction time tasks can be utilized to predict
cognitive group membership. We hypothesized that within each cognitive domain (episodic
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memory, processing speed, executive function), baseline experimental task intraindividual
variability measures would be able to predict future MCI group status. We also hypothesized
that baseline experimental task intraindividual variability measures would have greater efficacy
at predicting future MCI group status compared to the standard task measure.
Aim III: Determine whether across-domain baseline experimental task
intraindividual variability measures compared to across-domain baseline standard task
measures characterized future MCI group status. Research has revealed that across-domain
intraindividual variability has the ability to be used to differentiate healthy cognition from
dementia (Kalin et al., 2014; Vaughan et al., 2013). We aimed to discover if across-domain
intraindividual variability could be used to differentiate healthy cognition from MCI. We
hypothesized that across-domain (episodic memory, processing speed, executive function)
intraindividual variability would be able to distinguish between the cognitive outcome groups of
future MCI and HC. We also hypothesized that across-domain baseline experimental task
intraindividual variability measures would be able to classifying future MCI group status better
than across-domain baseline standard task measures.
Aim IV: Determine whether across-domain baseline experimental task
intraindividual variability measures compared to across-domain baseline standard task
measures predicted future MCI group status at different time points. There has been
limited research investigating whether across-domain baseline intraindividual variability can be
used to predict MCI group status at different time points. We investigated cognitive decline at
different time points to determine the earliest intervention stage for MCI. We hypothesized that
across-domain baseline experimental task intraindividual variability measures would be able to
predict MCI at different time points. We also hypothesized that across-domain baseline
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experimental task intraindividual variability measures could be used to predict future MCI group
status sooner than across-domain baseline standard task measures.

Methods
Participants
Participants were a subset of individuals drawn from the Einstein Aging Study (EAS), a
longitudinal community-based study of aging of individuals 70 years and older residing in the
Bronx, NY (Katz et al., 2012). Since 2004, EAS participants have been recruited from the New
York City Board of Elections-registered voter lists for Bronx County. Therefore, the sample was
representative of the community. Introductory letters were sent describing the study to those 70
years and older and these individuals were then contacted by telephone to complete a brief
screening interview (Katz et al., 2012). Potential participants who met initial eligibility were
invited for additional on-site screening to establish final eligibility. Participants who reported
severe sensory loss or medical conditions that would interfere with completion of
neuropsychological assessment were excluded. The EAS was approved by the local institutional
review board (IRB) and all participants provided written informed consent.
Data for the current study were collected as part of the aforementioned cohort study and
represent a subset of the larger EAS study (i.e., those recruited/enrolled into the EAS between
2005 and 2012 who completed their first and second visits). The current study was approved by
the local IRB and participants provided prior written informed consent. There were
approximately 250-400 participants (depending upon analyses).
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Procedure
EAS participants completed a battery of standard neuropsychological tests along with
clinical measures on their first visit. Tasks were administered by highly trained examiners in a
quiet room following standardized protocols. Memory was measured using the Free and Cued
Selective Reminding Test (Grober & Buschke, 1987) and the Logical Memory I subtest from the
WMS-R (Wechsler, 1987). Attention was measured using the Trail Making Test Part A (Army
Individual Test Battery, 1944) and Digit Span subtest of the WAIS-III (Wechsler, 1997).
Executive function was measured using the Trail Making Test Part B (Army Individual Test
Battery, 1944) and the Letter Fluency “FAS” task (Benton & Hamsher, 1989). Visuospatial
construction was measured using the Block Design subtest and the Digit Symbol subtest from the
WAIS-III (Wechsler, 1997). Language was measured using the Category Fluency task (animals,
vegetables, fruits) (Monsch et al., 1992) and the Boston Naming Test (Kaplan, Goodglass &
Weintraub, 1983).
As noted above, standard neuropsychological tests are frequently used to evaluate
cognitive performance and assess future likelihood of progressing to AD (though the field lacks a
single “gold standard” test battery). Therefore, non-demented participants were invited for a
second visit where they completed a battery of experimental computer-based neuropsychological
tasks (these tasks are described in detail below). The computer-based experimental tasks were
administered using a Dell Dimension 4500 computer. The Dell computer ran on a Windows XP,
2002 operating system. The 19-inch monitor and keyboard were situated on a desk 30 inches
high. The monitor was directly in front of participants during the study. The keyboard was in
front of participants only during the exercises that required its use. The Audio-Technica
microphone was held by participants at a 45-degree angle, seven inches away from participants’
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mouths during the speaking exercise. The computerized experimental tasks were displayed and
data recorded using E-Prime software (http://www.pstnet.com/eprime.cfm). The first and second
visits where standard and experimental tasks were administered, respectively, were considered
the baseline measurement stage. On average, there was a four-week time span between the first
and second EAS visits.
Participants also returned for annual follow-up visits that included both standard
neuropsychological test assessment and medical examinations. In addition, participant cognitive
status (healthy, MCI, dementia) was evaluated annually at a diagnostic case conference attended
by a study neurologist and neuropsychologist. Participants who met criteria for dementia, based
on the Diagnosis and Statistical Manual of Mental Disorders, Fourth Edition-Revised (DSM-IVTR; American Psychiatric Association, 2000) were excluded. Due to the longitudinal design of
the EAS cohort and goal of maintaining consistent approaches to measurement, the DSM-IV-TR
was used for clinical diagnosis of dementia where manifestations of cognitive deficits in memory
and one (or more) other cognitive domains must be present. These deficits must cause
significant impairment and represent a significant decline from previous functioning. The course
of impairment is characterized by gradual onset and progressive decline not due to other medical
or psychiatric conditions (American Psychiatric Association, 2000).

Classification Criteria
Participants at baseline were healthy elderly with no cognitive or functional impairment.
Cognitive profile was assessed using error scores on the BIMC. As noted above, the BIMC is a
33-item test that assesses orientation, long-term memory, recall and concentration (Blessed,
Tomlinson & Roth, 1968). Functional ability was assessed using the Lawton Instrumental
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Activities of Daily Living Scale (IADL; Lawton & Brody, 1969). We also assessed depressive
symptoms using the Geriatric Depression Scale-short form (GDS; Sheikh & Yesavage, 1986),
cognitive complaint using the Cognitive Impairment Questionnaire of the Consortium to
Establish a Registry for Alzheimer’s Disease (CERAD; Heyman, Fillenbaum, & Mirra, 1991;
Heyman, Fillenbaum, & Nash, 1997), and independent living skills using the IADL (Lawton &
Brody, 1969). These variables were examined to exclude participants who displayed significant
symptomology (e.g., clinical depression, compromised IADL) that may interfere with task
performance.
Healthy elderly (HC) were classified using a BIMC score of 3 or less (3 or fewer errors)
to indicate no cognitive impairment; and no functional impairment was indicated by the IADL
maximum score of 8 for females and 5 for males. The representative activities for males were
reduced in the IADL therefore leading to a lower maximum score for males compared to females
(Lawton & Brody, 1969). The outcome of interest was cognitive impairment: MCI. Two
classification methods for MCI were employed to prevent diagnostic circularity—i.e., when the
same or similar tests are used both to classify groups and as the primary outcome variables. All
analyses were performed utilizing both MCI classification methods.
Classification of MCI (referred to as EAS MCI) followed the typical methodology
reported in Katz et al. (2012), in which the domains of memory, attention, executive function,
visuospatial construction, and language were assessed utilizing two tests for each domain.
Diagnosis of EAS MCI consisted of objective cognitive impairment (impairment in one or more
cognitive domains, as defined by 1.5 standard deviations below the age-adjusted mean on the
two tests). In addition, participants must have a subjective cognitive complaint and little to no
functional impairment (Albert et al., 2011; Petersen et al., 2014). Subjective cognitive complaint
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and little to no functional impairment was ascertained using items from the self- and informantreport versions of the CERAD (e.g., does the participant have trouble remembering things that
happened recently; does the participant have trouble finding words in carrying on a conversation;
does the participant get lost in familiar surroundings).
For the current study, the alternative outcome of MCI - referred to as Alternate Criteria
MCI (AC MCI) was classified using objective cognitive impairment, subjective cognitive
complaint and little to no functional impairment (Petersen et al., 2014). Objective cognitive
impairment was measured using a BIMC score of 4 to 7 where a rate of change of 4 indicated a
decline from prior non-impaired criteria (Katzman et al., 1988). IADL scores of 7 or 8 for
females and 4 or 5 for males were used to indicate little to no functional impairment per standard
MCI criteria (Albert et al., 2011; Petersen et al., 2014). Notably, some participants with MCI
may have mild difficulty performing complex functional tasks, and a one-point decline in IADL
could capture that change in performance while still preserving daily functionality. Other
participants with MCI may have no noticeable change in functionality; therefore, including no
change in IADL is also acceptable. Subjective cognitive complaint was ascertained using items
on the Functional Assessment Staging (FAST; Reisberg, 1988) as indicated by a stage/score of 2
or 3 (i.e. participant complaints of forgetting location of objects; decreased functioning evident
to close friend/relative).

Study Measures by Cognitive Domain
We now describe both the standard and experimental tasks by cognitive domain. The
standard neuropsychological tests were administered and scored based on published procedures.
The experimental (computer-based) tasks were developed by Sliwinski, Smyth, Hofer and
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Stawski (2006) and Stawski, Sliwinski and Smyth (2006) to measure variability in performance
over short intervals in older adults. Short intervals of performance are measured as blocks (or
trials) of performance and take into account performance for multiple items within that block of
testing. Stawski, Sliwinski and Hofer (2013) and Ramratan et al. (2012) demonstrated that these
experimental tasks provided sensitive measures of intraindividual variability. All experimental
tasks independently measured participant performance per block by recording reaction time and
accuracy.

Episodic Memory Domain Tasks
Standard task: Free and Cued Selective Reminding Task (FCSRT; Grober & Buschke, 1987)
The Free and Cued Selective Reminding Task is a test of verbal cued learning and
memory that uses an encoding phase to maximize learning and ensure deep semantic processing
(Grober & Buschke, 1987). Participants were shown 16 images of objects on a computer screen
and asked to verbally identify each. Participants were then presented with the same 16 images
(four at a time in a 2x2 grid) and asked to identify each item after a categorical prompt. The grid
was removed and participants were asked to recall the item after being given the same
categorical cue. After all items were learned and recalled, participants were then asked to recall
all 16 items in any order (free-recall). For items not recalled, the researcher provided the
category cue for each forgotten item (cued-recall). This procedure was repeated for three blocks
and each block was preceded by 20 seconds of counting backwards as a distractor task. A total
score of 48 was possible for free-recall. If the number of items freely recalled totaled 24 or less,
participants were classified as having memory impairment (Grober & Kawas, 1997; Grober,
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Lipton, Hall, & Crystal, 2000). The total number of items freely recalled (free-recall) was used
for study analyses.

Experimental task: Cued-Recall Retrieval Speed Task (CRRST; Ramratan et al., 2012)
The Cued-Recall Retrieval Speed Task is a computer-administered test of verbal learning
and memory designed to simultaneously measure level and speed of performance over time. The
Cued-Recall Retrieval Speed Task had three phases: learning, cued-recall, and post-cued (Figure
3). In the learning phase, participants were presented with three words on a computer screen: a
cue and two possible matching words (one correct and one incorrect). Participants had 10
seconds to speak the correct matching word for all 16 cues. In the cued-recall phase, participants
were presented with the cue alone and had to recall the correct matching word within a given
time interval (5 seconds). Participants spoke their responses into a microphone, which registered
their reaction time while the examiner recorded whether responses were correct, incorrect, or no
response was given. Regardless of type of response given by participants, the correct matching
word was presented to the participants in the post-cued phase (for 2 seconds), which immediately
followed the cued-phase. Each block of the cued-recall phase included the single presentation of
each of the 16 cues. There was one block of the learning phase and six blocks of the cued-recall
and post-cued phases. Participants provided a total of 96 item responses for the cued-recall
phase, which was the primary outcome measure of interest. The E-Prime program recorded
participants’ reaction times in milliseconds. Reaction time was measured as the time interval
between the display of the cue to participants’ correct response for each item. The examiner
recorded participants’ accuracy by pressing either the 1, 2, 3 or 4 key on the keyboard. A “1”
indicated a correct answer, “2” indicated an incorrect answer, “3” indicated no response and “4”
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indicated a correct answer but an incorrect response time. Accuracy was measured as the percent
correct for each block. Mean reaction time and accuracy for each block was used for study
analyses. Variability was measured as the change in performance in reaction time and accuracy
across the six blocks.

Processing Speed Domain Tasks
Standard task: Trail Making Test Part A (TMT-A; Army Individual Test Battery, 1944)
The Trail Making Test Part A is a task that requires visual scanning and sustained
attention. Participants received a sheet of paper with the numbers 1 through 25 written inside of
circles that appeared to be randomly placed across the page. Participants were asked to draw a
line connecting the circles in numerical order, starting at 1 and ending at 25. Participants were
timed and told to complete the task as quickly as possible without making any errors. Scores
were generated as the time (recorded in seconds) that it took to complete the task. The number of
errors was also recorded. The time recorded was used for study analyses.

Experimental task: Number Match (NM; Sliwinski et al., 2006; Stawski et al., 2006)
The Number Match task is a computer-administered test that examines processing speed
efficiency. Participants were presented with two rows of three-digit numbers and were asked to
decide whether the rows of numbers were the same or different from each other, regardless of the
orientation of the numbers. If there was a difference, then the rows were considered different. If
only the orientation of numbers was different, but all numbers in the top row were present in the
bottom row, then the rows were considered to be the same (Figure 4). Participants pressed the
red key to indicate the rows were different and the green key to indicate that the rows were the
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same. Note that the “backward slash key” had a green sticker over it and the “Z” key had a red
sticker over it. This enabled participants to easily recognize which key to tap to indicate a
response. For this task, there were two blocks and response time was measured by how quickly
participants pressed the green or red key for each item within each block. There were 30 item
responses for each of the two blocks. Participants provided a total of 60 item responses, which
was the primary outcome measure of interest. Accuracy was measured as the percent correct for
each block. The mean reaction time and accuracy for each block was used for study analyses.
Variability was measured as the change in performance in reaction time and accuracy across the
two blocks.

Executive Function Domain Tasks
Standard task: Trail Making Test Part B (TMT-B; Army Individual Test Battery, 1944)
The Trail Making Test Part B is a test that requires mental planning and examines set
shifting and flexibility. Participants received a sheet of paper with circles that had the numbers 1
through 13 and the letters A through M that appeared to be randomly placed across the page.
Participants were asked to draw connecting lines between the circles, alternating between
numbers and letters in order starting at 1 and ending at M (i.e., 1, A, 2, B, 3…L, 13, M).
Participants were timed and told to complete the task as quickly as possible without making any
errors. Scores were generated as the time (recorded in seconds) that it took to complete the task.
The number of errors was also recorded. Time recorded was used for study analyses.
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Experimental task: N-Back 2 (NB2; Sliwinski et al., 2006; Stawski et al., 2006)
The N-Back 2 task is a computer-administered test which requires controlled and
effortful switching of attentional focus from one item to another. Participants were presented
with a single number at a time, continuously (Figure 5). The number was presented for a
maximum of 2 seconds before the next number was displayed. Participants were asked to decide
whether the number they saw was the same or different from two numbers prior. If the number
they saw was identical to the number seen two-before (i.e., 2-back), they pressed the green key;
if the number they saw was different from the number seen two-before (i.e., 2-back), they
pressed the red key. As noted above, the “backward slash key” had a green sticker over it and
the “Z” key had a red sticker over it for this task. For this task, there were three blocks and
response time was measured by how quickly participants pressed the green or red key for each
item in each block. There were 20 responses for each of the three blocks. Participants provided
a total of 60 responses, which was the primary outcome measure of interest. Accuracy was
measured as the percent correct for each block. The mean reaction time and accuracy for each
block was used for study analyses. Variability was measured as the change in performance in
reaction time and accuracy across the three blocks.

Testing Measures and Outcome
The domains of episodic memory, processing speed and executive function were initially
examined separately to determine domain specificity for cognitive impairment. Baseline
performance on the experimental task measures was compared to baseline performance on the
standard task measure. To examine episodic memory, performance on the experimental CRRST
was compared to performance on the standard FCSRT. To examine processing speed,
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performance on the experimental NM task was compared to performance on the standard TMTA. To examine executive function, performance on the experimental NB2 task was compared to
performance on the standard TMT-B. Additional analyses to explore across-domain variability
included tests from all three cognitive domains. For the standard tasks we recorded the number
of items correct and/or time to task completion – from here on will be referred to as standard task
measures. For the experimental tasks we recorded accuracy and reaction time (RT) for multiple
blocks – from here on will be referred to as measures. The repeated-block measurement allowed
for a calculation of central tendency (mean) and variability (intraindividual standard deviation –
ISD; intraindividual coefficient of variation – ICV (ISD divided by mean)) across all blocks
(Table 1). ISD and ICV measures of variability are widely used in studies examining changes in
speed of performance between MCI and cognitively healthy participants (Christensen et al.,
2005; Dixon et al., 2007; Gorus et al., 2008; Hultsch et al., 2000). In addition, basic
demographics such as age, education, gender and race were recorded and included in all
analyses. Tables below describe the sample that comprised each cognitive testing domain.
Classification outcomes (Table 2) were examined using three methods: (1) EAS MCI –
healthy controls (HC) and EAS definition of mild cognitive impairment (MCI); (2) AC MCI –
HC and alternate criteria of MCI; and (3) EAS MCI3 – HC, EAS definition of amnestic MCI
(aMCI) and EAS definition of non-amnestic MCI (naMCI). EAS MCI3 was a partitioning of the
EAS MCI outcome where within the EAS MCI outcome participants classified as MCI could be
aMCI or naMCI. The separation of MCI into aMCI and naMCI in the EAS MCI3 outcome
allowed for greater specificity of impairment and prediction. Incidence of MCI occurred at any
point after the baseline assessment, which ranged from one to ten years after baseline testing.
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Data Analysis
Overall Objective: To determine whether experimental task intraindividual variability
(IIV) measures have greater efficacy at characterizing and predicting MCI compared to
conventional standard task measures. Aims were derived to address the overall objective.
Specific statistics were used to address each aim. Separate descriptive measures (Table 1) were
calculated depending on aim and which domain(s) was/were examined. IBM SPSS statistical
software version 20 (IBM Corp., 2011) was used to calculate descriptive statistics and for withindomain analyses; and R software version 3.2.3 (R Core Team, 2013) was used for across-domain
analyses. Analyses using the R software version 3.2.3 were implemented using the ExPosition
Package (Beaton, Chin Fatt & Abdi, 2014). Also, for each group of participants, corresponding
classification rate of study-criteria healthy controls compared to EAS criteria of healthy/nonimpaired elderly at baseline were calculated. The study-criteria group classification of healthy
controls was implemented to avoid circularity. In addition, each aim was also examined using an
alternate outcome definition in order to avoid circularity.
Preliminary analyses: To determine whether within-domain baseline experimental task
measures compared to the within-domain baseline standard task measure characterized future
MCI group status. Preliminary analyses were performed using a Multivariate Analysis of
Variance (MANOVA) to determine whether within-domain baseline experimental task measures
(at each block) characterized future MCI group status compared to the within-domain baseline
standard task measure. MANOVA examined whether differences between group means were
present. Levene’s test was conducted to test for homogeneity of variance. If Levene’s test was
significant, it was indicative of unequal variances between groups and a more robust test should
be used that does not rely on equal variances. If Levene’s test was significant, the Welch

42
ANOVA was implemented; if Levene’s test was not significant, then we can accept results from
the MANOVA. Post hoc analyses were conducted to determine differences between groups if
there were more than three outcome groups (i.e., EAS MCI3). If variances were homogenous,
Tukey’s HSD, Fisher’s LSD and Bonferroni post hoc tests were used. If variances were nonhomogenous, the Games-Howell post hoc test was used. Preliminary analyses using a Repeated
Measures MANOVA were also conducted to determine whether within-domain repeated blocks
of baseline experimental (across-block) task measures characterized future MCI group status.
Repeated measures MANOVA examined whether differences between group means were
present for related test measures over time. Mauchly’s test of sphericity was used to determine if
variances of the differences between all possible pairs of groups were equal. If the assumption
of sphericity was not met, then the variances were not equal and measures were re-evaluated
using a Greenhouse-Geisser correction, which allowed sphericity to be met. Post hoc analyses
using Tukey’s LSD were executed to examine specific differences between blocks and between
groups over time.
Aim I: To determine whether within-domain baseline experimental task intraindividual
variability (IIV) measures compared to the within-domain baseline standard task measure
characterized future MCI group status. MANOVA was conducted to test the hypothesis that
experimental task IIV measures were able to differentiate between MCI and HC groups
compared to the standard task measure. Levene’s test was conducted to test for homogeneity of
variance. If significant (indicating that variances differed between groups), the Welch ANOVA
was implemented. Partial correlation analyses were used to test for relationships between testing
measures, outcome and demographics. Multivariate Analysis of Covariance (MANCOVA) were
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conducted to test for covariates. MANCOVA examined if covariates were present and if they
influenced differences between group means.
Aim II: To determine whether within-domain baseline experimental task
intraindividual variability (IIV) measures compared to the within-domain baseline standard
task measure predicted future MCI group status. Binomial Logistic Regression analyses were
conducted to test the hypothesis that experimental task IIV measures were able to predict MCI
compared to the standard task measure. Binomial Logistic Regression analyses predicted the
likelihood that the observed outcome occurred based on the testing measures. Nagelkerke R
Square values were calculated to determine the explained variance. The percentage of accuracy
was also calculated. Wald’s test was used to determine the predictive value of each measures.
Aim III: To determine whether across-domain baseline experimental task
intraindividual variability (IIV) measures compared to across-domain baseline standard task
measures characterized future MCI group status. Principal Component Analysis (PCA) with
Inference was conducted to test the hypothesis that across-domain experimental task IIV
measures were able to reveal a pattern of incident MCI compared to standard task measures.
PCA with inference used a data reduction procedure aimed at characterizing the data in terms of
maximum variance explained (Abdi & Williams, 2010b).
Aim IV: To determine whether across-domain baseline experimental task
intraindividual variability (IIV) measures compared to across-domain baseline standard task
measures predicted future MCI group status at different time points. Barycentric Discriminant
Analyses (BADA) with Inference were conducted to test the hypothesis that experimental task
IIV measures were able to significantly separate MCI groups from HC as compared to standard
task measures. BADA with inference maximized group differences, and simultaneously
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determined which measures were responsible for significant differences between outcome groups
(Abdi & Williams. 2010a).

Results
Episodic Memory Domain
Descriptive Statistics
Participants who completed the CRRST and the FCSRT were included in these analyses.
Descriptive statistics for demographics and outcomes are shown in Tables 3 and 4. There were
426 participants who had an approximate average age of 80 years. The sample consisted of
approximately 41% males and was primarily Caucasian (75%). 91.3% of the sample had a high
school degree or higher and 95.1% had GDS classification of non-significant clinical symptoms
of depression. In addition, there was a 90.8% corresponding classification rate of healthy
controls compared to the EAS definition of healthy/non-impaired elderly. Table 5 includes
means and standard deviations for CRRST RT and CRRST accuracy per block by group.

Preliminary analyses to determine whether within-domain baseline experimental task
measures (each block) compared to the within-domain baseline standard task measure
characterized future MCI group status.
MANOVA was performed to examine the differences between HC and MCI (EAS MCI
outcome) based on CRRST RT and CRRST accuracy compared to FCSRT (Figures 6, 7 and 12).
Significant differences were found between groups for each block for CRRST RT (p<0.001),
each block of CRRST accuracy (p<0.05) and FCSRT (F(1,424) = 11.175, p=0.001), indicating
that group differences were present for both CRRST RT and CRRST accuracy and also FCSRT,
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with the MCI group performing worse compared to HC on both tasks. Levene’s test for
homogeneity of variance was not significant for FCSRT, CRRST RT blocks and CRRST
accuracy blocks 5 and 6 (p>0.05) indicating that variances did not differ between groups; it was
significant for CRRST accuracy blocks 1 through 4 (p<0.05) indicating that variances did differ
between groups and we may not be able to trust the above MANOVA results. The Welch
ANOVA, which does not depend on equal variances between groups, was performed and a
significant difference was found in CRRST accuracy blocks 1 through 4 (p<0.01) between the
MCI group and HC. We can conclude that whether variances were equal or unequal, the results
remained the same, which may be due to the large sample sizes utilized.
MANOVA was performed to examine the differences between HC and MCI (AC MCI
outcome) based on CRRST RT and CRRST accuracy compared to FCSRT (Figures 8, 9 and 13).
Significant differences were found between groups for each block of CRRST RT (p<0.01) and
CRRST accuracy blocks 1 through 4 and block 6 (p<0.01), but not CRRST accuracy block 5
(p>0.05) indicating that group differences were present for CRRST RT and most blocks of
CRRST accuracy, with the MCI group performing worse compared to HC. No significant
differences were found between groups for FCSRT (F(1,424)=1.412, p>0.05). Levene’s test for
homogeneity of variance was not significant for FCSRT, CRRST RT blocks 1 through 5 and
CRRST accuracy blocks 1 and 4 (p>0.05); it was significant for CRRST RT block 6 and CRRST
accuracy blocks 2, 3, 5 and 6 (p<0.05). The Welch ANOVA found a significant difference
between groups for CRRST RT block 6 and CRRST accuracy blocks 2, 3 and 6 (p<0.05), but not
block 5 (p>0.05) indicating that even when accounting for unequal variances, the MCI group and
HC did not significantly differ for CRRST accuracy block 5.
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MANOVA was performed to examine the differences between HC, aMCI and naMCI
(EAS MCI3 outcome) based on CRRST RT and CRRST accuracy compared to FCSRT (Figures
10, 11 and 14). Significant differences were found between groups for each block of CRRST RT
(p<0.001), CRRST accuracy blocks 1 through 5 of accuracy (p<0.01), but not block 6 (p>0.05)
and FCSRT (F(2,423) = 19.946, p<0.001), indicating that group differences were present for
FCSRT, CRRST RT and most blocks of CRRST accuracy. Levene’s test for homogeneity of
variance was not significant for FCSRT (p>0.05), CRRST RT blocks 1, 2, 4 through 6 (p>0.05)
and CRRST accuracy blocks 4 through 6 (p>0.05); but was significant for CRRST RT block 3
(p<0.05) and CRRST accuracy blocks 1, 2 and 3 (p<0.05). The Welch ANOVA revealed a
significant difference between groups for CRRST RT block 3 and CRRST accuracy blocks 1, 2
and 3 (p<0.05). Post hoc analyses for measures with homogenous variances found that the aMCI
group was significantly different from HC for FCSRT, CRRST RT blocks 1, 2, 4 through 6 and
CRRST accuracy blocks 4 and 5 (p<0.05) and CRRST accuracy block 6 (when using Fisher’s
LSD test, p<0.05) indicating that the aMCI group performed significantly poorer than HC on
FCSRT and CRRST measures. The naMCI group performed significantly worse than HC for
CRRST RT blocks 2, 5 and 6 (p<0.05) but not blocks 1 or 4 (p>0.05). Although the naMCI
group performed worse for CRRST RT blocks 1, 2, 4, 5 and 6 compared to HC, a significantly
poorer performance was only present for blocks 2, 5 and 6. The naMCI group did not differ
from HC in CRRST accuracy at blocks 4 through 6 (p>0.05) nor FCSRT (p>0.05). The aMCI
group significantly differed from the naMCI group on FCSRT (p<0.05) but not on any CRRST
RT or CRRST accuracy blocks (p>0.05), therefore although the aMCI group performed worse on
the FCSRT compared to the naMCI group, the aMCI group performed similarly to the naMCI
group on the CRRST RT and CRRST accuracy. Post hoc analyses for non-homogenous
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measures found that the aMCI group performed significantly poorer than HC for CRRST RT
block 3 and CRRST accuracy blocks 1, 2 and 3 (p<0.05); the naMCI group was significantly
worse than HC at CRRST RT block 3 (p<0.05) but not at CRRST accuracy blocks 1, 2 and 3
(p>0.05); the aMCI group did not significantly differ from the naMCI group on CRRST RT
block 3 (p>0.05) or CRRST accuracy blocks 1, 2 and 3 (p>0.05).

Preliminary analyses to determine whether within-domain repeated blocks of baseline
experimental task (across-block) measures characterized future MCI group status.
Repeated Measures MANOVA was performed to examine differences between HC and
MCI (EAS MCI outcome) based on repeated CRRST RT and CRRST accuracy over time
(Figures 6 and 7). There was a significant effect of blocks over time (F(10,415) = 89.966,
p<0.001; Pillai’s Trace = 0.684) indicating repeated blocks had an effect on performance over
time. Mauchly’s test for sphericity found that the assumption of sphericity was not met
(p<0.001) indicating that the variances of the differences between all possible pairs of groups
were not equal. When re-evaluated with a Greenhouse-Geisser correction, CRRST RT was
statistically significant (F(3.614, 1532.259) = 245.794, p<0.001) and CRRST accuracy was
statistically significant (F(4.194, 1778.277) = 157.246, p<0.001), thus indicating that regardless
of equal or unequal variances, there was a significant effect of blocks over time for both CRRST
RT and CRRST accuracy. The MCI group performed significantly worse than HC on CRRST
RT (F(1,424) = 22.977, p<0.001) and CRRST accuracy (F(1,424) = 11.545, p=0.001) over time.
Post hoc analyses examining within-subjects repeated contrasts, when taking group membership
into account, found that the MCI group performed significantly worse on CRRST RT at each
block (p<0.001) and on CRRST accuracy at each block (p<0.05) compared to HC. But, the MCI
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group significantly improved in performance for CRRST RT from blocks 1 to 3 (p<0.01) and
from block 5 to 6 (p<0.05) but not between blocks 3 to 5 (p>0.05). And the MCI group
significantly improved in CRRST accuracy from blocks 1 to 5 (p<0.01) but not from blocks 5 to
6 (p>0.05). HC significantly improved in CRRST RT over all blocks (p<0.01) and CRRST
accuracy blocks (p<0.01) except from block 5 to 6 (p>0.05).
Repeated Measures MANOVA was performed to examine differences between HC and
MCI (AC MCI outcome) based on repeated CRRST RT and CRRST accuracy over time (Figures
8 and 9). There was a significant effect of blocks over time (F(10,415) = 73.671, p<0.001;
Pillai’s Trace = 0.640) indicating repeated blocks had an effect on performance over time.
Mauchly’s test for sphericity found that the assumption of sphericity was not met (p<0.001).
When re-evaluated with a Greenhouse-Geisser correction, CRRST RT was statistically
significant (F(3.613, 1532.031) = 196.805, p<0.001) and CRRST accuracy was statistically
significant (F(4.190, 1776.735) = 131.308, p<0.001). The MCI group performed significantly
poorer than HC on CRRST RT (F(1,424) = 13.375, p<0.001) and CRRST accuracy (F(1,424) =
14.976, p<0.001) over time. Post hoc analyses examining within-subjects repeated contrasts,
when taking group membership into account, found that the MCI group performed significantly
poorer on CRRST RT at each block (p<0.01) and CRRST accuracy at each block (p<0.01)
except at block 5 (p>0.05) compared to HC. In addition, the MCI group significantly improved
in performance on CRRST RT from blocks 1 to 4 (p<0.05) but not between blocks 4 to 6
(p>0.05). The MCI group significantly improved in CRRST accuracy from blocks 1 to 3
(p<0.01) and from blocks 4 to 6 (p<0.05) but not from block 3 to 4 (p>0.05). HC significantly
improved in CRRST RT over all blocks (p<0.01) and CRRST accuracy blocks (p<0.01) except
from block 5 to 6 (p>0.05).
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Repeated Measures MANOVA was performed to examine differences between HC,
aMCI and naMCI (EAS MCI3 outcome) based on repeated CRRST RT and CRRST accuracy
over time (Figures 10 and 11). There was a significant effect of blocks over time (F(10,414) =
56.575, p<0.001; Pillai’s Trace = 0.577) indicating repeated blocks had an effect on performance
over time. Mauchly’s test for sphericity found that the assumption of sphericity was not met
(p<0.001). When re-evaluated with a Greenhouse-Geisser correction, CRRST RT was
statistically significantly (F(3.609,1526.443) = 154.496, p<0.001) and CRRST accuracy was
statistically significant (F(4.201,1776.831) = 97.835, p<0.001). Outcome groups significantly
differed in CRRST RT (F(2,423) = 11.591, p<0.001) and CRRST accuracy (F(2,423) = 7.475,
p=0.001). Post hoc analyses revealed the aMCI group performed significantly poorer than HC
(p<0.001) but not the naMCI group (p>0.05) for CRRST RT; and the naMCI group performed
significantly poorer than HC (p<0.05) for CRRST RT. For CRRST accuracy, the aMCI group
performed significantly poorer than HC (p<0.001) but was not significantly different from the
naMCI group (p>0.05); the naMCI group did not significantly differ from HC (p>0.05). Post
hoc analyses examining within-subjects repeated contrasts, when taking group membership into
account, revealed that the aMCI group performed significantly worse than HC on all CRRST RT
blocks (p<0.01) and all CRRST accuracy blocks (p<0.05). The aMCI group did not significantly
differ from the naMCI group on any CRRST RT blocks (p>0.05); but did differ on CRRST
accuracy blocks 1 and 3 (p<0.05) but not for blocks 2, 4, 5 and 6 (p>0.05). The naMCI group
performed significantly poorer on CRRST RT for blocks 2, 3, 5 and 6 (p<0.05) but not for
blocks 1 and 4 (p>0.05) or for any CRRST accuracy blocks (p>0.05) compared to HC. In
addition, the aMCI group significantly improved in CRRST RT from blocks 1 to 3 (p<0.01) and
from blocks 4 to 5 (p<0.01) but not between blocks 3 to 4 (p>0.05) or blocks 5 to 6 (p>0.05).
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The aMCI group significantly improved in CRRST accuracy from blocks 1 to 5 (p<0.05) but not
from block 5 to 6 (p>0.05). The naMCI group significantly improved in CRRST RT from
blocks 1 to 4 (p<0.05) but not from blocks 4 to 6 (p>0.05). The naMCI group significantly
improved in CRRST accuracy from blocks 1 to 3 (p<0.05) and from block 4 to 5 (p<0.05) but
not from blocks 3 to 4 (p>0.05) or 5 to 6 (p>0.05). HC significantly improved in CRRST RT
over all blocks (p<0.01) and CRRST accuracy blocks (p<0.01) except from block 5 to 6
(p>0.05).

Aim I: Determine whether within-domain baseline experimental task IIV measures
compared to the within-domain baseline standard task measure characterized future MCI
group status.
MANOVA was performed to examine differences between HC and MCI (EAS MCI
outcome) based on CRRST RT and CRRST accuracy mean and variability (intraindividual
standard deviation, intraindividual coefficient of variation) compared to FCSRT (Table 6). The
MCI group performed significantly worse compared to HC for FCSRT, CRRST RT mean,
CRRST accuracy mean, CRRST RT ISD, CRRST accuracy ISD, and CRRST accuracy ICV
(p<0.01) but not CRRST RT ICV (p>0.05). Levene’s test for homogeneity of variance was not
significant for FCSRT, CRRST RT mean, CRRST accuracy ISD and CRRST RT ICV (p>0.05)
but was significant for CRRST accuracy mean, CRRST RT ISD and CRRST accuracy ICV
(p<0.05). The Welch ANOVA found a significant difference between groups for CRRST
accuracy mean, CRRST RT ISD and CRRST accuracy ICV (p<0.05) thus indicating that when
unequal variances were accounted for, the MCI group performed worse on all measures
compared to HC.
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Partial correlations were computed to determine the association between the classification
outcome groups of EAS MCI and all testing measures when controlling for demographic
variables (age, gender, ethnicity, education, GDS). Without controlling for demographics, there
were significant correlations between outcome and all testing measures (p<0.05) except CRRST
RT ICV (p>0.05). Controlling for demographics did not affect the relationship between outcome
and testing measures indicating that demographic variables had little influence on the
relationship between outcome and testing measures. MANCOVA testing for covariates showed
there were no significant interactions between age, gender, ethnicity, education, GDS and
outcome (p>0.05).
MANOVA was performed to examine differences between HC and MCI (AC MCI
outcome) based on CRRST RT and CRRST accuracy mean and variability (intraindividual
standard deviation, intraindividual coefficient of variation) compared to FCSRT (Table 6). The
MCI group performed significantly worse compared to HC for CRRST RT mean, CRRST
accuracy mean, CRRST RT ISD, CRRST accuracy ISD, and CRRST accuracy ICV (p<0.01) but
not FCSRT and CRRST RT ICV (p>0.05). Levene’s test for homogeneity of variance was not
significant for FCSRT, CRRST RT mean, CRRST accuracy ISD, CRRST RT ICV and CRRST
accuracy ICV (p>0.05) but was significant for CRRST accuracy mean and CRRST RT ISD
(p<0.05). The Welch ANOVA found a significant difference between groups for CRRST
accuracy mean and CRRST RT ISD (p<0.05), thus indicating that when unequal variances were
accounted for, the MCI group performed worse on most of the mean and variability CRRST
measures compared to HC.
Partial correlations were computed to determine the association between the classification
outcome groups of AC MCI and all testing measures when controlling for demographic variables
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(age, gender, ethnicity, education, GDS). Without controlling for demographics, there were
significant correlations between outcome and all testing measures (p<0.05) except FCSRT and
CRRST RT ICV (p>0.05). Controlling for demographics did not affect the relationship between
outcome and testing measures indicating that demographic variables had little influence on the
relationship between outcome and testing measures. MANCOVA testing for covariates showed
there were no significant interactions between age, ethnicity, education, GDS and outcome
(p>0.05). There was a significant interaction between ethnicity-dichotomized groups (Caucasian
vs. non-Caucasian) and outcome (p<0.05) – when ethnicity was accounted for, outcome groups
were still significantly different (p<0.05). There was a significant interaction between gender
and outcome – when gender was accounted for, outcome groups were still significantly different
(p<0.05).
MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS
MCI3 outcome) based on CRRST RT and CRRST accuracy mean and variability (intraindividual
standard deviation, intraindividual coefficient of variation) compared to FCSRT (Table 6). The
outcome groups were significantly different in FCSRT, CRRST RT mean, CRRST accuracy
mean, CRRST RT ISD, CRRST accuracy ISD, and CRRST accuracy ICV (p<0.05) but not
CRRST RT ICV (p>0.05). Levene’s test for homogeneity of variance was not significant for
FCSRT, CRRST RT mean and CRRST RT ICV (p>0.05) but was significant for CRRST
accuracy mean, CRRST RT ISD, CRRST accuracy ISD and CRRST accuracy ICV (p<0.05).
The Welch ANOVA found a significant difference between groups for CRRST accuracy mean,
CRRST RT ISD, CRRST accuracy ISD and CRRST accuracy ICV (p<0.05). Post hoc analyses
for measures with homogenous variances found that the aMCI group performed significantly
poorer compared to HC for FCSRT and CRRST RT mean (p<0.05) but not CRRST RT ICV
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(p>0.05). The naMCI group performed significantly poorer compared to HC for CRRST RT
mean (p<0.05) but not for FCSRT or CRRST RT ICV (p>0.05). The aMCI group performed
significantly worse than the naMCI group for FCSRT (p<0.05) but not for CRRST RT mean or
CRRST RT ICV (p>0.05). Post hoc analyses for non-homogenous measures found that the aMCI
group performed significantly poorer than HC for CRRST accuracy mean, CRRST RT ISD,
CRRST accuracy ISD and CRRST accuracy ICV (p<0.05). The naMCI group did not
significantly differ from HC on any measure (p>0.05). The aMCI group performed significantly
worse compared to the naMCI group in CRRST accuracy ICV (p<0.05) but not on other
measures (p>0.05).
Partial correlations were computed to determine the association between the classification
outcome group of EAS MCI3 and all testing measures when controlling for demographic
variables (age, gender, ethnicity, education, GDS). Without controlling for demographics, there
were significant correlations between outcome and CRRST RT mean and CRRST accuracy
mean (p<0.05) but no other measures (p>0.05). When controlling for demographics, only the
relationship between outcome and CRRST RT mean remained significant (p<0.05) indicating
that demographic variables had some influence on the relationship between outcome and CRRST
accuracy mean but not CRRST RT mean. MANCOVA testing for covariates showed that there
were no significant interactions between age, gender, ethnicity, education, GDS and outcome
(p>0.05).
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Aim II: Determine whether within-domain baseline experimental task IIV measures
compared to the within-domain baseline standard task measure predicted future MCI
group status.
Binomial Logistic Regression was performed to examine the prediction of HC and aMCI
(EAS aMCI outcome) based on variability (intraindividual standard deviation, intraindividual
coefficient of variation) in CRRST RT and CRRST accuracy compared to FCSRT. A model for
goodness of fit with only FCSRT as a predictor of aMCI was statistically significant, (χ2(1) =
32.262, p<0.001). The model explained 11.7% (Nagelkerke R2) of the variance and correctly
classified 81.2% of cases. When CRRST RT ISD, CRRST accuracy ISD, CRRST RT ICV and
CRRST accuracy ICV were added to the model, it did not significantly differ from the prior
model (χ2(4) = 6.587, p>0.05). Examining all predictors in the model, only FCSRT was
significant (Wald χ2(1) = 19.424, p<0.001), while other variability measures were not (p>0.05).
A model for goodness of fit with CRRST RT ISD, CRRST accuracy ISD, CRRST RT ICV and
CRRST accuracy ICV as predictors of aMCI was statistically significant, (χ2(4) = 18.147,
p=0.001). The model explained 6.7% (Nagelkerke R2) of the variance and correctly classified
80.8% of cases. When FCSRT was added to the model, it was significantly different from the
prior model (χ2(1) = 20.703, p<0.001). Examining all predictors in model, only FCSRT was
significant (Wald χ2(1) = 19.424, p<0.001), while other variability measures were not (p>0.05).
Binomial Logistic Regression was performed to examine the prediction of HC and MCI
(AC MCI outcome) based on variability (intraindividual standard deviation, intraindividual
coefficient of variation) in CRRST RT and CRRST accuracy compared to FCSRT. A model for
goodness of fit with only FCSRT as a predictor of MCI was not statistically significant, (χ2(1) =
1.392, p>0.05). When CRRST RT ISD, CRRST accuracy ISD, CRRST RT ICV and CRRST
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accuracy ICV were added to the model, it was significantly different from the prior model (χ2(4)
= 13.571, p<0.01). The model explained 5.5% (Nagelkerke R2) of the variance and correctly
classified 80.3% of cases. When all predictors in the model were included, none were significant
(p>0.05). The model for goodness of fit with CRRST RT ISD, CRRST accuracy ISD, CRRST
RT ICV and CRRST accuracy ICV as predictors of MCI was statistically significant, (χ2(4) =
14.942, p<0.01). The model explained 5.5% (Nagelkerke R2) of the variance and correctly
classified 80.3% of cases. When FCSRT was added to the model, it was not significantly
different from the prior model (p>0.05). When all predictors in the model were included, none
were significant (p>0.05).

Processing Speed Domain
Descriptive Statistics
Participants who completed NM and TMT-A were included in these analyses.
Descriptive statistics for demographics and outcome are shown in Tables 3 and 7. There were
423 participants who had an approximate average age of 80 years. The sample consisted of
approximately 41% males and was primarily Caucasian (75%). 91.5% of the sample had a high
school degree or higher and 95% had GDS classification of non-significant clinical symptoms of
depression. In addition, there was a 90.8% corresponding classification rate of healthy controls
compared to the EAS definition of healthy/non-impaired elderly. Table 8 includes means and
standard deviations for NM RT and NM accuracy per block per group.
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Preliminary analyses to determine whether within-domain baseline experimental task
measures (each block) compared to the within-domain baseline standard task measure
characterized future MCI group status.
MANOVA was performed to examine differences between HC and MCI (EAS MCI
outcome) based on NM RT and NM accuracy compared to TMT-A (Figures 15, 16 and 21).
There was a significant difference between groups for each block of NM RT (p<0.05) but not for
NM accuracy blocks (p>0.05) or TMT-A (F(1,421) = 0.982, p>0.05) indicating that significant
group differences were present for only NM RT with the MCI group performing significantly
worse for NM RT but not for other measures compared to HC. Levene’s test for homogeneity of
variance was not significant for TMT-A, NM RT blocks or NM accuracy blocks (p>0.05).
MANOVA was performed to examine differences between HC and MCI (AC MCI
outcome) based on NM RT and NM accuracy compared to TMT-A (Figures 17, 18 and 22).
There was a significant difference between groups for NM RT (p=0.001) and NM accuracy
block 1 (p<0.05) but not for NM accuracy block 2 (p>0.05) or TMT-A (F(1,421) = 2.392,
p>0.05) indicating that the MCI group performed significantly worse for NM RT and for NM
accuracy block 1 but not for NM accuracy block 2 nor TMT-A. Levene’s test for homogeneity
of variance was not significant for TMT-A and NM accuracy block 2 (p>0.05); it was significant
for NM RT blocks and NM accuracy block 1 (p<0.05). The Welch ANOVA found a significant
difference between groups for NM RT blocks (p<0.01) but not NM accuracy block 1 (p>0.05)
indicating that when we account for unequal variances the MCI group performed significantly
worse than HC on NM RT blocks, but no other measures.
MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS
MCI3 outcome) based on NM RT and NM accuracy compared to TMT-A (Figures 19, 20 and
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23). There were significant differences between groups for NM RT block 2 (p<0.05) but not for
NM RT block 1 (p>0.05), NM accuracy blocks (p>0.05) or TMT-A (F(2, 420) = 0.841, p>0.05)
indicating that group differences were present for NM RT only at block 2 but not for any blocks
of NM accuracy or TMT-A. Levene’s test for homogeneity of variance was not significant for
TMT-A, NM RT or NM accuracy blocks (p>0.05). Post hoc analyses for homogeneous
measures found that the naMCI group performed significantly worse than HC for NM RT blocks
1 and 2 (p<0.05) and NM accuracy block 2 when using Fisher’s LSD test (p<0.05) but did not
differ in NM accuracy block 1 or TMT-A (p>0.05). The aMCI group was not significantly
different from HC or the naMCI group for TMT-A, NM RT and NM accuracy blocks (p>0.05).

Preliminary analyses to determine whether within-domain repeated blocks of baseline
experimental task (across-block) measures characterized future MCI group status.
Repeated Measures MANOVA was performed to examine differences between HC and
MCI (EAS MCI outcome) based on repeated NM RT and NM accuracy over time (Figures 15
and 16). There was a significant effect of blocks over time (F(2,420) = 8.227, p<0.001; Pillai’s
Trace = 0.038) indicating repeated blocks had an effect on performance over time. Mauchly’s
test for the assumption of sphericity was not necessary because we were examining only two
levels. When sphericity was assumed, NM RT was statistically significant (F(1, 421) = 9.729,
p<0.01) but NM accuracy was not statistically significant (F(1, 421) = 0, p>0.05). The MCI
group performed significantly poorer compared to HC for NM RT (F(1,421) = 5.970, p<0.05)
but not NM accuracy (F(1,421) = 2.539, p>0.05) over time. Post hoc analyses examining withinsubjects repeated contrasts, while taking group membership into account, found that the MCI
group performed significantly worse compared to HC for each block of NM RT (p<0.05) but not
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on any NM accuracy blocks (p>0.05). In addition, the MCI group showed no significant
improvement in NM RT (p>0.05) or NM accuracy over time (p>0.05), while HC improved in
NM RT (p<0.001) but not NM accuracy over time (p>0.05).
Repeated Measures MANOVA was performed to examine differences between HC and
MCI (AC MCI outcome) based on repeated NM RT and NM accuracy over time (Figures 17 and
18). There was a significant effect of blocks over time (F(2,420) = 4.031, p<0.05; Pillai’s Trace
= 0.019) indicating that repeated blocks had an effect on performance over time. When
sphericity was assumed NM RT was statistically significant (F(1, 421) = 6.192, p<0.05) but NM
accuracy was not statistically significant (F(1, 421) = 0.294, p>0.05). The MCI group performed
significantly worse compared to HC in NM RT (F(1,421) = 12.597, p<0.001) but not NM
accuracy (F(1,421) = 1.581, p>0.05) over time. Post hoc analyses examining within-subjects
repeated contrasts, while taking group membership into account, found that the MCI group
performed significantly poorer compared to HC for each block of NM RT (p=0.001) and NM
accuracy block 1 (p<0.05) but did not significantly differ for NM accuracy block 2 (p>0.05). In
addition, the MCI group showed no significant improvement in NM RT (p>0.05) or NM
accuracy over time (p>0.05), while HC improved in NM RT (p<0.001) but not NM accuracy
over time (p>0.05).
Repeated Measures MANOVA was performed to examine differences between HC,
aMCI and naMCI (EAS MCI3 outcome) based on repeated NM RT and NM accuracy over time
(Figures 19 and 20). There was a significant effect of blocks over time (F(2,419) = 7.133,
p=0.001; Pillai’s Trace = 0.033) indicating repeated blocks had an effect on performance over
time. When sphericity was assumed, NM RT was statistically significant (F(1,420) = 5.337,
p<0.05) while NM accuracy was not statistically significant (F(1,420) = 0.658, p>0.05).
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Outcome groups significantly differed in NM RT (F(2,420) = 3.254, p<0.05) but not NM
accuracy (F(2,420) = 1.973, p>0.05). Post hoc analyses examining within-subjects repeated
contrasts, while taking group membership into account, found that the naMCI group performed
significantly worse compared to HC on all NM RT blocks and NM accuracy block 2 (p<0.05)
but not NM accuracy block 1 (p>0.05). The aMCI group was not significantly different from HC
or the naMCI group on any NM RT or NM accuracy blocks (p>0.05). In addition, the naMCI
group showed no improvement over time in NM RT (p>0.05) or NM accuracy (p>0.05), the
aMCI group showed no significant improvement in NM RT (p>0.05) or NM accuracy over time
(p>0.05), while HC improved in NM RT (p<0.001) but not NM accuracy over time (p>0.05).

Aim I: Determine whether within-domain baseline experimental task IIV measures
compared to the within-domain baseline standard task measure characterized future MCI
group status.
MANOVA was performed to examine differences between HC and MCI (EAS MCI
outcome) based on NM RT and NM accuracy mean and variability (intraindividual standard
deviation, intraindividual coefficient of variation) compared to TMT-A (Table 9). The MCI
group performed significantly worse compared to HC for NM RT mean and NM RT ISD
(p<0.05) but not TMT-A, NM accuracy mean, NM accuracy ISD, NM RT ICV and NM
accuracy ICV (p>0.05). Levene’s test for homogeneity of variance was not significant for TMTA, NM RT mean, NM accuracy mean, and NM RT ICV (p>0.05) but was significant for NM RT
ISD, NM accuracy ISD and NM accuracy ICV (p<0.05). The Welch ANOVA found no
significant difference between groups for NM RT ISD, NM accuracy ISD and NM accuracy ICV
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(p>0.05). Thus, when unequal variances were accounted for, the MCI group performed worse
only on NM RT mean compared to HC.
Partial correlations were computed to determine the association between the classification
outcome group of EAS MCI and all testing measures when controlling for demographic
variables (age, gender, ethnicity, education, GDS). Without controlling for demographics, there
were significant correlations between outcome and NM RT mean and NM RT ISD (p<0.05) but
no other variables (p>0.05). When controlling for demographics, the relationship between
outcome and NM RT mean and NM RT ISD were no longer significant (p>0.05) indicating that
demographic variables had a strong influence on the relationship between outcome and testing
measures. MANCOVA testing for covariates found no significant interactions between age,
gender, education, GDS and outcome (p>0.05). There was a significant interaction between
ethnicity and outcome – when ethnicity was accounted for outcome groups were no longer
significantly different (p>0.05), thus after adjusting for ethnicity as a covariate, there was no
longer a difference between outcome groups.
MANOVA was performed to examine differences between HC and MCI (AC MCI
outcome) based on NM RT and NM accuracy mean and variability (intraindividual standard
deviation, intraindividual coefficient of variation) compared to TMT-A (Table 9). The MCI
group performed significantly worse than HC in NM RT mean (p<0.05) but not TMT-A, NM
accuracy mean, NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV (p>0.05).
Levene’s test for homogeneity of variance was not significant for TMT-A, NM accuracy mean,
NM accuracy ISD, NM RT ICV and NM accuracy ICV (p>0.05) but was significant for NM RT
mean and NM RT ISD (p<0.05). The Welch ANOVA found a significant difference between
groups for NM RT mean (p<0.05) but not NM RT ISD (p>0.05).
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Partial correlations were computed to determine the association between the classification
outcome group of AC MCI and all testing measures when controlling for demographic variables
(age, gender, ethnicity, education, GDS). Without controlling for demographics, there was a
significant correlation only between outcome and NM RT mean (p<0.05) but no other measures
(p>0.05). When controlling for demographics, the relationship between outcome and NM RT
mean remained significant (p<0.05) indicating that demographic variables had little influence on
the relationship between outcome and testing measures. MANCOVA testing for covariates
found no significant interactions between age, gender, ethnicity, education, GDS and outcome
(p>0.05).
MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS
MCI3 outcome) based on NM RT and NM accuracy mean and variability (intraindividual
standard deviation, intraindividual coefficient of variation) compared to TMT-A (Table 9).
Outcome groups significantly differed for NM RT mean (p<0.05) but not TMT-A, NM accuracy
mean, NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV (p>0.05). Levene’s
test for homogeneity of variance was not significant for TMT-A, NM RT mean and NM
accuracy mean (p>0.05) but was significant for NM RT ISD, NM accuracy ISD, NM RT ICV
and NM accuracy ICV (p<0.05). The Welch ANOVA found no significant differences between
groups for NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV (p>0.05). Post
hoc analyses for homogenous measures found that the naMCI group performed significantly
worse compared to HC for NM RT mean when using Fisher’s LSD test (p<0.05) but did not
significantly differ on TMT-A or NM accuracy mean (p>0.05). The naMCI group did not
significantly differ from the aMCI group for TMT-A, NM RT mean or NM accuracy mean
(p>0.05). The aMCI group did not significantly differ from HC for TMT-A, NM RT mean or
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NM accuracy mean (p>0.05). Post hoc analyses for non-homogenous measures found that the
naMCI group did not significantly differ from aMCI or HC for NM RT ISD, NM accuracy ISD,
NM RT ICV and NM accuracy ICV (p>0.05); aMCI did not significantly differ from HC on any
measure (p>0.05).
Partial correlations were computed to determine the association between the classification
outcome groups of EAS MCI3 and all testing measures when controlling for demographic
variables (age, gender, ethnicity, education, GDS). Without controlling for demographics, there
were significant correlations between outcome and NM RT mean and NM RT ISD (p<0.05) but
no other measures (p>0.05). When controlling for demographics, only the relationship between
outcome and NM RT ISD remained significant (p<0.05) indicating that demographic variables
had an influence on the relationship between outcome and NM RT mean but not NM RT ISD.
MANCOVA testing for covariates found no significant interactions between age, gender,
ethnicity, education, GDS and outcome (p>0.05).

Aim II: Determine whether within-domain baseline experimental task IIV measures
compared to the within-domain baseline standard task measure predicted future MCI
group status.
Binomial Logistic Regression was performed to examine the prediction of HC and
naMCI (EAS naMCI outcome) based on variability (intraindividual standard deviation,
intraindividual coefficient of variation) in NM RT and NM accuracy compared to TMT-A. A
model for goodness of fit with only TMT-A as a predictor of naMCI was not statistically
significant, (χ2(1) = 1.310, p>0.05). When NM RT ISD, NM accuracy ISD, NM RT ICV and
NM accuracy ICV were added to the model, it did not significantly differ from the prior model
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(χ2(4) = 1.966, p>0.05). A model for goodness of fit with NM RT ISD, NM accuracy ISD, NM
RT ICV and NM accuracy ICV as predictors of naMCI was not statistically significant, (χ2(4) =
2.231, p>0.05). When TMT-A was added to the model, it was not significantly different from
the prior model (χ2(1) = 1.045, p>0.05). A model for goodness of fit with NM RT mean, NM
accuracy mean, NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV as
predictors of naMCI was not statistically significant, (χ2(6) = 7.808, p>0.05). Examining all
predictors in the model, only NM accuracy mean was significant (Wald χ2(1) = 4.469, p<0.05),
while other measures were not (p>0.05). When TMT-A was added to the model, it was not
significantly different from the prior model (χ2(1) = 0.164, p>0.05). Examining all predictors in
the model, only NM accuracy mean was significant (Wald χ2(1) = 4.221, p<0.05), while other
measures were not (p>0.05).
Binomial Logistic Regression was performed to examine the prediction of HC and MCI
(AC MCI outcome) based on variability (intraindividual standard deviation, intraindividual
coefficient of variation) in NM RT and NM accuracy compared to TMT-A. A model for
goodness of fit with only TMT-A as a predictor of MCI was not statistically significant (χ2(1) =
2.191, p>0.05). When NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV
were added to the model, it was not significantly different from the prior model (χ2(4) = 8.569,
p>0.05). A model for goodness of fit with NM RT ISD, NM accuracy ISD, NM RT ICV and
NM accuracy ICV as predictors of MCI was statistically significant, (χ2(4) = 10.265, p<0.05).
The model explained 3.8% (Nagelkerke R2) of the variance and correctly classified 80.1% of
cases. Examining all predictors in model, NM RT ISD (Wald χ2(1) = 6.977, p<0.01) and NM
RT ICV (Wald χ2(1) = 4.929, p<0.05) were significant while other measures were not significant
(p>0.05). When TMT-A was added to the model, it was not significantly different from the prior
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model (χ2(1) = 0.495, p>0.05); and only NM RT ISD remained a significant predictor (Wald
χ2(1) = 5.423, p<0.05). A model for goodness of fit with NM RT mean, NM accuracy mean,
NM RT ISD, NM accuracy ISD, NM RT ICV and NM accuracy ICV as predictors of MCI was
statistically significant, (χ2(6) = 17.299, p<0.01). The model explained 6.4% (Nagelkerke R2) of
the variance and correctly classified 80.9% of cases. Examining all predictors in the model, NM
RT mean (Wald χ2(1) = 3.910, p<0.05) and NM accuracy mean were significant (Wald χ2(1) =
4.042, p<0.05), while other measures were not (p>0.05). When TMT-A was added to the model,
it was not significantly different from the prior model (χ2(1) = 0.001, p>0.05). Examining all
predictors in the model, only NM accuracy mean remained significant (Wald χ2(1) = 4.014,
p<0.05), while other measures were not (p>0.05).

Executive Function Domain
Descriptive Statistics
Participants who completed NB2 and TMT-B were included in these analyses.
Descriptive statistics for demographics and outcome are shown in Tables 3 and 10. There were
248 participants who had an approximate average age of 80 years. The smaller sample size is
due to the implementation of the NB2 task into the normal EAS testing protocol one year after
other measures. The current sample consisted of approximately 42% males and was primarily
Caucasian (76%). 91.1% of the sample had a high school degree or higher and 96.8% had GDS
classification of non-significant clinical symptoms of depression. In addition, there was a 94%
corresponding classification rate of healthy controls compared to the EAS definition of
healthy/non-impaired elderly. Table 11 includes means and standard deviations for NB2 RT and
NB2 accuracy per block per group.
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Participants who did not have executive function domain testing did not significantly
differ in age, gender and education (p>0.05) from those who had such testing. Participants with
executive function testing had a slightly greater distribution of Caucasian individuals and
displayed fewer depressive symptoms but were not significantly different (p>0.05) from those
without executive function testing. In addition, at follow-up, participants with executive
function testing had fewer incidences of MCI compared to participants without executive
function testing but were not significantly different (p>0.05). Descriptive statistics for
demographics and outcome are shown in Table 3.

Preliminary analyses to determine whether within-domain baseline experimental task
measures (each block) compared to the within-domain baseline standard task measure
characterized future MCI group status.
MANOVA was performed to examine differences between HC and MCI (EAS MCI
outcome) based on NB2 RT and NB2 accuracy compared to TMT-B (Figures 24, 25 and 30).
The MCI group performed significantly worse compared to HC on NB2 RT block 1 (p<0.05)
and NB2 accuracy block 1 (p<0.05) but there were no significant differences between groups for
NB2 RT blocks 2 and 3 (p>0.05), NB2 accuracy blocks 2 and 3 (p>0.05) and TMT-B (F(1,246)
= 0.117, p>0.05); indicating that group differences were only present at the beginning of NB2
RT and NB2 accuracy. Levene’s test for homogeneity of variance was significant for NB2
accuracy block 1 (p>0.05) but no other blocks of NB2 accuracy or NB2 RT or TMT-B (p>0.05).
The Welch ANOVA found a significant difference between groups for NB2 accuracy block 1
(p<0.05), indicating that whether variances were equal or unequal, the MCI group performed
significantly worse than HC on NB2 RT block 1 and NB2 accuracy block 1.
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MANOVA was performed to examine differences between HC and MCI (AC MCI
outcome) based on NB2 RT and NB2 accuracy compared to TMT-B (Figures 26, 27 and 31).
The MCI group performed significantly worse than HC on NB2 RT blocks 1 and 3 (p<0.05) and
NB2 accuracy blocks 1 and 3 (p<0.05) but not for NB2 RT block 2 or NB2 accuracy block 2
(p>0.05) indicating that group differences were present for both NB2 RT and NB2 accuracy at
the beginning and end of the session, but not in the middle. No significant differences were
found between groups for TMT-B (F(1,246) = 0.076, p>0.05). Levene’s test for homogeneity of
variance was not significant for NB2 RT block 1, NB2 accuracy blocks 1 and 2 and TMT-B
(p>0.05); it was significant for NB2 RT blocks 2 and 3 and NB2 accuracy block 3 (p<0.05). The
Welch ANOVA found a significant difference between groups for NB2 accuracy block 3
(p<0.05) but not for NB2 RT blocks 2 and 3 (p>0.05). Therefore, when we account for unequal
variances, the MCI group performed significantly worse compared to HC only for NB2 RT block
1 and NB2 accuracy blocks 1 and 3.
MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS
MCI3 outcome) based on NB2 RT and NB2 accuracy compared to TMT-B (Figures 28, 29 and
32). There were no significant differences between groups for TMT-B (F(2,245) = 0.063,
p>0.05), or any NB2 RT blocks (p>0.05) or any NB2 accuracy blocks (p>0.05) indicating that
group differences were not present for TMT-B, NB2 RT and NB2 accuracy. Levene’s test for
homogeneity of variance was not significant for TMT-B, any NB2 RT blocks and NB2 accuracy
blocks 1 and 2 (p>0.05); it was significant for NB2 accuracy block 3 (p<0.05). The Welch
ANOVA found no significant difference between groups for NB2 accuracy block 3 (p>0.05).
Post hoc analyses for measures with homogenous variances found that the naMCI group did not
significantly differ from the aMCI group or HC for TMT-B, any NB2 RT blocks and NB2
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accuracy blocks 1 and 2 (p>0.05). The aMCI group was not significantly different from HC for
any measure (p>0.05). Post hoc analyses for non-homogenous measures found the naMCI group
was not significantly different from the aMCI or HC on accuracy block 3 (p>0.05); aMCI group
was not significantly different from HC for NB2 accuracy block 3 (p>0.05). Therefore, when we
account for unequal variances, there were no significant differences between the groups.

Preliminary analyses to determine whether within-domain repeated blocks of baseline
experimental task (across-block) measures characterized future MCI group status.
Repeated Measures MANOVA was performed to examine differences between HC and
MCI (EAS MCI outcome) based on repeated NB2 RT and NB2 accuracy over time (Figures 24
and 25). There was a significant effect of blocks over time (F(4,243) = 16.233, p<0.001; Pillai’s
Trace = 0.211) indicating that repeated blocks had an effect on performance over time.
Mauchly’s test for sphericity found that the assumption of sphericity was not met (p<0.001).
When re-evaluated with a Greenhouse-Geisser correction, NB2 RT was not statistically
significantly (F(1.405, 345.595) = 0.497, p>0.05) but NB2 accuracy was statistically significant
(F(1.509, 371.231) = 12.401, p<0.001). The MCI group was not significantly different from HC
in NB2 RT (F(1,246) = 2.464, p>0.05) and NB2 accuracy (F(1,246) = 3.248, p>0.05) over time.
Post hoc analyses examining within-subjects repeated contrasts, while taking group membership
into account, showed that the MCI group performed significantly worse compared to HC for
NB2 RT block 1 (p<.05) but not blocks 2 or 3 (p>0.05). The MCI group performed significantly
worse compared to HC for NB2 accuracy block 1 (p<0.05) but not blocks 2 or 3 (p>0.05). In
addition, the MCI group did not significantly improve over time for NB2 RT (p>0.05). The MCI
group performed significantly poorer in NB2 accuracy from block 1 to 2 (p<0.05) but did not
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significantly improve or worsen from block 2 to 3 (p>0.05). When we compared NB2 accuracy
performance at the beginning compared to the end of the task, the MCI group performed
significantly worse at block 3 compared to block 1 (p<0.05) indicating the MCI group had poorer
performance over time for NB2 accuracy. HC did not significantly improve in NB2 RT over
time (p>0.05). HC performed significantly worse in NB2 accuracy from block 1 to 2 (p<0.01)
but did not significantly improve or worsen in performance from block 2 to 3 (p>0.05). When
we compared NB2 accuracy performance at the beginning compared to the end of the task, HC
performed significantly worse at block 3 compared to block 1 (p<0.05) indicating HC had poorer
performance over time for NB2 accuracy.
Repeated Measures MANOVA was performed to examine differences between HC and
MCI (AC MCI outcome) based on repeated NB2 RT and NB2 accuracy over time (Figures 26
and 27). There was a significant effect of blocks over time (F(4,243 = 14.673, p<0.001; Pillai’s
Trace = 0.195), indicating that repeated blocks had an effect on performance over time.
Mauchly’s test for sphericity found that the assumption of sphericity was not met (p<0.001).
When re-evaluated with a Greenhouse-Geisser correction, NB2 RT was not statistically
significantly (F(1.405, 345.556) = 0.122, p>0.05) but NB2 accuracy was statistically significant
(F(1.508, 370.845) = 15.027, p<0.001) indicating that the effect of blocks was only present for
NB2 accuracy. The MCI group performed significantly poorer compared to HC for NB2 RT
(F(1,246) = 5.541, p<0.05) and NB2 accuracy (F(1,246) = 8.481, p<0.01) over time. Post hoc
analyses examining within-subjects repeated contrasts, while taking group membership into
account, showed that the MCI group performed significantly worse than HC for NB2 RT and
NB2 accuracy blocks 1 and 3 (p<0.05) but not block 2 (p>0.05). In addition, the MCI group did
not significantly improve over time in NB2 RT (p>0.05). The MCI group performed

69
significantly worse in NB2 accuracy (p<0.05) over time. HC did not significantly improve from
NB2 RT block 1 to 2 (p>0.05) but did improve from block 2 to 3 (p<0.05). HC performed
significantly worse in NB2 accuracy from block 1 to 2 (p<0.05) but did not improve or worsen
from block 2 to 3 (p>0.05). When we compared NB2 accuracy performance at the end of task
compared to the beginning, HC performed significantly worse at block 3 compared to block 1
(p<0.05) indicating HC had poorer performance over time.
Repeated Measures MANOVA was performed to examine differences between HC,
aMCI and naMCI (EAS MCI3 outcome) based on repeated NB2 RT and NB2 accuracy over
time (Figures 28 and 29). There was a significant effect of blocks over time (F(4,242) = 11.414,
p<0.001; Pillai’s Trace = 0.159) indicating that repeated blocks had an effect on performance
over time. Mauchly’s test for sphericity found that the assumption of sphericity was not met
(p<0.001). When re-evaluated with a Greenhouse-Geisser correction, NB2 RT was not
statistically significantly (F(1.405, 344.134) = 0.571, p>0.05) while NB2 accuracy was
statistically significant (F(1.506,369.074) = 7.922, p=0.001). Outcome groups did not
significantly differ in NB2 RT (F(2,245) = 1.386, p>0.05) nor NB2 accuracy (F(2,245) = 1.668,
p>0.05). Post hoc analyses examining within-subjects repeated contrasts, while taking group
membership into account, found that the naMCI group was not significantly different from the
aMCI or HC groups for any NB2 RT or NB2 accuracy blocks (p>0.05). The aMCI group did not
significantly differ from HC for any NB2 RT or NB2 accuracy blocks (p>0.05). In addition, the
naMCI group did not significantly improve in NB2 RT or NB2 accuracy over time (p>0.05).
The aMCI group did not significantly improve in NB2 RT (p>0.05), but did perform poorer at
the end of NB2 accuracy compared to the beginning (p<0.05) indicating that the aMCI group had
poorer performance over time for NB2 accuracy. HC did not significantly improve in NB2 RT
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(p>0.05) over time. HC performed significantly poorer from NB2 accuracy block 1 to 2
(p<0.05) and did not improve or worsen from block 2 to 3 (p>0.05). When we compare NB2
accuracy performance at the end compared to the beginning of the task, HC performed
significantly worse at block 3 compared to block 1 (p<0.05) indicating HC had poorer
performance over time.

Aim I: Determine whether within-domain baseline experimental task IIV measures
compared to the within-domain baseline standard task measure characterized future MCI
group status.
MANOVA was performed to examine differences between HC and MCI (EAS MCI
outcome) based on NB2 RT and NB2 accuracy mean and variability (intraindividual standard
deviation, intraindividual coefficient of variation) compared to TMT-B (Table 12). The MCI
group performed significantly worse than HC for NB2 RT ICV (p<0.05) but not TMT-B, NB2
RT mean, NB2 accuracy mean, NB2 RT ISD, NB2 accuracy ISD and NB2 accuracy ICV
(p>0.05). Levene’s test for homogeneity of variance was not significant for TMT-B, NB2 RT
mean, NB2 accuracy mean, NB2 RT ISD, NB2 accuracy ISD and NB2 accuracy ICV (p>0.05)
but was significant for NB2 RT ICV (p<0.05). The Welch ANOVA found no significant
difference between groups for NB2 RT ICV (p>0.05), indicating that when unequal variances
were accounted for, there were no significant differences between groups.
Partial correlations were computed to determine the association between the classification
outcome groups of EAS MCI and all testing measures when controlling for demographic
variables (age, gender, ethnicity, education, GDS). Without controlling for demographics, there
were significant correlations between outcome and NB2 RT ICV (p<0.05) but no other measures
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(p>0.05). When controlling for demographics, the relationship between outcome and NB2 RT
ICV was no longer significant (p>0.05) indicating that demographic variables had a strong
influence on the relationship between outcome and testing measures. MANCOVA testing for
covariates found no significant interactions between age, gender, ethnicity, education, GDS and
outcome (p>0.05).
MANOVA was performed to examine differences between HC and MCI (AC MCI
outcome) based on NB2 RT and NB2 accuracy mean and variability (intraindividual standard
deviation, intraindividual coefficient of variation) compared to TMT-B (Table 12). The MCI
group performed significantly worse compared to HC for NB2 RT mean, NB2 accuracy mean,
NB2 RT ISD and NB2 RT ICV (p<0.05) but not TMT-B, NB2 accuracy ISD and NB2 accuracy
ICV (p>0.05). Levene’s test for homogeneity of variance was not significant for TMT-B and
NB2 accuracy mean (p>0.05) but was significant for NB2 RT mean, NB2 RT ISD, NB2
accuracy ISD, NB2 RT ICV and NB2 accuracy ICV (p<0.05). The Welch ANOVA found a
significant difference between groups for NB2 RT mean (p<0.05) but not RT ISD, accuracy ISD,
RT ICV and accuracy ICV (p>0.05). Therefore, after accounting for unequal variances, the MCI
group was significantly different from HC for only NB2 RT mean and NB2 accuracy mean.
Partial correlations were computed to determine the association between the classification
outcome groups of AC MCI and all testing measures when controlling for demographic variables
(age, gender, ethnicity, education, GDS). Without controlling for demographics, there were
significant correlations between outcome and NB2 RT mean, NB2 accuracy mean, NB2 RT ISD
and NB2 RT ICV (p<0.05) but no other measures (p>0.05). When controlling for demographics,
the relationship between outcome and NB2 RT mean and NB2 accuracy mean were still
significant (p<0.05) but the relationship between outcome and NB2 RT ISD and NB2 RT ICV
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was no longer significant (p>0.05) indicating that demographic variables had some influence on
the relationship between outcome and testing measures – specifically variability measures.
MANCOVA testing for covariates found no significant interactions between age, gender,
ethnicity, education, GDS and outcome (p>0.05).
MANOVA was performed to examine differences between HC, aMCI and naMCI (EAS
MCI3 outcome) based on NB2 RT and NB2 accuracy mean and variability (intraindividual
standard deviation, intraindividual coefficient of variation) compared to TMT-B (Table 12).
There were no significant differences between groups for TMT-B, NB2 RT mean, NB2 accuracy
mean, NB2 RT ISD, NB2 accuracy ISD and NB2 accuracy ICV (p>0.05) but there was a
significant difference between groups for NB2 RT ICV (p<0.05). Levene’s test for homogeneity
of variance was not significant for TMT-B, NB2 RT mean, NB2 accuracy mean, NB2 accuracy
ISD and NB2 accuracy ICV (p>0.05) but was significant for NB2 RT ISD and NB2 RT ICV
(p<0.05). The Welch ANOVA found no significant difference between groups for NB2 RT ISD
and NB2 RT ICV (p>0.05), thus indicating that when unequal variances were accounted for,
groups were no longer significantly different. Post hoc analyses for measures with homogenous
variances found that the naMCI was not significantly different from the aMCI or HC groups for
TMT-B, NB2 RT mean, NB2 accuracy mean, NB2 accuracy ISD and NB2 accuracy ICV
(p>0.05); the aMCI group did not significantly differ from HC for any measure (p>0.05). Post
hoc analyses for measures with non-homogenous variances found the naMCI group was not
significantly different from the aMCI or HC groups for NB2 RT ISD and NB2 RT ICV (p>0.05);
the aMCI group was not significantly different from HC for any measure (p>0.05).
Partial correlations were computed to determine the association between the classification
outcome groups of EAS MCI3 and all testing measures when controlling for demographic
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variables (age, gender, ethnicity, education, GDS). Without controlling for demographics, there
were no significant correlations between outcome and testing measures (p>0.05). MANCOVA
testing for covariates found no significant interactions between age, gender, ethnicity, education,
GDS and outcome. There was a significant interaction between ethnicity dichotomized groups
(Caucasian vs. non-Caucasian) and outcome – when ethnicity was accounted for, outcome
groups were not significantly different (p>0.05).

Aim II: Determine whether within-domain baseline experimental task IIV measures
compared to the within-domain baseline standard task measure predicted future MCI
group status.
Binomial Logistic Regression was performed to examine the prediction of HC and
naMCI (EAS naMCI outcome) based on variability (intraindividual standard deviation,
intraindividual coefficient of variation) in NB2 RT and NB2 accuracy compared to TMT-B. A
model for goodness of fit with only TMT-B as a predictor of naMCI was not statistically
significant, (χ2(1) = 0.011, p>0.05). When NB2 RT ISD, NB2 accuracy ISD, NB2 RT ICV and
NB2 accuracy ICV were added to the model, it did not significantly differ from the prior model
(χ2(4) = 2.714, p>0.05). A model for goodness of fit with NB2 RT ISD, NB2 accuracy ISD,
NB2 RT ICV and NB2 accuracy ICV as predictors of naMCI was not statistically significant,
(χ2(4) = 2.715, p>0.05). When TMT-B was added to the model, it was not significantly different
from the prior model (χ2(1) = 0.010, p>0.05).
Binomial Logistic Regression was performed to examine the prediction of HC and MCI
(AC MCI outcome) based on variability (intraindividual standard deviation, intraindividual
coefficient of variation) in NB2 RT and NB2 accuracy compared to TMT-B. A model for
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goodness of fit with only TMT-B as a predictor of MCI was not statistically significant, (χ2(1) =
0.094, p>0.05). When NB2 RT ISD, NB2 accuracy ISD, NB2 RT ICV and NB2 accuracy ICV
were added to the model, it was not significantly different from the prior model (χ2(4) = 5.499,
p>0.05). A model for goodness of fit with NB2 RT ISD, NB2 accuracy ISD, NB2 RT ICV and
NB2 accuracy ICV as predictors of MCI was not statistically significant, (χ2(4) = 5.562, p>0.05).
When TMT-B was added to the model, it was not significantly different from the prior model
(χ2(2) = 12.747, p<0.05). When NB2 RT mean and NB2 accuracy mean were added to the
model, it was significantly different from the prior model (χ2(4) = 5.499, p>0.05). The model
explained 11.7% (Nagelkerke R2) of the variance and correctly classified 81.5% of cases.
Examining all predictors in the model, NB2 RT mean (Wald χ2(1) = 5.101, p<0.05) and NB2
accuracy mean were significant (Wald χ2(1) = 6.317, p<0.05), while other measures were not
(p>0.05).

Across-Domain
Descriptive Statistics
Participants who completed the CRRST, NM, NB2, FCSRT, TMT-A and TMT-B were
included in these analyses. Descriptive statistics for demographics and outcome are shown in
Table 3 under the heading for the executive function domain. Principle component analyses
(PCA) and Barycentric discriminant analyses (BADA) were executed and initial results indicated
a possible outlier – which was then removed for the following analyses and results.
Additionally, the intraindividual coefficient of variation was strongly correlated with the
intraindividual standard deviation and indicated they were redundant variables; therefore, the
intraindividual coefficient of variation was removed from the following analyses. Also, scores
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on the FCSRT were reverse-scored in order to have the same directionality for all variables (i.e.
higher scores indicate poorer task performance).

Aim III: Determine whether across-domain baseline experimental task IIV measures
compared to across-domain baseline standard task measures characterized future MCI
group status.
PCA was performed to examine variability (intraindividual standard deviation) in
CRRST, NM and NB2 RT and CRRST, NM and NB2 accuracy compared to FCSRT, TMT-A
and TMT-B. Statistical significance of the components was determined via a permutation test,
and the first three components (which accounted for approximately 56% of the total variance)
were found to be significant (p<0.001; Tables 13 and 14, Figure 33). Component one had the
highest positive loadings for: TMT-B, TMT-A, CRRST RT ISD, NB2 RT ISD, NB2 accuracy
ISD, FCSRT, CRRST accuracy ISD and NM accuracy ISD (Figures 33 and 34). This
component represented participants who had better performance on all of these tasks at baseline
and as such, showed lower variability on experimental tasks and lower scores on standard tasks
for all domains. Component two had the highest positive loadings for: NB2 Accuracy ISD and
NB2 RT ISD; and the highest negative loadings for: TMT-A, FCSRT, TMT-B, CRRST RT ISD
and CRRST accuracy ISD (Figures 33 and 35). This component represented participants that
who had greater variability on the executive function experimental task IIV measures, but lesser
variability on the episodic memory experimental task variability measures and better
performance on all standard task measures. Component three had the highest positive loadings
for: CRRST accuracy ISD, CRRST RT ISD, NM accuracy ISD, FCSRT and NM RT ISD; and
the highest negative loadings for: TMT-A and TMT-B (Figure 36). This component represented
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participants who had lower variability for the episodic memory and processing speed
experimental task variability measures and better performance on the episodic memory standard
task measure but poorer performance on other standard task measures. The FCSRT, TMT-A,
TMT-B, CRRST RT ISD and CRRST accuracy ISD contributed to all three components
indicating that these measures were the most meaningful when examining cognitive impairment.

Aim IV: Determine whether across-domain baseline experimental task IIV measures
compared to across-domain baseline standard task measures predicted future MCI group
status at different time points.
Outcome (Table 2) was measured using two methods: (1) EAS MCI3 – EAS definition of
HC, aMCI and naMCI; and (2) AC pre-MCI – HC, pre-MCI and MCI. AC pre-MCI was a
partitioning of the AC MCI outcome where within the AC MCI outcome participants who were
classified as HC could be HC or fall somewhere between HC and MCI. Participants who did not
fit the criteria of HC or the criteria of MCI, but were somewhere in-between, were considered to
be representative of a possible pre-MCI stage. This group of participants included individuals
who (1) have a cognitive impairment as described by the BIMC, little or no functional
impairment as described by the IADL and no cognitive complaint as described by the FAST or
(2) no cognitive impairment as described by the BIMC, slight functional impairment as described
by the IADL and cognitive complaint or no complaint as described by the FAST. Additionally,
when we examined incidence of MCI or pre-MCI, we noted that these outcomes could occur at
any point following baseline testing.
BADA was performed to examine differences between HC, aMCI and naMCI (EAS
MCI3 outcome) based on variability (intraindividual standard deviation) in CRRST, NM and
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NB2 RT and CRRST, NM and NB2 accuracy compared to FCSRT, TMT-A and TMT-B.
Because there were three groups, BADA extracted two components that explained 100% of the
variance (Abdi & Williams, 2010a). The percentage of variance explained by the first
component was 73.497% (p=0.283). Component one had significant loadings for FCSRT
(p<0.05). In addition, the HC and aMCI groups were significantly different for component one
(p<0.05), based on bootstrap confidence intervals (Beaton et al., 2014). The percentage of
variance explained by the second component was 26.503% (p=0.717). Component two had
significant loadings for TMT-B (p<0.05). The HC and naMCI groups were significantly
different for component two (p<0.05), based on bootstrap confidence intervals (Beaton et al.,
2014). Thus, when examining the EAS MCI3 outcome, standard task measures contributed
reliably to the first two components while experimental task IIV measures did not.
BADA was then performed to examine differences between HC, pre-MCI and MCI (AC
pre-MCI outcome) based on variability (intraindividual standard deviation) in CRRST, NM and
NB2 RT and CRRST, NM and NB2 accuracy compared to FCSRT, TMT-A and TMT-B.
Because there were three groups, BADA extracted two components that explained 100% of the
variance. The percentage of variance explained by the first component was 77.91% (p=0.125).
The percentage of variance explained by the second component was 22.09% (p=0.875). No
measures significantly contributed to component one or two (p>0.05) when examining the AC
pre-MCI outcome. But, based on bootstrap confidence intervals, the HC and the MCI groups
were significantly different for component one (p<0.05).
Participants were classified as MCI at any point during their successive waves.
Participants were not classified as MCI during the same follow-up period (i.e. some participants
had incident MCI three years after baseline while others had incident MCI seven years after
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baseline). Also, participants did not continue in the study for the same follow-up period (i.e.
some participants only completed one year of follow-up while others completed five years of
follow-up). Table 15 summarizes the follow-up period for participants that completed the entire
baseline testing and also includes incident MCI occasions. This information allowed for
analyses that examined when MCI occurred following baseline measurement, and when
experimental task IIV measures compared to standard task measures were able to predict the
incidence of MCI. Outcome (Table 2) was measured using four methods: (1) EAS MCI 3 vs 4 HC, EAS definition of first incidence of MCI within three years after baseline and EAS
definition of first incidence of MCI four or more years after baseline; (2) AC MCI 3 vs 4 – HC,
Alternate Criteria definition of first incidence of MCI within three years after baseline and
Alternate Criteria definition of first incidence of MCI four or more years after baseline; (3) AC
pre-MCI 3- HC, Alternate Criteria definition of first incidence of pre-MCI within three years
after baseline and Alternate Criteria definition of first incidence of MCI within three years after
baseline; and (4) AC pre-MCI 4 - HC, Alternate Criteria definition of first incidence of pre-MCI
four or more years after baseline and Alternate Criteria definition of first incidence of MCI four
or more years after baseline.
BADA was performed to examine differences between HC, MCI within three years after
baseline and MCI four or more years after baseline (EAS MCI 3 vs 4 outcome) based on
variability (intraindividual standard deviation) in CRRST, NM and NB2 RT and CRRST, NM
and NB2 accuracy compared to FCSRT, TMT-A and TMT-B. Because there were three groups,
BADA extracted two components that explained 100% of the variance. The percentage of
variance explained by the first component was 80.531% (p=0.092). Component one had
significant loadings for FCSRT, CRRST RT ISD and TMT-B (p<0.05) when examining the EAS
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MCI 3 vs 4 outcome. In addition, the HC and the MCI within three years after baseline groups
were significantly different for component one (p<0.05). The percentage of variance explained
by the second component was 19.469% (p=0.908). No measures significantly contributed to
component two (p>0.05). Also, groups did not significantly differ for component two (p>0.05).
BADA was performed to examine differences between HC, MCI within three years after
baseline and MCI four or more years after baseline (AC MCI 3 vs 4 outcome) based on
variability (intraindividual standard deviation) in CRRST, NM and NB2 RT and CRRST, NM
and NB2 accuracy compared to FCSRT, TMT-A and TMT-B. Because there were three groups,
BADA extracted two components that explained 100% of the variance. The percentage of
variance explained by the first component was 74.705% (p=0.268). The HC and the MCI within
three years after baseline groups were significantly different for component one (p<0.05). The
percentage of variance explained by the second component was 25.295% (p=0.732). No
measures significantly contributed to component one or two (p>0.05) when examining the AC
MCI 3 vs 4 outcome.
BADA was performed to examine differences between HC, pre-MCI within three years
after baseline and MCI within three years after baseline (AC pre-MCI 3 outcome) based on
variability (intraindividual standard deviation) in CRRST, NM and NB2 RT and CRRST, NM
and NB2 accuracy compared to FCSRT, TMT-A and TMT-B. Because there were three groups,
BADA extracted two components that explained 100% of the variance. The percentage of
variance explained by the first component was 80.102% (p=0.171). The HC and the MCI within
three years after baseline groups were significantly different for component one (p<0.05). The
percentage of variance explained by the second component was 19.898% (p=0.829). The HC and
the pre-MCI within three years after baseline groups were significantly different for component
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two (p<0.05). No measures significantly contributed to component one or component two
(p>0.05) when examining the AC pre-MCI 3 outcome.
Participants who did not have four or more years of follow-up data were removed from
the final analysis below (descriptive statistics included in Table 16). Participants with three or
fewer waves of follow-up data did not significantly differ in age, gender, ethnicity, education or
depressive symptoms (p>0.05) from those who had four or more waves of follow-up data. In
addition, participants with 3 or fewer waves of follow-up data had significantly fewer incidences
of MCI and pre-MCI compared to participants with four or more waves of follow-up data
(p<0.01). Descriptive statistics for demographics and outcome are shown in Table 16.
BADA with inference was performed to examine differences between HC, pre-MCI four
or more years after baseline and MCI four or more years after baseline (AC pre-MCI 4 outcome)
based on variability (intraindividual standard deviation) in CRRST, NM and NB2 RT and
CRRST, NM and NB2 accuracy compared to FCSRT, TMT-A and TMT-B. Because there were
three groups, BADA extracted two components that explained 100% of the variance. The
percentage of variance explained by the first component was 71.618% (p=0.298). Component
one had no significant loadings (p>0.05). The percentage of variance explained by the second
component was 28.382% (p=0.702). Component two had significant loadings for TMT-A
(p<0.05). In addition, the HC and the pre-MCI four or more years after baseline groups were
significantly different for component two (p<0.05).

Discussion
The overall objective of the current study was to determine whether novel, experimental
task measures of intraindividual variability are better able to characterize and predict MCI as
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compared to standard neuropsychological task measures within the same cognitive domains. We
examined across-block performance within and across domains to determine if measures of
variability and performance over time were able classify and predict future MCI group status
better than conventional standard measures. We also examined incident MCI group status at
varying time intervals, to determine if measures of variability were able to predict MCI group
status at earlier time points compared to conventional measures. Experimental task variability
measures were able to distinguish between MCI and HC groups for the episodic memory domain
but not processing speed or executive function domains. Experimental task variability measures
were able to predict future MCI for the episodic memory domain when utilizing the alternate
criteria but not when examining the traditional MCI classification. Non-variability experimental
task measures were able to distinguish between MCI and HC and predict future MCI but
standard task measures were unable to do so. Experimental task variability measures and
standard task measures examined together were meaningful in distinguishing between MCI and
HC. Experimental task variability measures and standard task measures together were able to
predict MCI up to 3 years prior to diagnosis. Results are summarized (Table 17) and discussed
below with implications for current practice and future research efforts.

Episodic Memory Domain
Preliminary analyses to determine whether within-domain baseline experimental task
measures compared to the within-domain baseline standard task measure characterized future
MCI group status.
Within the episodic memory domain, we examined differences between future MCI and
HC at baseline using EAS MCI as the outcome. The MCI group performed worse on all blocks
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of reaction time and accuracy for the experimental task and performed worse on the standard
task compared to HC, supporting our hypothesis that baseline differences between groups were
present before MCI classification was determined. We were surprised, however, that group
differences in episodic memory performance between HC and MCI could be present up to 10
years before an actual MCI diagnosis. To further explore this idea, we also examined the
measures using a different outcome – AC MCI. As noted above, we employed an alternate
classification criterion to avoid diagnostic circularity. In a cross-sectional analysis, circularity
becomes an issue when the same measures are used both to classify groups and as the primary
outcome measures. For the current study, we used the standard task measures at baseline and the
same standard task measures at a later time point for diagnoses – a type of longitudinal
assessment where we should not have had an issue with circularity. Nevertheless, we also
examined differences in baseline performance on all testing measures between MCI and HC
using AC MCI as the outcome.
We examined differences between future MCI and HC at baseline using AC MCI as the
outcome and found that the MCI group performed significantly worse than HC on all blocks of
reaction time and most blocks of accuracy for the experimental task. Experimental task
performance differences found between future MCI and HC groups for the AC MCI outcome
were similar to the results found for the EAS MCI outcome indicating that even when using an
alternate group classification method, baseline differences between groups were still present.
The experimental task was very robust such that even when groups were diagnosed using an
alternate criteria, differences between MCI and HC were still present at baseline. The most
interesting difference was that when utilizing the AC MCI outcome, the HC and MCI groups had
no significant baseline differences for the standard task, whereas with the EAS MCI outcome

83
there were significant baseline differences. It is possible that there is some issue of circularity
with the EAS MCI classification criteria even years after baseline testing. The experimental task
is able to distinguish future MCI from HC regardless of the classification method used. As there
is no “gold standard” for assessing MCI, a task utilizing repeated measurement in a short amount
of time could provide a good option for assessing subtle deficits in episodic memory years before
clinical changes manifest.
We further investigated the specificity of using episodic memory tasks to assess
individuals with future impairment in memory compared to individuals with future impairment
in non-memory domains. The EAS MCI3 outcome divides participants previously classified as
future MCI into future aMCI and naMCI – participants with and without memory impairment.
We found that HC and MCI groups significantly differed on the standard and experimental tasks.
Specifically, the aMCI group performed significantly poorer than HC on all blocks of reaction
time and accuracy for the experimental task and also for the standard task. The aMCI group
performed significantly worse than the naMCI group only for the standard task and not the
experimental task. In this instance, the experimental task was able to distinguish between future
memory-impaired individuals from cognitively healthy, but was unable to distinguish at a more
sensitive level – between memory-impaired and non-memory impaired. When testing at a crosssectional level, individuals classified as memory-impaired present with poorer recall of learned
items resulting as reduced total item scores or poorer accuracy. In this instance, we again note
that individuals present with poorer episodic memory performance years before diagnosis as
memory-impaired. Also, these individuals present with slower processing speed indicating that
not only do they have difficulty retrieving items, they also require more time to do so. This
could mean that these individuals also have deficits in non-memory domains or their deficiency
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in speed may be directly related to episodic memory tasks alone. Further investigation
examining processing speed performance in aMCI is required in order to discern whether the
observed deficit is related to episodic memory or a combination of impairments.
In addition, the naMCI group performed significantly worse than HC on measures of
speed but not on measures of accuracy for the experimental task, nor did the groups differ for the
standard task. The future naMCI group had deficits in speed of performance but not recall of
items. Also, the naMCI group did not perform poorer compared to HC at all blocks of reaction
time, but on most. Thus, it appears that the naMCI group only had deficits in non-memory
domains and also those deficits may be slight and not noticeable on an every-day basis. Also,
when we re-examine the prior EAS MCI outcome, we observed differences between groups for
all measures, but at the EAS MCI3 outcome, differences between groups are not present for all
measures. We conclude that the differences in episodic memory recall in the MCI participants
are related to memory impairment in the aMCI group – these participants had a large influence
on the overall MCI group performance when we analyzed data using EAS MCI as the outcome.

Preliminary analyses to determine whether within-domain repeated blocks of baseline
experimental task (across-block) measures characterized future MCI group status.
We examined differences between future MCI and HC at baseline using EAS MCI as the
outcome and found that the MCI group performed worse on the experimental task over time
compared to HC. This finding supported our hypothesis that baseline differences between
groups were present before MCI classification was determined. The CRRST was a repeatedblock task (as are the other experimental tasks) in which repeated test blocks were implemented
primarily to measure learning potential over time. Taking the repeated-block aspect of the
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experimental task into account, the MCI group performed significantly different at each block of
reaction time and accuracy compared to HC. Interestingly, the MCI and HC groups had a similar
trend of performance over time such that both groups generally improved in performance for
reaction time and accuracy. The MCI group significantly improved in reaction time at the
beginning and end of the session but not in the middle – there was no consistent improvement.
However, HC improved in all reaction time blocks over time illustrating constant improvement
over the course of the task. Those with MCI could have become fatigued and therefore were
unable to improve on their speed over time, whereas HC did not suffer the same effects. The
MCI and HC groups improved in accuracy over time, but reached their plateau and displayed no
significant increase in words retrieved after the fifth block. Although the amount of words
recalled differed between groups, the ability to retrieve words over time were similar. We
conclude that both groups shared a similar trend of reaching their maximum threshold for
accessing stored information but there are differences between groups in the threshold limits,
years before an actual MCI or HC diagnosis.
We examined differences between future MCI and HC at baseline using AC MCI as the
outcome and found that the MCI group performed poorer on the experimental task over time
compared to HC. As observed with the EAS MCI outcome, HC significantly improved in
reaction time across all blocks and most blocks of accuracy – plateauing at block 5, with no
significant difference between block 5 and 6. The MCI group significantly improved in reaction
time at the beginning of the testing session but not on later blocks (the MCI group plateaued at
block 4). In addition, the MCI group improved in accuracy at the beginning and at the end of the
session but not in the middle. Again, we observed that those with MCI are unable to consistently
improve throughout the testing session. This could indicate that those with MCI are more prone
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to fatigue and tests of repeated measurement are more difficult due to the constant effort that
must be sustained. With a multi-block design we are able to measure performance at different
time points, but traditional tasks sum up performance and do not allow for subtle changes in
performance to be detected across blocks.
We further investigated if the fluctuation in performance in the MCI group could be a
result of differing performance profiles between aMCI and naMCI participants. Utilizing the
EAS MCI3 outcome, we found that HC and MCI groups were significantly different on reaction
time and accuracy over time. Specifically, the aMCI group performed significantly poorer than
HC on all blocks of reaction time and accuracy, but performed poorer than the naMCI group
only for a few blocks of accuracy and no blocks of reaction time. We note that the future aMCI
group took longer to retrieve words and had less accuracy compared to HC and was therefore
unable to utilize the repeated-block design to their advantage. We also observed that the
repeated speed and accuracy measures of the episodic memory task were able to discriminate
between future aMCI and HC but were unable to discriminate at a more finite level – between
aMCI and naMCI. When we examined the naMCI in comparison to HC, we found the naMCI
group performed poorer than HC on most blocks of reaction time but did not differ for accuracy
blocks. When we examined the EAS MCI outcome, we noted that the MCI group had poorer
reaction time and accuracy performance over time in comparison to HC. When we separated the
MCI group into aMCI and naMCI, we found that the poorer accuracy was due to the aMCI
group, while poorer reaction time was exhibited by both aMCI and naMCI years before actual
diagnosis.
In the Ramratan and colleagues (2012) cross-sectional study, the authors examined
experimental task performance in aMCI compared to HC and found that the aMCI group
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exhibited poorer reaction and accuracy over time compared to HC. In the current study, we have
similar findings – but to a lesser degree, suggesting that we may be tapping into the early stages
of decline and deficits in episodic memory that present years before previously thought. In
addition, we further examined within-group performance and found that the HC were able to
consistently improve on their reaction and accuracy performance over time, whereas the aMCI
and naMCI groups had less consistency in performance over time. This change, or variation in
performance over short periods of time could indicate cognitive instability, which is detrimental
on tasks requiring speeded and efficient processing of information (Walhovd & Fjell, 2007).
Further analyses are required to explore these changes in performance over time.

Aim I: Determine whether within-domain baseline experimental task IIV measures compared
to the within-domain baseline standard task measure characterized future MCI group status.
We examined differences between future MCI and HC at baseline using EAS MCI as the
outcome and found that the MCI group performed worse on mean and variability measures for
the experimental task and also for the standard task measure compared to HC. This finding
supported our hypothesis that differences between groups in baseline mean and variability
measures were present before MCI classification was established. In the preliminary analyses
we found differences between groups examining baseline performance on experimental and
standard tasks. We did not change how we interpreted performance on the standard task
therefore the results should remain unchanged, which they did. The experimental task mean and
variability measures used for the current analyses were derived from the original block data,
therefore if differences between groups were present at each block and across-block it is fair to
assume that these differences between groups should also exist when examining change or
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variability over multiple blocks, which they were. Within-person variability was calculated
using a standard deviation score across-block per participant. Standard deviation is a measure of
spread of scores within a set of data – in this case, participant performance across multiple
blocks. A large spread indicates that there are probably large differences or greater variation
between individual scores. And within the MCI group there was a larger spread of scores
compared to HC thus indicating that there was greater inconsistency in performance for the MCI
group compared to HC. Also, after controlling for demographics, no significant associations
remained between outcome and testing measures. Also, there were no significant interactions
between demographics and outcome.
We then examined differences between future MCI and HC at baseline using AC MCI as
the outcome and found that the MCI group performed worse on most mean and variability
measures for the experimental task compared to HC, but there was no difference between groups
for the standard task. Similar to the prior preliminary analyses, we did not find a significant
difference between the HC and MCI groups for the standard task, so we did not expect to find a
difference in this analysis. When utilizing the alternate classification for MCI, differences
between MCI and HC groups for the experimental task reaction time and accuracy mean and
variability measures were still present. Surprisingly, the HC and MCI groups also did not differ
when we measured the coefficient of variation for reaction time. The coefficient of variation is
calculated based on the standard deviation divided by the mean across-blocks per person. The
coefficient of variation measures spread and captures the amount of variability relative to the
mean. The amount of reaction time variability relative to the mean did not differ between MCI
and HC groups. Gorus and colleagues (2008) previously found that those with aMCI had greater
intraindividual coefficient of variation values compared to HC only when performing complex
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tasks; simple tasks did not provide any difference in the intraindividual coefficient of variation
between groups. It is possible that a reaction time measure for an episodic memory task may not
provide enough complexity to reveal differences between HC and MCI when utilizing the
coefficient of variation. We therefore later examined these experimental task variability
measures specifically in the aMCI group. Also, after controlling for demographic variables, no
significant associations remained between outcome and testing measures. There was a
significant interaction between ethnicity and outcome and gender and outcome. When
demographics were accounted for, outcome groups were still significantly different. It therefore
appears that the differences between groups were a result of baseline task performance and not
due to the influence of other contributing factor.
Utilizing the EAS MCI3 outcome, we investigated if baseline experimental task mean
and variability measures and performance on the standard task differed between HC, aMCI and
naMCI groups. The aMCI group performed significantly poorer than HC on the standard task
(which we saw earlier) and most mean and variability measures of the experimental task but
groups did not differ for the reaction time coefficient of variation measure. These findings
correspond to the results by Gorus and colleagues (2008) and lend support to the idea that the
reaction time component of an episodic memory task may not be sufficiently complex to allow
for differentiation between groups when examined using the coefficient of variation. Other
variability measures, such as the intraindividual standard deviation, may be better equipped to
reveal group differences.
We also found the aMCI group performed significantly poorer than naMCI for the
experimental task accuracy coefficient of variation measure. Thus, the aMCI group had a
significantly greater amount of dispersion of accuracy scores across-block compared to the
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naMCI group. Also, the episodic memory level of performance may be a better measure of task
complexity compared to speed of performance when comparing aMCI and naMCI groups. The
naMCI group performed poorer than HC only for the experimental task reaction time mean
measure. In the prior analysis, the naMCI group performed worse than HC on most
experimental task reaction time blocks but still maintained a similar trajectory of improvement.
Due to the similar performance over time, differences between the HC and naMCI groups were
only present for the experimental task reaction time mean but not variability measures. After
controlling for demographics, the relationship between outcome and the experimental task
reaction time mean remained significant. There were no significant interactions between
demographic variables and outcome.

Aim II: Determine whether within-domain baseline experimental task IIV measures compared
to the within-domain baseline standard task measure predicted future MCI group status.
Previous analyses revealed that the HC and MCI groups differed at baseline on
experimental task variability measures and standard task performance. In addition, group
differences between HC and aMCI groups were present for experimental task variability
measures and the standard task measure. Because the experimental task variability measures and
standard task measure were both able to characterize future MCI group status, and also specify to
future aMCI group status, we hypothesized that experimental task variability measures at
baseline would also be able to predict which individuals in the future would be classified as
aMCI. A model for goodness of fit with the standard task measure as a predictor of aMCI was
significant thus indicating that the baseline standard task performance was able to predict which
participants would transition to aMCI. When the experimental task variability measures were
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added as predictors to the model, the model for goodness of fit did not significantly improve and
only the standard task measure remained a significant predictor. Thus, while baseline
experimental task variability measures were able to characterize future aMCI group status, these
measures were unable to predict which participants would transition to aMCI. The standard task
measure was very robust and was shown to have great utility in characterizing future memory
impairment and also in predicting future memory impairment. However, this could be due to the
issue of diagnostic circularity, and thus findings should be interpreted with caution. We further
examined the prediction of the alternate classification of MCI and whether the standard task
continued to reveal group differences.
We examined if differences between groups in baseline experimental task variability
measures were able to predict which individuals would in the future be classified as MCI for the
AC MCI outcome. A model for goodness of fit with a combination of experimental task
variability measures as predictors of MCI was significant thus indicating that baseline
experimental task variability measures were able to predict which participants would transition to
MCI – although, no specific measure was individually significant. Although the model was
significant, it explained only a small amount of the variance. When the standard task measure
was added to the model, the model for goodness of fit did not significantly improve and there
were no significant predictors. The addition of the standard task to the model eliminated the
ability of the experimental task measures to predict future MCI. We should also note that the
standard task measure was unable to aid in the prediction of MCI when using an alternate
classification approach and could only aid in prediction when utilizing the EAS MCI outcome.
Thus, for the EAS MCI outcome, future cognitive functionality appears to depend upon baseline
cognitive function and traditional tests may provide a better indicator of future impairment.
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Processing Speed Domain
Preliminary analyses to determine whether within-domain baseline experimental task
measures compared to the within-domain baseline standard task measure characterized future
MCI group status.
We examined differences between future MCI and HC at baseline using EAS MCI as the
outcome and found that the MCI group performed poorer on all blocks of reaction time for the
experimental task but not for accuracy blocks or for the standard task measure. This finding
supported our hypothesis that baseline experimental task differences between groups were
present before MCI classification was established. The experimental task was a simple
processing speed task that enabled participants to have high accuracy scores regardless of their
future cognitive status. Although we hypothesized that differences would be present at baseline
for the experimental task reaction time and accuracy measures, due to the relative simplicity of
the task, only differences in reaction time were present – many years before an actual MCI
diagnosis. Processing speed tasks measure the ability to focus and sustain attention and capture
the time it takes to perceive information. Basic processing speed tasks, like the ones used here,
focus more on an individual’s speed of performance than their cognitive ability. Therefore the
accuracy component of the task should be appropriate no matter the cognitive ability or reserve
of an individual or group being measured. Differences in speed of performance between the
future MCI and HC groups indicate that deficits in perceiving and processing information for
MCI occur earlier than previously believed. Interestingly, there were no differences between
groups for baseline performance on the standard task. We were then interested in examining
whether these same results would be applicable when employing a different outcome – AC MCI.
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When we examined differences between future MCI and HC at baseline using AC MCI
as the outcome, the MCI group performed poorer on all blocks of the experimental task reaction
time but not accuracy blocks or the standard task measure. These results are analogous to our
findings for the EAS MCI outcome. Thus, regardless of how MCI is classified, MCI individuals
have slower performance on the processing speed experimental task. We also observed that for
the standard task, there was no issue of circularity – group performance on the standard task did
not change when an alternate classification was used. Also, with both classification outcomes,
only baseline experimental task reaction time blocks reliably differentiated groups. The standard
task measure showed no efficacy in discriminating groups, but that could be because traditionally
the standard task measure has been used as a basic processing speed task to differentiate MCI–
specifically naMCI from HC.
The EAS MCI3 outcome permitted examination of differences at baseline in the
experimental task reaction time and accuracy performance and the standard task performance for
future classification of HC, aMCI and naMCI. The naMCI group performed significantly poorer
than HC on the experimental task but not the standard task. By contrast, the aMCI group did not
significantly differ from the naMCI or HC groups for the experimental or standard task. Thus,
even at baseline, the naMCI group performed significantly different from HC – these differences
are measurable years before an actual diagnosis. When we previously examined the EAS MCI
outcome, we noticed that the MCI and HC groups differed only on experimental task reaction
time blocks. When we separated MCI participants into aMCI and naMCI groups we observed
that the aMCI and HC groups were not significantly different but the naMCI group was
significantly different from HC. Thus, the aMCI group, which is classified as memory impaired,
did not differ from HC in its processing speed task performance, which we expected to find
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based on their previous performance for the episodic memory experimental task (greater reaction
time and poorer accuracy). We can conclude that the slower speed of the aMCI group was
directly related to the retrieval aspect of the episodic memory task rather than reduced speed of
processing information. We can also speculate that the prior significant difference between MCI
and HC groups when examining the EAS MCI outcome was really a result of differences
between the naMCI group and HC. We can note that domain specific decline is present for the
naMCI group years before diagnosis when utilizing the experimental task but not the standard
task. As the standard task is traditionally used to differentiate groups when impairment is
already present, the experimental task may detect subtle changes in processing speed that are not
tapped by traditional techniques and require further investigation.

Preliminary analyses to determine whether within-domain repeated blocks of baseline
experimental task (across-block) measures characterized future MCI group status.
As the experimental task utilizes repeated blocks of testing, we examined whether
differences between groups in baseline performance over time for the experimental task were
present for future MCI and HC using EAS MCI as the outcome. We found that the MCI group
performed significantly worse compared to HC on reaction time blocks over time but not
accuracy. Also, the MCI group showed no significant improvement in reaction time or accuracy
blocks over time, while HC did improve in performance over time in reaction time but not
accuracy. These findings support our hypothesis that baseline differences between groups were
present before MCI classification. The experimental task is simple and employs a two-block
design. We could presume that because there were so few blocks, participants were not given
ample opportunity to show significant improvement over time. While both groups displayed
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some improvement, the MCI group did not show any significant improvement while HC
demonstrated a significant change over time for reaction time. In this instance, HC were able to
utilize the limited two-block design of the task to their advantage for the reaction time
component while future MCI participants were unable to do so. Another aspect of early
cognitive decline could be the inability to utilize multi-block testing to improve performance
over time.
We also examined whether differences in baseline performance over time for the
experimental task were present for future MCI and HC using AC MCI as the outcome. The MCI
group performed significantly worse than HC on reaction time blocks over time but not
accuracy. The MCI group also showed no significant improvement in reaction time or accuracy
while HC improved in reaction time but not accuracy. These results match the prior EAS MCI
outcome results. As with the prior results, we could assume that the MCI group was unable to
utilize the limited two-block design of the task to its advantage for the reaction time and
accuracy. This does not explain why HC did not improve on accuracy performance over time;
rather, there was no significant change in their performance. Due to the simplicity of the
processing speed task, it was easy to attain high accuracy for both blocks. HC achieved almost
perfect accuracy for both blocks and the same trend in performance can be seen for the MCI
group, though to a lesser degree. Therefore the accuracy component of the processing speed task
was unable to differentiate groups but performance on the reaction time component over time
provided discriminant group information.
We also examined whether differences in baseline performance over time for the
experimental task were present for future naMCI, aMCI and HC using EAS MCI3 as the
outcome. Outcome groups differed on reaction time over time but not accuracy. The naMCI and
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aMCI groups showed no significant improvement in reaction time or accuracy over time, while
HC improved in reaction time but not accuracy. Neither of the impaired groups was able to
improve speed of performance or accuracy over time. Additionally, the naMCI group had poorer
performance on the reaction time compared to HC but the aMCI group did not differ from HC.
Therefore, the poorer performance for reaction time in the MCI group from the EAS MCI
outcome appears to be due to the naMCI participants (as seen here in the EAS MCI3 outcome).
We predicted that the naMCI group would perform poorer than the aMCI group, and the aMCI
group performance may even be comparable to HC performance. While we did observe that the
aMCI group performance was similar to HC performance, it was also similar to the naMCI
group. The simplicity of the task may not allow for true differences between groups to be
revealed. We hope to re-examine these groups using a more complex task that and determine
whether differences between aMCI and naMCI groups are present.

Aim I: Determine whether within-domain baseline experimental task IIV measures compared
to the within-domain baseline standard task measure characterized future MCI group status.
We examined baseline differences in the experimental task mean and variability
measures and the standard task measure between future MCI and HC using EAS MCI as the
outcome. Results indicated that the MCI group performed worse on the experimental task
reaction time mean measure compared to HC. There were no significant differences between
MCI and HC groups for variability measures. Although these findings supported our hypothesis
that the experimental task measure was able to differentiate groups at baseline better than the
standard task measure, they did not support our hypothesis that differences between groups in
baseline experimental task variability measures would be present prior to MCI classification was
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determined. For both the MCI and HC groups there was little change in performance over time
for the experimental task accuracy measure and baseline performance did not differ at the block
level. Therefore, it is reasonable that there were no differences between groups when we
examined experimental task variability measures.
Because there were differences between the MCI and HC groups for the experimental
task reaction time measure at the block level as well as between groups, we expected differences
in experimental task variability measures also to be present. Instead, MCI and HC group
differences were only present for the experimental task reaction time mean measure. It is
possible that utilizing too few blocks of performance may not be effective when trying to
determine variability over a short time. This aspect of variability should be examined further to
fully understand how many blocks are required for adequate measurement of variability over
short periods of time. Also, after controlling for demographics, no significant associations
remained between outcome and testing measures. There was a significant interaction for
ethnicity and outcome- when accounted for, outcome groups were no longer significantly
different. Thus, differences between groups may be a result of unequal distributions of ethnic
groups.
We next examined differences in the experimental task mean and variability measures
and standard task measure between future MCI and HC using AC MCI as the outcome. Results
indicated that the MCI group performed poorer on only the experimental task reaction time mean
measure compared to HC, matching our results when we examined the EAS MCI outcome. In
addition, we found a significant association between the experimental task reaction time mean
measure and outcome; when demographics were controlled for, the relationship remained
significant. There were no significant interactions between demographics and outcome. Thus,
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differences between groups were a result of baseline task performance and not due to the
influence of any additional contributing factor.
We further examined EAS MCI3 outcome, which allowed for examination of differences
at baseline in the experimental task mean and variability measures and the standard task measure
for future classification of HC, aMCI and naMCI. Results indicated that the outcome groups
significantly differed on the experimental task reaction time mean but no other measures. The
naMCI performed significantly worse than HC on the experimental task reaction time mean
measure but the aMCI group did not differ from HC or naMCI groups on any task measure.
Again, we can conclude that the poorer performance on the experimental task reaction time mean
measure in the MCI group from the EAS MCI outcome is due to the performance of the naMCI
participants. There was a significant association between outcome and the experimental task
reaction time mean measure that remained significant after controlling for demographics. There
were no significant interactions between outcome and demographics, therefore it appears that
differences between groups were a result of baseline task performance and not due to covariates.

Aim II: Determine whether within-domain baseline experimental task IIV measures compared
to the within-domain baseline standard task measure predicted future MCI group status.
Previous analyses showed that HC and MCI groups differ at baseline for the experimental
task reaction time mean measure but not any other experimental task measures or the standard
task measure. In addition, group differences at baseline were present between the HC and
naMCI groups only for the experimental task reaction time mean measure. Because only one
experimental task measure was able to classify future MCI group status, and also specify to
future naMCI group status, we hypothesized that the experimental task reaction time mean at
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baseline would be able to predict which individuals would be classified as naMCI in the future.
A model for goodness of fit with experimental task mean and variability measures was not
significant, but the experimental task accuracy mean measure was a significant predictor. When
the standard task measure was added as a predictor to the model, the model for goodness of fit
did not significantly improve, but the experimental task accuracy mean remained a significant
predictor. These results indicate that although the experimental task accuracy mean measure was
unable to classify groups it may have some utility predicting which individuals will transition to
naMCI.
We also examined whether these results would be replicated when using groups defined
with the AC MCI outcome. When we previously compared groups using the AC MCI outcome,
differences between groups were consistently found for the experimental task reaction time mean
measure. As there was only one experimental task measure that was able to consistently
characterize future MCI group status, we hypothesized that the experimental task reaction time
mean measure at baseline would be able to predict which individuals in the future would be
classified as MCI for the AC MCI outcome. The model for goodness of fit with experimental
task mean and variability measures was significant, with the reaction time mean and accuracy
mean measures as significant predictors of MCI. When the standard task measure was added to
the model, the model for goodness of fit did not significantly improve and only the experimental
task accuracy mean measure remained a significant predictor. These results indicate that
although the experimental task accuracy mean measure was unable to reliably classify groups, it
may have some utility predicting which individuals will transition to MCI. In addition, the
experimental task reaction time mean measure also had value in predicting who would transition
to MCI, but that effect was not maintained when the standard task measure was added to the
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model. It is notable that the experimental task accuracy mean measure rather than reaction time
mean measure was able to consistently predict future group status when it had no influence in
characterizing groups, and reaction time mean measure was able to characterize groups but
unable to predict group membership. This was an unexpected finding and requires further
investigation in other non-memory domains.

Executive Function Domain
Preliminary analyses to determine whether within-domain baseline experimental task
measures compared to the within-domain baseline standard measure characterized future
MCI group status.
We examined baseline differences for the experimental task reaction time and accuracy
measures and the standard task measure between future MCI and HC groups for the EAS MCI
outcome. Results indicated that the MCI group performed poorer on the experimental task at the
beginning, but at no other time and did not differ on the standard task measure compared to HC.
This finding supported our hypothesis that baseline differences between groups for the
experimental task measures were present before MCI classification was determined. The
executive function experimental task requires controlled and effortful switching of attentional
focus from one item to another (Sliwinski et al., 2006). Compared to the standard task, the
experimental task may be a more complex task and thus tap into higher-order processing which
may begin to deteriorate at the earliest stages of cognitive decline. We were then interested in
examining whether these same results would be applicable when employing the alternate
outcome – AC MCI.
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We examined differences at baseline for the experimental task reaction time and accuracy
measures and the standard task measure between future MCI and HC groups for the AC MCI
outcome. Results indicated that the MCI group performed poorer on the experimental task at the
beginning (block 1) and at the end (block 3) of the session but did not differ on the standard task
measure compared to HC. These results are similar to our prior findings where we examined
groups using the EAS MCI outcome group classification. Again, the standard task measure
showed no efficacy in discriminating groups years prior to diagnosis, but that could be because
the standard task has customarily aimed to detect participants with impairment in non-memory
cognitive domains who transition from MCI to AD (Gomar et al., 2011).
We next examined differences at baseline for the experimental task reaction time and
accuracy measures and the standard task measure for future naMCI, aMCI and HC.
Surprisingly, we found no significant differences between groups for any task measure. These
findings did not support our hypothesis that differences between groups would be present at
baseline for an executive function task. When we tested group differences using the EAS MCI
and AC MCI outcome we found that the MCI group performed significantly worse on the
experimental task compared to HC. We then expected to find that the naMCI group would have
greatly influenced those findings (as we observed for processing speed). It is possible that
differences for the executive function task between naMCI, aMCI and HC groups were not
discernible due to the small sample sizes utilized for the impaired groups – specifically the
naMCI group, which was reduced by almost half compared to sample in the processing speed
task analyses. The smaller sample size was a result of the later implementation of the executive
function task into the EAS protocol. In the future, research could explore performance on the
executive function experimental task with a larger sample to discover whether differences
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between amnestic and non-amnestic groups were present (as were observed for the processing
speed and episodic memory tasks).

Preliminary analyses to determine whether within-domain repeated blocks of baseline
experimental task (across-block) measures characterized future MCI group status.
As the executive function experimental task is a repeated block task, we examined
whether differences in baseline performance over time for the experimental task reaction time
and accuracy measures were present for future MCI and HC groups using EAS MCI as the
outcome. We found that the MCI group was not significantly different from HC for reaction
time or accuracy over time. The MCI group did not show any significant change in performance
over time for reaction time but did have poorer performance in accuracy. HC showed no
significant change over time for reaction time performance, but did perform significantly worse
for accuracy. These findings did not support our hypothesis that group differences were present
at baseline. These results indicate that the executive function task was difficult to complete for
individuals who did not display current or future cognitive impairment (HC). We would expect
those with cognitive impairment to have even more difficulty with this task – which they did, but
not enough to discriminate between cognitive groups. The future MCI and HC groups
performed similarly over time such that their performance worsened over time for accuracy but
not for reaction time. Neither of the groups were able to utilize the multi-block design of the
task to improve their speed of performance or accuracy.
Because both groups also had poorer accuracy over time, this could indicate that
participants actually found the task to be more difficult over time and the repeated block-design
was a detriment to performance. This could mean that the cognitive demands of the task
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(requiring participants to constantly attend to new information and reject old information) are
greater and as a result participants were unable to maintain a constant alertness to enhance their
performance. Chan and colleagues (2008) proposed that the inability to activate inhibitory and
excitatory commands within the neural network stems from reduced neurotransmitters and when
the levels of these chemicals (i.e. dopamine) are restored cognitive performance may improve.
Nagaraja and Jayashree (2001) stated that there was an association between age-related decrease
in dopamine D2 receptors and impaired performance on neurocognitive tasks such as executive
function and response inhibition. They proposed that age-related decline in dopamine activity
may contribute to cognitive impairment and introduced a dopamine receptor agonist to patients.
They found that patients with cognitive impairment had improved global cognitive function
when treated with the dopamine receptor agonist. Future studies could extend this research by
examining preclinical and MCI participants with reduced dopamine neurotransmitters and
determine if restoring neurotransmitters improves performance on complex executive function
tasks.
Next, we examined differences in baseline performance over time for the experimental
task reaction time and accuracy measures between future MCI and HC groups for the AC MCI
outcome. The MCI group showed no change in performance over time for reaction time but
performed significantly worse in accuracy over time. And HC showed no change in
performance over time for reaction time but did perform significantly worse in accuracy over
time. The similar findings when utilizing the alternate criteria for MCI indicate that regardless of
how MCI is classified, the experimental task may place strong cognitive demands on the
individual and therefore provide no utility in distinguishing cognitive groups. Sliwinski and
colleagues (2006) stated that the executive function experimental task required controlled and
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effortful switching of attentional focus from one item to another but older adults may have a
diminished capacity to inhibit off-task information and therefore are unable to cope with the high
functional demands of the task. Further investigation examining performance in a younger age
group could clarify whether poorer performance is a result of older age and poorer cognitive
ability to cope with task demands.
We next examined differences at baseline for the experimental task reaction time and
accuracy measures over time between future naMCI, aMCI and HC groups using the EAS MCI3
outcome. The naMCI group showed no change in performance for reaction time or accuracy
measures. The aMCI group showed no change in performance for reaction time but did perform
poorer on accuracy over time. HC showed no change in performance over time for reaction time
but did perform poorer in accuracy. Interestingly, we found that the aMCI group (of EAS MCI3)
influenced the results of the MCI group (from EAS MCI) such that poorer accuracy over time
could be attributed to the aMCI group rather than to the naMCI group. We expected that
individuals with future impairment in non-memory cognitive domains would perform poorer on
an executive function task, but instead, we found that there was no change in their performance
over time and the future memory-impaired group displayed poorer accuracy. This could indicate
that individuals with future memory impairment may also present with other non-memory
impairments and these individuals may decline as a faster rate compared to others who have
impairment in only a single cognitive domain (Garcia-Herranz, Diaz-Mardomingo & Peraita,
2015; Loewenstein et al., 2009; Peraita, Garcia-Herranz & Diaz-Mardomingo, 2010; Summers &
Saunders, 2012).
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Aim I: Determine whether within-domain baseline experimental task IIV measures compared
to the within-domain baseline standard task measure characterized future MCI group status.
We examined differences in baseline experimental mean and variability measures and the
standard task measure between future MCI and HC using EAS MCI as the outcome and found
that after accounting for unequal variances, there were no differences between the MCI and HC
groups. After controlling for demographics, no significant associations remained between
outcome and testing measures. There were no significant interactions between demographics
and outcome. These findings did not support our hypothesis that baseline differences in
experimental task variability measures are able to discriminate future MCI and HC groups.
However, based on our prior analyses in which the MCI and HC groups had a similar trajectory
of performance decline over time, we therefore did not expect to find group differences for the
experimental task variability measures or the standard task measure.
We next examined differences in baseline experimental mean and variability measures
and the standard task measure between future MCI and HC using AC MCI as the outcome.
Results indicated that after accounting for unequal variances, the MCI group was significantly
different from HC for the experimental task reaction time mean and accuracy mean measures.
After controlling for demographics, significant associations between task measures and outcome
remained. There were no significant interactions between demographics and outcome. When
we utilized the alternate criteria for MCI we found that there were differences between cognitive
groups in mean performance. Future MCI cognitive status is based on decline in global
cognition (as noted by BIMC scores) - but at baseline there were no differences in global
cognition. However, differences for the experimental task reaction time and accuracy mean
measures between groups were still present. At baseline slight changes in performance may
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present in those who will later decline beyond normative aging and the experimental task may
capture those subtle changes.
We next examined differences in baseline experimental mean and variability measures
and the standard task measure between future naMCI, aMCI and HC using EAS MCI3 as the
outcome. After accounting for unequal variances, there were no significant differences between
groups. Further, the naMCI did not differ from the HC for any task measure and the aMCI group
did not differ from the naMCI or HC groups for any task measure. After controlling for
demographics, no significant associations remained between outcome and testing measures.
While these results do not support our hypothesis, they are not surprising based on the null
findings from our previous analyses when we examined group performance using the EAS MCI
outcome.

Aim II: Determine whether within-domain baseline experimental task IIV measures compared
to the within-domain baseline standard task measure predicted future MCI group status.
Previous analyses did not reveal that experimental task variability measures or the
standard task measure in the executive function domain characterized future MCI group status.
We then examined whether experimental task variability measures or the standard task had any
ability to predict future MCI group status, specifically naMCI. A model for goodness of fit with
the experimental task variability measures as predictors of naMCI was not significant. When the
standard task was added as a predictor to the model, the model for goodness of fit did not
significantly improve. We concluded that neither experimental task variability measures nor the
standard task measure were able to predict which participants would transition to naMCI. The
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limited sample size of naMCI participants may account for why there were no differences
between groups and also why no prediction of naMCI was possible.
We then examined whether the experimental task variability measures would be able to
predict future MCI group status compared to the standard task measure when using the AC MCI
outcome. We previously found that the experimental task reaction time mean and accuracy
mean measures were able to characterize future MCI group status; therefore, we tested an
additional model that included these measures. A model for goodness of fit with the
experimental task variability measures was not significant and when the standard task measure
was added to the model, the model for goodness of fit did not significantly improve. When the
experimental task reaction time and accuracy mean measures were added to the model, the
model for goodness of fit significantly improved, and reaction time mean and accuracy mean
measures were significant predictors of group status. These results indicated that the
experimental task reaction time and accuracy mean measures may have some ability to not only
characterize future MCI group status but also predict who will transition to MCI when utilizing
the AC MCI outcome.

Across-Domain
Up to this point, we examined performance in each cognitive domain separately. We
were also interested in examining performance across-domain. Dementia is diagnosed when
impairments are present across domains, not just within one domain, so this may provide
additional information on how we conceptualize the role of variability as an early indicator of
disease. For the next set of aims, we utilized participants that completed testing in all three
cognitive domains previously explored. These analyses aimed at examining performance on the
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experimental task variability measures and the standard task measures across all domains in
order to determine if variability in multiple domains would enhance classification and prediction
of future MCI group status. We initially examined MCI classification at any point (anytime
between one to ten years after baseline) and later examined MCI after differing time periods
(within three years after baseline compared to four or more years after baseline) to determine
whether prediction was improved based on when MCI group status was diagnosed.

Aim III: Determine whether across-domain baseline experimental task IIV measures
compared to across-domain baseline standard task measures characterized future MCI group
status.
We examined the experimental task variability measures and the standard task measures
to determine if there was a particular grouping among task measures. The PCA found three
significant components that accounted for approximately 56% of the total variance. Component
one had the highest positive loadings for all standard task measures and most of the experimental
task measures. For this component, higher scores on all tasks indicated better performance;
therefore, this component most likely represented participants who performed well on all of these
tasks at baseline and have a lower likelihood of being classified as MCI. Component two had the
highest positive loadings for the executive function experimental task measures and the highest
negative loadings for all standard task measures and the episodic memory experimental task
measures. For this component, higher scores on the executive function experimental task
measures were associated with lower scores on all standard task measures and the episodic
memory experimental task measures, therefore participants performed poorly on the
experimental executive function task but better on all standard tasks and the experimental
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episodic memory task. These participants could be impaired only in the executive function
domain as measured by the experimental task. Component three had the highest positive
loadings for the episodic memory and processing speed experimental task measures and the
episodic memory standard task measure and the highest negative loadings for: processing speed
and executive function standard task measures. For this component, lower scores on episodic
memory and processing speed experimental tasks measures and episodic memory standard task
measure were associated with higher scores on processing speed and executive function standard
task measures, therefore these participants performed better on both episodic memory tasks and
the experimental processing speed task but poorer on the processing speed and executive
function standard tasks. These participants may have impairment in non-memory domains as
noted by performance on the standard tasks. From these components, we see groups of
participants that performed poorly: (1) across no domains, (2) only on executive functioning
experimental task, or (3) only processing speed and executive function standard tasks.

Aim IV: Determine when across-domain baseline experimental task IIV measures compared to
across-domain baseline standard task measures predicted future MCI group status.
We examined which baseline experimental task variability measures and/or standard task
measures predicted MCI group status at any time using the EAS MCI3 outcome. Components
one and two had significant loadings for the episodic memory standard task and the executive
function standard task, respectively. When utilizing the EAS MCI3 outcome, standard task
measures were better predictors of MCI group status than experimental task variability measures.
Also, performance on the episodic memory standard task was significantly different for the
aMCI and HC groups. These results concur with our prior findings, which showed that the
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performance on the episodic memory standard task was related to MCI group status. In addition,
performance on the executive function standard task was significantly different for the naMCI
and HC groups. These findings did not agree with our previous results where we were unable to
utilize the executive function standard task to characterize or predict naMCI and HC groups. We
suggested that using such a small sample size for prior analyses could explain why there were no
differences between groups. By using the BADA technique, we maximized the group
differences, and used bootstrap resampling to determine significance between the groups; we
were then able to determine that the executive function standard task significantly contributes to
the difference between the naMCI and HC groups.
Next, we examined which baseline experimental task variability measures and/or
standard task measures predicted MCI group status at any time using the AC pre-MCI outcome.
Components one and two had no significant loadings—and the HC and MCI groups were
significantly different for component one. While there was no specific measure that was
significant along component one, the episodic memory experimental task accuracy measures
approached significance. Notably, along both components, the pre-MCI group was not
significantly different from the MCI or HC groups. By definition pre-MCI participants did not
correspond to either the MCI or HC groups. We also observed that their performance for the
experimental and standard task measures were unable to provide any aid in diagnostic
characterization or prediction.
Roberts and colleagues (2014) examined the rate of progression from MCI to dementia in
individuals who reverted to cognitively healthy after a previous MCI diagnosis. They found that
participants who reverted from MCI to cognitively healthy eventually regressed to MCI or
progressed further to dementia. Although individuals who fluctuated between MCI and
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cognitively healthy had a lower incidence of dementia compared to those with a consistent MCI
diagnosis, they had a greater incidence compared to those that never transitioned to MCI. Thus,
an MCI diagnosis at any time may have prognostic value (Roberts et al., 2014). Also,
participants who vacillate may represent the low-risk individuals that Jack and colleagues (2013)
hypothesized. These results suggest that individuals who revert may have a pathological process
that presents as cognitive impairment but due to greater cognitive reserve, these individuals are
better able to compensate for their physiological burden. Further research is needed to
understand the mechanisms underlying MCI stability and progression.
Up to this point, all of our analyses included using classification of MCI group status at
any time point. We then decided to examine classification of MCI group status at differing time
points with the assumption that participants who were diagnosed as MCI closer to their baseline
testing period (within three years) may differ from participants who were diagnosed much later
following their baseline testing (four or more years later). We were able to address this
hypothesis using a variety of outcome definitions. Howieson and colleagues (2008) found that
individuals with MCI had a preclinical stage of accelerated cognitive loss on tests of verbal
memory, animal fluency, and visuospatial constructions, which was observed three to four years
before the diagnosis of MCI. They reported that evidence from memory performance before the
change point suggests that a slow decline in memory precedes the period of accelerated decline
in the development of MCI. We were also able to see this preclinical stage of decline in our
results.
We examined which baseline experimental task variability measures and/or standard task
measures predicted MCI group status using the EAS MCI 3 vs 4 outcome. Component one had
significant loadings for the episodic memory and executive function standard task measures and
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episodic memory experimental task variability measures, while no task measures loaded
significantly for component two. The HC and “MCI within three years” groups were
significantly different along component one. Therefore, participants who may never transition to
MCI were different from those who transition to MCI within three years – specifically when we
examined baseline performance for the episodic memory and executive function standard task
measures and episodic memory experimental task variability measures. There was no significant
difference between the HC and “MCI four or more years later” groups. Our results indicated that
baseline performance for the episodic memory and executive function standard task measures
and episodic memory experimental task variability measures have greater efficacy distinguishing
participants who will transition to MCI sooner after baseline testing rather than later.
We then examined which baseline experimental variability measures and/or standard task
measures predicted MCI group status using the AC MCI 3 vs 4 outcome. Components one and
two had no significant loadings. Yet, the HC and “MCI within three years” groups were
significantly different along component one. Again, while no specific task measure was
significant along component one, the episodic memory experimental task variability measure
was approaching significance. We also observed that when we used the alternate classification
criteria for MCI, the results were the same, such that participants who may never transition to
MCI were different from those who transition to MCI within three years but not different from
those who transition to MCI four or more years after baseline testing. Therefore, again we
observe that baseline task performance has greater utility at distinguishing participants who
transition to MCI sooner rather than later.
We were then interested in examining if future pre-MCI participants displayed any
differences in baseline performance compared to future MCI participants. We examined which
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baseline experimental task variability measures and/or standard task measures predicted MCI
group status using the AC pre-MCI 3 outcome. Components one and two had no significant
loadings. Interestingly, the HC and “MCI within three years” groups were significantly different
along component one, which agreed with our previous results. While no specific task measure
was significant along component one, the episodic memory experimental task variability
measure was approaching significance level. We also found the HC and “pre-MCI within three
years” groups were significantly different along component two. While there was no specific
measure that was significant along component one, the episodic memory standard task measure
and processing speed experimental variability measures approached significance. Thus, for this
outcome, participants classified as pre-MCI and MCI appear to be different from HC. This
means that baseline performance of participants that transition to pre-MCI or MCI within three
years differed from baseline performance of participants that may never transition to MCI. We
were unable to observe baseline performance differences between the pre-MCI and MCI groups,
indicating that pre-MCI participants may be more like MCI participants and that any change
from HC may be noted as the beginning of MCI.
Finally, we examined which baseline experimental task variability measures and/or
standard task measures predicted MCI group status using the AC pre-MCI 4 outcome.
Component one had no significant loadings. Component two had significant loadings for the
processing speed standard task measure. The HC and “pre-MCI four or more years later” groups
were significantly different along component two. We can conclude that for this outcome,
participants classified as pre-MCI were different from HC, but they did not differ from MCI
participants. Based on our prior findings and these results, we observed that baseline
performance of participants classified as “pre-MCI within three years” and “pre-MCI four or
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more years later” differed from HC. We were also able to discern that pre-MCI participants did
not differ from MCI at any time point – these groups had similar baseline performance, while
still differed from HC baseline performance. The pre-MCI group baseline performance
corresponded more to the MCI group baseline performance, which leads us to believe that the
pre-MCI are closer to MCI along the cognitive spectrum compared to HC.

General Conclusions
Our overall objective was to determine whether experimental intraindividual variability
measures have greater efficacy at characterizing and predicting MCI compared to conventional
standard task measures. When we examined specific cognitive domains we found that baseline
experimental task measures of variability and performance over time were able to characterize
and predict future MCI group status better than conventional standard task measures. When we
examined performance across all domains, we found that both experimental task variability
measures and standard task measures had efficacy in predicting future MCI group status. When
we examined incident MCI group status at different time intervals, we found both experimental
task variability measures and standard task measures were reliable at predicting MCI,
specifically incident MCI diagnosed closer to the baseline testing period. We were able to utilize
large samples of participants and also longitudinal outcomes to investigate the relationship
between baseline performance and future cognitive decline.
It is important to determine which tests have the greatest accuracy in predicting cognitive
decline and also utilize tests in memory and non-memory domains to allow for enhanced
sensitivity and specificity in detecting future impairment. An inherent problem within the
construct of MCI diagnosis is the rate of false diagnoses, in which participants revert to non-
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impaired status at later testing periods. Klekociuk and colleagues (2014) reported, using a
combination of complex sustained attention, semantic memory, working memory, episodic
memory and selective attention neuropsychological measures, increased correct classification
and decreased rate of false positive diagnoses of MCI. For the current study, we utilized testing
measures from multiple cognitive domains. As a result, we revealed that at baseline, participants
who transitioned to MCI demonstrate poorer performance for experimental tasks in more than
one cognitive domain. We also examined specific cognitive impairment sub-groups (amnestic
versus non-amnestic) and found that within each sub-group there was a primary impairment
followed by a lesser secondary impairment, such that aMCI individuals presented with poorer
episodic memory performance but also poorer performance on processing speed and executive
function tasks. The aMCI group did not perform as poorly as the naMCI group for non-episodic
memory tasks, but still performed poorer than the HC. In addition, when we examined the full
MCI group across-domains we also observed poorer performance in more than one cognitive
domain. The DSM-V (2013) classifies major neurocognitive disorder due to probable/possible
AD when impairments are in more than one cognitive domain; therefore, these early
presentations of poorer performance in multiple domains may signal a more rapid transition to
MCI.
We also employed an alternate method of MCI classification to independently test for
relationships between standard task measures and incident MCI. As a result we were able to
determine whether the relationship between task measures was in fact real or misleading due to
circularity. We found that once we used the alternate MCI classification criterion, future MCI
and HC groups no longer differed in their performance on the episodic memory standard task
measure. In this instance, we observed that performance on the episodic memory standard task
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at baseline, years before actual transition, may have an effect on later diagnosis. We did not see
this effect for the processing speed and executive functioning standard task measures – there
were no baseline differences between MCI and HC groups therefore an alternate MCI was
unnecessary, but still examined. Baerrensen and colleagues (2015) found tests of episodic
memory predicted conversion to MCI two years prior to conversion. The entorhinalhippocampus system plays an important role in episodic and spatial memories. Research has
suggested that tau protein tangles and amyloid plaques spread in a predictable, nonrandom
manner beginning in the entorhinal region, spreading to the hippocampus and neocortex.
Baerrensen and colleagues (2014) suggested that because the entorhinal region is one of the first
areas impacted by tau tangles – accumulating and eventually causing neuronal death – it is
expected that the relying on adequate structure and function in this region would predict
conversion before tests reliant on domains impacted later in the disease process (such as
processing speed and executive function). It is possible that the brain regions accessed for tests
of processing speed and executive function have not sustained sufficient damage to induce
impaired performance and therefore differences between groups were unnoticeable for standard
task measures.
Grand and colleagues (2016) found that greater intraindividual variability at baseline was
associated with poorer cognitive performance at the initial year of assessment, declining
cognitive function, and also predicted poorer cognitive performance six years later.
Additionally, because intraindividual variability measures fluctuation or change in performance
over time, persistent fluctuations, despite experience with a task, may reflect a lack of processing
robustness and maladaptive functioning (Grand, Stawski & MacDonald, 2016). Increased
performance fluctuations may reflect diminished processing capacity and poorer underlying
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neural integrity, which could indicate limited extent to which neural resources are available to
support higher level cognitive processing. As a result, when these neural mechanisms are
compromised, there is greater observable cognitive impairment, such as we find in individuals
with MCI. Intraindividual variability may pose as a neurocognitive marker and serve to denote
preclinical changes associated with subtle cognitive decline/impairment.
Our overall objective was to examine the utility of intraindividual variability measures to
discriminate groups prior to diagnosis. We observed that intraindividual variability measures for
the experimental episodic memory task distinguished and predicted future MCI group status.
Intraindividual variability measures for processing speed and executive function experimental
tasks were unable to reveal differences between groups at baseline. The episodic memory
experimental task was a six-block task, while the processing speed and executive function
experimental tasks utilized two- and three-blocks, respectively. MacDonald and colleagues
(2009) stated that in order to reliably index intraindividual variability, the task must have more
than seven blocks. The episodic memory experimental task was closer to meeting this criterion
than the other tasks and could explain why intraindividual variability measures for processing
speed and executive function were inconclusive, even though the groups fluctuated in
performance across blocks. In addition, MacDonald and colleagues (2009) stated that the mean
has a greater proportion of systematic variance available for association with cognitive
outcomes. In our results, for the processing speed and executive function experimental tasks, we
observed that the MCI group had a poorer mean performance compared to HC. This supports
the idea that there were noticeable differences across-blocks that were undetected by measures of
variability due to the limited resources available for computation.
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Limitations
In order to utilize the large sample sizes available, we did not re-examine classification
outcomes per domain (memory and processing speed) for participants who completed all tasks.
Null findings from the executive function analyses led us to believe that by reducing the sample
size, we would have limited significance between outcome groups due to small sample size
rather than no actual differences between groups. It would be beneficial to examine the
executive function domain with a larger sample to discover if our previous null findings are
replicated or learn that the small sample size led to false results.
Within the current study, our sample was comprised of participants that we defined as
healthy elderly. Our sample did not fully correspond to the EAS classification of healthy elderly.
Due to the small difference between classification criteria (5-10%), we felt it was unnecessary to
remove non-corresponding participants and reduce our sample. Also, when further evaluated,
participants classified as EAS MCI within this sample reverted to healthy elderly at later time
points. Nevertheless, it would be interesting to analyze a group of participants that had a 100%
corresponding classification rate and determine if our results were replicated.
In addition, for the current study we established a “pre-MCI” group based on specific
criteria. This group was not validated nor fully examined to establish whether these criteria are
maintained over time for different populations. In addition, we failed to monitor these “preMCI” participants to determine if they transition to MCI or if they revert to back to healthy
elderly. Further investigation is required to fully understand this group.
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Conclusions and Future Directions
Sperling and colleagues (2011) proposed that subtle cognitive decline and subjective
complaints can be observed throughout the preclinical trajectory several years before MCI or AD
onset. They hypothesized that cognitively normal individuals with abnormal AD biomarkers are
in the long preclinical phase of AD that precedes MCI, where there is evolving AD
pathophysiology, particularly Aβ peptide accumulation and initial neuronal injury. Rajan and
colleagues (2015) found differences in baseline cognitive functioning on tests of episodic
memory, executive function, and global cognition, up to 18 years before the clinical diagnosis of
AD. In addition poorer baseline performance also predicted the development of AD (Rajan,
Wilson, Weuve, Barnes & Evans, 2015). If we follow the theory that abnormal AD biomarkers
are present before subtle cognitive decline presents, then as Rajan and colleagues (2015) suggest,
we must extend our study of aging to include middle-aged individuals to understand the earliest
manifestations of the disease process. Thus, it would be of value to repeat our study in a younger
cohort of individuals with subtle objective cognitive difficulties.
In addition, cognitively healthy participants who exhibit subtle cognitive deficits could be
representative of a pre-clinical AD asymptomatic stage where there is evidence of biomarkers
associated with AD present, such as amyloid of tau protein alterations (Edmonds et al., 2015).
The next stage would be to examine these cognitively healthy participants who later transition to
MCI and discover if they also possess abnormal AD biomarkers at this asymptomatic stage. If
abnormal biomarkers are present then we can assume that these participants may be in the
preclinical stage of AD. If abnormal biomarkers are not present, we can assume that the
differences in baseline cognitive performance may present before AD pathogenesis begins.
Impaired baseline performance on tests that measure subtle cognitive deficits (such as tests that
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measure one’s performance in respect to self) may allow for detection of cognitive decline at the
point of onset.
Edmonds and colleagues (2015) proposed that cognitive decline reflected by sensitive
episodic memory measures is as valuable or even superior to biomarkers in predicting
development of AD. Bondi and colleagues (2014) suggested that examination of within-person
cognitive change may better identify trajectories of decline than comparisons to group norms.
Intraindividual variability measures allow for the detection of within-person change and can help
quantify the trajectory of cognitive decline over time. Future research should attempt to clarify
the cognitive and neural mechanisms underlying intraindividual variability, as well as the utility
of intraindividual variability for identifying those who will go on to develop MCI and AD.
Increased intraindividual variability may represent subtle cognitive decline that goes undetected
by traditional methods. Cognitively normal individuals who present with increased
intraindividual variability may characterize the preclinical AD stage. Increased intraindividual
variability on multi-block cognitive tests (especially for the domain of episodic memory) could
serve as a cognitive biomarker for the onset of MCI and AD pathology. In particular, a multiblock episodic memory task (like the one used in the current study) could provide valuable
information relating to subtle cognitive decline. Finally, it would be instructive to determine
whether greater intraindividual variability is associated with neuropathology of AD or if neural
changes have yet to manifest. Intraindividual variability may also serve as a novel predictor of
future neural changes associated with AD.
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Tables
Table 1
List of abbreviations and full name/title
______________________________________________________________________________
Abbreviation

Full Name/Title

AC MCI

Alternate Criteria Mild Cognitive Impairment

AD

Alzheimer’s Disease

aMCI

amnestic Mild Cognitive Impairment

BIMC

Blessed Information-Memory-Concentration Test

CRRST

Cued-Recall Retrieval Speed Task

EAS MCI

Einstein Aging Study Mild Cognitive Impairment

FAST

Functional Assessment Staging

FCSRT

Free and Cued Selective Reminding Test

FCSRT Rev

Free and Cued Selective Reminding Test reverse scored

HC

Healthy Controls

IADL

Instrumental Activities of Daily Living Scale

ICV

Intraindividual Coefficient of Variation

IIV

Intraindividual Variability

ISD

Intraindividual Standard Deviation

MCI

Mild Cognitive Impairment

naMCI

non-amnestic Mild Cognitive Impairment

NM

Number Match Task

NB2

N-Back 2 Task

RT

Reaction Time

TMT-A

Trail Making Test Part A

TMT-B

Trail Making Test Part B

______________________________________________________________________________
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Table 2
Outcome group definition
______________________________________________________________________________
Outcome

Group 1

Group 2

Group 3

EAS MCI

HC

EAS MCI

N/A

AC MCI

HC

AC MCI

N/A

EAS MCI3

HC

EAS aMCI

EAS naMCI

EAS aMCI

HC + naMCI

aMCI

N/A

EAS naMCI

HC + aMCI

naMCI

N/A

AC pre-MCI

HC

pre-MCI

AC MCI

EAS MCI 3 vs 4

HC

EAS MCI within 3 yrs

EAS MCI 4 or more yrs later

AC MCI 3 vs 4

HC

AC MCI within 3 yrs

AC MCI 4 or more yrs later

AC pre-MCI 3

HC

pre-MCI within 3 yrs

AC MCI within 3 years

AC pre-MCI 4

HC

pre-MCI 4 or more yrs later AC MCI 4 or more yrs later

______________________________________________________________________________
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Table 3
Descriptive statistics by cognitive domain
______________________________________________________________________________
Episodic
Memory

Processing
Speed

Executive
Function

No Executive
Function

N

426

423

248

178

Age in years M(SD)

79.89(5.05)

79.86(5.05)

79.67(4.94)

80.18(5.20)

Males (%)

40.8

40.7

41.9

39.3

Caucasian (%)

74.9

74.9

76.2

73.0

Education HS or higher (%) 91.3

91.5

91.1

91.6

GDS 5 or less (%)

95.1

95.0

96.8

92.7

EAS Baseline HC (%)

90.8

90.8

94.0

86.5

EAS Follow-up MCI (%)

28.2

28.4

26.2

30.9

EAS Follow-up aMCI (%)

19.0

19.1

16.9

N/A

EAS Follow-up naMCI (%) 9.2

9.2

9.3

N/A

AC Follow-up MCI (%)

19.9

17.7

22.5

19.7

______________________________________________________________________________

67.5
91.7
93.3

43.1
77.8

0.97(0.98)
32.59(5.58)
1247.78(256.24)
0.838(0.12)
179.70(87.32)

0.143(0.06)

Caucasian (%)

Education HS or higher (%) 91.2
95.8

Males (%)

GDS 5 or less (%)

BIMC M(SD)

FCSRT M(SD)

CRRST RT M(SD)

CRRST Accuracy M(SD)

CRRST RT ISD M(SD)

CRRST RT ICV M(SD)

0.165(0.12)

CRRST Accuracy ICV M(SD) 0.133(0.09)

0.180(0.13)

0.123(0.06)

0.153(0.07)

216.95(115.31)

0.133(0.09)

0.103(0.05)

0.143(0.06)

180.92(87.61)

0.836(0.12)

1262.65(258.67)

32.18(5.73)

0.93(0.95)

95.6

91.8

77.5

40.6

79.62(5.02)

342

AC HC

0.176(0.11)

0.121(0.05)

0.153(0.06)

214.54(112.04)

0.776(0.16)

1380.75(290.46)

31.35(5.89)

1.65(1.02)

92.9

89.3

64.3

41.7

80.96(5.07)

84

AC MCI

____________________________________________________________________________________________________________

0.116(0.06)

CRRST Accuracy ISD M(SD) 0.103(0.05)

0.148(0.06)

207.58(106.23)

0.776(0.16)

1391.48(291.2)

1383.22(277.30)
0.791(0.15)

28.68(5.72)

1.30(0.98)

92.6

90.1

70.4

35.8

81.14(5.03)

81

EAS aMCI

30.54(5.97)

1.33(1.02)

35.0

80.81(4.99)

79.52(5.03)

Age in years M(SD)

120

306

EAS MCI

N

EAS HC

____________________________________________________________________________________________________________

Descriptive statistics for the episodic memory domain

Table 4
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1441.02(372.31)
1347.88(329.30)
1316.89(295.89)
1290.17(289.92)
1260.07(271.25)

1296.08(307.94)

1217.41(282.50)

1188.46(275.53)

1160.94(262.83)

1134.07(259.59)

Block 2

Block 3

Block 4

Block 5

Block 6

1261.56(267.26)

1290.04(306.27)

1266.26(228.46)

1341.54(259.87)

1349.67(326.65)
1306.12(299.76)
1279.56(284.95)

1230.70(291.13)
1204.62(280.57)
1177.15(271.11)

1265.11(322.14)

1436.75(403.82)

1312.39(309.44)

1146.09(248.80)

1647.30(389.46)

AC MCI
RT M(SD)

1504.93(350.19)

AC HC
RT M(SD)

0.666(0.21)
0.751(0.21)
0.793(0.17)
0.823(0.16)
0.857(0.15)

0.726(0.18)

0.810(0.16)

0.845(0.15)

0.870(0.13)

0.887(0.13)

Block 1

Block 2

Block 3

Block 4

Block 5

0.843(0.17)

0.814(0.17)

0.772(0.19)

0.736(0.23)

0.640(0.22)

EAS aMCI
Accuracy M(SD)

0.886(0.13)

0.843(0.14)

0.838(0.14)

0.782(0.15)

0.721(0.16)

EAS naMCI
Accuracy M(SD)

0.883(0.13)

0.870(0.13)

0.844(0.15)

0.808(0.17)

0.725(0.19)

AC HC
Accuracy M(SD)

0.860(0.17)

0.804(0.16)

0.778(0.18)

0.736(0.21)

0.645(0.19)

AC MCI
Accuracy M(SD)

0.889(0.13)
Block 6
0.853(0.15)
0.850(0.16)
0.859(0.13)
0.890(0.13)
0.833(0.17)
____________________________________________________________________________________________________________

EAS MCI
Accuracy M(SD)

EAS HC
Accuracy M(SD)

____________________________________________________________________________________________________________

1259.19(274.80)

1290.24(283.68)

1341.27(321.85)

1350.93(359.44)

1444.33(350.57)

1592.34(303.22)

1667.82(406.19)

1643.29(376.22)

1489.75(347.83)

Block 1
1439.43(384.46)

EAS naMCI
RT M(SD)

EAS aMCI
RT M(SD)

EAS MCI
RT M(SD)

EAS HC
RT M(SD)

____________________________________________________________________________________________________________

Reaction time (in milliseconds) and accuracy (proportion correct) block performance by group for the episodic memory experimental
task

Table 5
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p<0.01

p>0.05

p<0.05

p<0.05

EAS MCI
MCI vs HC

AC MCI
MCI vs HC

EAS MCI3
aMCI vs HC

EAS MCI3
aMCI vs naMCI
p<0.05

p<0.05

p<0.01

p<0.01

CRRST
RT mean

p>0.05

p<0.05

p<0.05

p<0.05

CRRST
RT ISD

p<0.05

p>0.05

p>0.05

p>0.05

CRRST
RT ICV

p>0.05

p<0.05

p<0.05

p<0.05

CRRST
Accuracy mean

p>0.05

p<0.05

p<0.01

p<0.01

CRRST
Accuracy ISD

p<0.05

p<0.05

p<0.01

p<0.05

CRRST
Accuracy ICV

Note: Significant results in bold. FCSRT = Free and Cued Selective Reminding Test; CRRST = Cued-Recall Retrieval Speed Task; RT
= reaction time; ISD = Intraindividual standard deviation; ICV = Intraindividual coefficient of variation.

EAS MCI3
naMCI vs HC
p>0.05
p<0.05
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
____________________________________________________________________________________________________________

FCSRT

Outcome

____________________________________________________________________________________________________________

Aim I results for the episodic memory domain

Table 6
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67.5
91.7
93.3

42.9
77.9

0.97(0.98)
52.79(26.11)
2189.03(668.30)
0.969(0.05)
175.20(214.94)
0.078(0.069)
0.022(0.05)

0.027(0.09)

Caucasian (%)

Education HS or higher (%) 91.4
95.7

Males (%)

GDS 5 or less (%)

BIMC M(SD)

TMT-A M(SD)

NM RT M(SD)

NM Accuracy M(SD)

NM RT ISD M(SD)

NM RT ICV M(SD)

NM Accuracy ISD M(SD)

NM Accuracy ICV M(SD)

0.055(0.22)

0.036(0.11)

0.098(0.13)

270.02(517.66)

0.031(0.11)

0.025(0.06)

0.080(0.08)

182.23(265.33)

0.968(0.06)

0.039(0.15)

0.029(0.079)

0.090(0.10)

247.15(418.64)

0.960(0.06)

____________________________________________________________________________________________________________

0.047(0.18)

0.034(0.09)

0.092(0.11)

245.41(451.41)

0.951(0.08)

2472.09(873.77)
2181.95(610.64)

2432.85(649.67)

2367.16(694.89)
0.960(0.07)

57.20(24.05)

1.65(1.02)

92.9

89.3

64.3

41.7

80.96(5.07)

84

AC MCI

52.61(24.41)

0.93(0.95)

95.6

92.0

77.6

40.4

79.59(5.02)

339

AC HC

58.08(18.73)

1.41(1.12)

94.9

94.9

61.5

33.3

80.13(4.92)

39

EAS naMCI

55.39(19.32)

1.33(1.02)

35.0

80.81(4.99)

79.49(5.03)

Age in years M(SD)

120

303

EAS MCI

N

EAS HC

____________________________________________________________________________________________________________

Descriptive statistics for the processing speed domain

Table 7
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2399.10(652.01)
2335.22(896.15)

2241.36(676.03)

2136.71(712.54)

Block 1

Block 2
2397.99(888.09)

2467.70(629.07)

2366.08(664.06)
2304.99(903.94)

EAS naMCI
RT M(SD)

EAS aMCI
RT M(SD)

2495.84(843.92)
2448.34(1025.02)

2129.76(684.24)

AC MCI
RT M(SD)

2234.14(613.03)

AC HC
RT M(SD)

0.972(0.08)

Block 2
0.958(0.013)

0.962(0.04)

EAS MCI
Accuracy M(SD)

0.967(0.11)

0.961(0.04)

EAS aMCI
Accuracy M(SD)

0.9380.16)

0.964(0.04)

EAS naMCI
Accuracy M(SD)

0.969(0.90)

0.968(0.04)

AC HC
Accuracy M(SD)

0.962(0.11)

0.957(0.05)

AC MCI
Accuracy M(SD)

____________________________________________________________________________________________________________

0.967(0.04)

Block 1

EAS HC
Accuracy M(SD)

____________________________________________________________________________________________________________

EAS MCI
RT M(SD)

EAS HC
RT M(SD)

____________________________________________________________________________________________________________

Reaction time (in milliseconds) and accuracy (proportion correct) block performance by group for the processing speed experimental
task

Table 8
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p>0.05

p>0.05

p>0.05

p>0.05

EAS MCI
MCI vs HC

AC MCI
MCI vs HC

EAS MCI3
naMCI vs HC

EAS MCI3
naMCI vs aMCI
p>0.05

p<0.05

p<0.05

p<0.05

NM
RT mean

p>0.05

p>0.05

p>0.05

p>0.05

NM
RT ISD

p>0.05

p>0.05

p>0.05

p>0.05

NM
RT ICV

p>0.05

p>0.05

p>0.05

p>0.05

NM
Accuracy mean

p>0.05

p>0.05

p>0.05

p>0.05

NM
Accuracy ISD

p>0.05

p>0.05

p>0.05

p>0.05

NM
Accuracy ICV

Note: Significant results in bold. TMT-A = Trail Making Test Part A; NM = Number Match Task; RT = reaction time; ISD =
Intraindividual standard deviation; ICV = Intraindividual coefficient of variation.

EAS MCI3
aMCI vs HC
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
____________________________________________________________________________________________________________

TMT-A

Outcome

____________________________________________________________________________________________________________

Aim I results for the processing speed domain

Table 9
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69.2
92.3
96.9

43.7
78.7

0.89(0.94)
111.63(52.46)
2071.50(914.93)

Caucasian (%)

Education HS or higher (%) 90.7
96.7

Males (%)

GDS 5 or less (%)

BIMC M(SD)

TMT-B M(SD)

NB2 RT M(SD)

0.125(0.13)
0.288(0.50)

0.170(0.11)
0.106(0.12)

NB2 RT ICV M(SD)

NB2 Accuracy ISD M(SD)

NB2 Accuracy ICV M(SD) 0.225(0.44)

0.253(0.47)

0.119(0.12)

0.180(0.10)

405.12(336.34)

0.219(0.43)

0.104(0.11)

0.172(0.11)

401.20(447.62)

0.780(0.18)

0.350(0.54)

0.143(0.14)

0.215(0.15)

570.01(590.17)

0.691(0.21)

2425.19(1087.03)
2062.56(889.15)

2195.08(999.33)
0.738(0.17)

134.14(66.68)

1.52(0.98)

97.7

88.6

70.5

43.2

82.19(5.32)

44

AC MCI

114.22(55.01)

0.84(0.92)

96.6

91.7

77.5

41.7

79.13(4.69)

204

AC HC

146.00(69.64)

1.04(0.93)

100

95.7

65.2

30.4

80.46(4.77)

23

EAS naMCI

____________________________________________________________________________________________________________

0.205(0.13)

513.91(528.97)

401.75(457.96)

NB2 RT ISD M(SD)

0.729(0.20)

0.777(0.18)

NB2 Accuracy M(SD)

2282.87(980.78)

134.98(67.64)

1.18(0.99)

36.9

81.34(4.81)

79.08(4.85)

Age M(SD)

65

183

EAS MCI

N

EAS HC

____________________________________________________________________________________________________________

Descriptive statistics for the executive function domain

Table 10
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2337.39(1204.70)
2370.07(1516.94)

2100.60(1120.52) 2297.50(1211.37)

2019.79(1240.97) 2259.07(1411.89)

Block 2

Block 3
2056.38(1201.76)

2224.67(1247.24)

2304.19(729.45)

EAS naMCI
RT M(SD)

2349.42(761.24)

AC MCI
RT M(SD)

1994.31(1202.41) 2491.40(1586.03)

2091.26(1093.14) 2434.76(1342.02)

2102.12(669.44)

AC HC
RT M(SD)

0.779(0.13)
0.712(0.26)
0.695(0.31)

0.816(0.11)

0.767(0.24)

0.7460.27)

Block 1

Block 2

Block 3
0.677(0.33)

0.713(0.27)

0.779(0.14)

EAS aMCI
Accuracy M(SD)

0.726(0.25)

0.709(0.25)

0.780(0.12)

EAS naMCI
Accuracy M(SD)

0.756(0.26)

0.767(0.24)

0.816(0.12)

AC HC
Accuracy M(SD)

0.623(0.33)

0.687(0.28)

0.765(0.12)

AC MCI
Accuracy M(SD)

____________________________________________________________________________________________________________

EAS MCI
Accuracy M(SD)

EAS HC
Accuracy M(SD)

____________________________________________________________________________________________________________

2285.39(725.45)

2292.04(721.20)

2094.12(675.06)

Block 1

EAS aMCI
RT M(SD)

EAS MCI
RT M(SD)

EAS HC
RT M(SD)

____________________________________________________________________________________________________________

Reaction time (in milliseconds) and accuracy (proportion correct) block performance by group for the executive function experimental
task

Table 11
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p>0.05

p>0.05

p>0.05

p>0.05

EAS MCI
MCI vs HC

AC MCI
MCI vs HC

EAS MCI3
naMCI vs HC

EAS MCI3
naMCI vs aMCI
p>0.05

p>0.05

p<0.05

p>0.05

NB2
RT mean

p>0.05

p>0.05

p>0.05

p>0.05

NB2
RT ISD

p>0.05

p>0.05

p>0.05

p>0.05

NB2
RT ICV

p>0.05

p>0.05

p<0.05

p>0.05

NB2
Accuracy mean

p>0.05

p>0.05

p>0.05

p>0.05

NB2
Accuracy ISD

p>0.05

p>0.05

p>0.05

p>0.05

NB2
Accuracy ICV

Note: Significant results in bold. TMT-B = Trail Making Test Part B; NB2 = N-Back 2 Task; RT = reaction time; ISD =
Intraindividual standard deviation; ICV = Intraindividual coefficient of variation.

EAS MCI3
aMCI vs HC
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
p>0.05
____________________________________________________________________________________________________________

TMT-B

Outcome

____________________________________________________________________________________________________________

Aim I results for the executive function domain

Table 12
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Table 13
PCA correlations between variable and component across-domain
______________________________________________________________________________
Component 1

Component 2

Component 3

FCSRT Rev

0.375

-0.310

0.190

TMT-A

0.682

-0.312

-0.504

TMT-B

0.768

-0.299

-0.366

CRRST RT ISD

0.478

-0.269

0.528

CRRST Accuracy ISD

0.290

-0.196

0.628

NM RT ISD

0.115

0.066

0.174

NM Accuracy ISD

0.188

0.021

0.421

NB2 RT ISD

0.444

0.832

0.028

NB2 Accuracy ISD

0.430

0.844

0.017

______________________________________________________________________________
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Table 14
PCA variable contributions to components across-domain
______________________________________________________________________________
Component 1

Component 2

Component 3

FCSRT Rev

7.26%

5.32%

2.76%

Trails A

23.98%

5.39%

19.45%

Trails B

30.4%

4.96%

10.25%

CRRST RT ISD

11.81%

4.03%

21.34%

CRRST Accuracy ISD

4.33%

2.13%

30.23%

NM RT ISD

0.68%

0.24%

2.31%

NM Accuracy ISD

1.82%

0.02%

13.58%

NB2 RT ISD

10.16%

38.38%

0.06%

NB2 Accuracy ISD

9.56%

39.53%

0.02%

______________________________________________________________________________
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Table 15
Incidence of follow-up MCI by wave
______________________________________________________________________________
Waves of Data
After Baseline

Total
Participants (N)

Incidence of
EAS MCI (N)

Incidence of
AC MCI (N)

1

35

12

9

2

28

11

8

3

32

8

5

4

16

8

3

5

32

8

8

6

30

4

5

7

19

8

1

8

36

5

3

9

18

1

2

10
1
0
0
______________________________________________________________________________
Total
247
65
44
______________________________________________________________________________
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Table 16
Descriptive statistics for participants with/without four or more years of follow-up data
______________________________________________________________________________
3 or Fewer Waves

4 or More Waves

N

95

152

Age M(SD)

79.17(4.99)

79.94(4.87)

Males (%)

44.2

40.1

Caucasian (%)

76.8

75.7

Education HS or higher (%)

90.5

91.4

GDS 5 or less (%)

94.7

98.0

EAS Baseline HC (%)

90.5

96.1

EAS Follow-up MCI (%)

12.6

34.9

AC Follow-up MCI (%)

4.2

26.3

AC Follow-up pre-MCI (%)

20.0

32.9

______________________________________________________________________________

Across-Domain

Episodic memory IIV and all standard
tasks distinguished groups.

Episodic memory IIV, episodic memory and
executive function standard tasks predicted MCI up
to 3 years prior to diagnosis. Episodic memory IIV
predicted pre-MCI up to 3 years prior to diagnosis.

Aim III: IIV better at characterization
Aim IV: IIV better at prediction
of future MCI?
of future MCI?
____________________________________________________________________________________________________________

Executive Function

RT and accuracy mean distinguished
RT and accuracy mean predictors for only AC MCI
MCI for only AC MCI outcome and
outcome and better than standard task.
better than standard task.
____________________________________________________________________________________________________________

Processing Speed

IIV did not distinguished between MCI and
Accuracy mean predictor for EAS MCI outcome.
HC. RT mean distinguished groups
IIV predictor only for AC MCI outcome.
better than standard task.
____________________________________________________________________________________________________________

Episodic Memory

IIV distinguished between MCI and HC for
IIV predictor only for AC MCI outcome.
all outcomes and better than standard task.
____________________________________________________________________________________________________________

____________________________________________________________________________________________________________
Aim I: IIV better at characterization
Aim II: IIV better at prediction
Domain
of future MCI?
of future MCI?

Hypotheses and summary of results

Table 17
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Figures

Figure 1. Biomarker model adapted from Jack, C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M.,
Aisen, P.S., Weiner, M.W., … Trojanowski, J.Q. (2010).
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Figure 2. Updated biomarker model adapted from Jack, C.R., Knopman, D.S., Jagust, W.J.,
Petersen, R.C., Weiner, M.W., Aisen, P.S., … Trojanowski, J.Q. (2013).
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A

B

Learning

Cued-Recall

DOG
ANIMAL

Post-Cued

ANIMAL
ANIMAL

SQUARE

DOG

Figure 3. Visual display of learning and cued-recall stages of the computerized Cued-Recall
Retrieval Speed Task adapted from Ramratan, W.S., Rabin, L.A., Wang, C., Zimmerman, M.E.,
Katz, M.J., Lipton, R.B., & Buschke, H. (2012).
A: 16 category cues presented with two possible exemplars (one correct, one incorrect) for 10
sec sequentially.
B: 6 blocks of: 16-item cued-recall (5 sec) immediately followed by post-cue presentation (2
sec).
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A

B

356
635

356
685

SAME

DIFFERENT

Figure 4. Visual display of the computerized Number Match task.
A: Rows of numbers are the same.
B: Rows of numbers are different.
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Number Presentation

5

8

5

Single digit number presented on
screen for 2 sec – participants
determine if number presented
same/different from 2-back.

38
2

First Number

5

Second Number

Question 1

Question 2

Question 3

5

3

8

8
A

B

…

Question 20

2
D

C

Figure 5. Visual display of the computerized N-Back 2 task.
A: Question 1: Does this number match the first number presented?
B: Question 2: Does this number match the second number presented?
C: Question 3: Does this number match the number presented 2-back?
D: Question 20: Does this number match the number presented 2-back?
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______________________________________________________________________________
Figure 6. CRRST mean reaction time (ms) across blocks for the EAS MCI outcome. The MCI
group had significantly greater reaction times than HC at each block. Standard errors (+2SE) of
the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 7. CRRST mean accuracy (proportion correct) across blocks for the EAS MCI outcome.
The MCI group had significantly poorer accuracy than HC at each block. Standard errors
(+2SE) of the mean are represented in the figure by error bars at each block.

145

______________________________________________________________________________
Figure 8. CRRST mean reaction time (ms) across blocks for the AC MCI outcome. The MCI
group had significantly greater reaction times than HC at each block. Standard errors (+2SE) of
the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 9. CRRST mean accuracy (proportion correct) across blocks for the AC MCI outcome.
The MCI group had significantly poorer accuracy than HC at each block, except at block 5.
Standard errors (+2SE) of the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 10. CRRST mean reaction time (ms) across blocks for the EAS MCI3 outcome. The
aMCI group had significantly greater reaction times than HC at each block. Standard errors
(+2SE) of the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 11. CRRST mean accuracy (proportion correct) across blocks for the EAS MCI3
outcome. The aMCI group had significantly poorer accuracy than HC at each block. Standard
errors (+2SE) of the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 12. FCSRT mean (items recalled) for the EAS MCI outcome. The MCI group recalled
significantly fewer items than HC. Standard errors (+2SE) of the mean are represented in the
figure by the error bars attached at each box.
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______________________________________________________________________________
Figure 13. FCSRT mean (items recalled) for the AC MCI outcome. The MCI and HC groups
did not significantly differ in the number of items recalled. Standard errors (+2SE) of the mean
are represented in the figure by the error bars attached at each box.
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______________________________________________________________________________
Figure 14. FCSRT mean (items recalled) for the EAS MCI3 outcome. The aMCI group recalled
significantly fewer items than HC. Standard errors (+2SE) of the mean are represented in the
figure by the error bars attached at each box.
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______________________________________________________________________________
Figure 15. NM mean reaction time (ms) across blocks for the EAS MCI outcome. The MCI
group had significantly greater reaction times than HC at each block. Standard errors (+2SE) of
the mean are represented in the figure by error bars at each block.

153

______________________________________________________________________________
Figure 16. NM mean accuracy (proportion correct) across blocks for the EAS MCI outcome.
The MCI and HC groups did not significantly differ in accuracy at any block. Standard errors
(+2SE) of the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 17. NM mean reaction time (ms) across blocks for the AC MCI outcome. The MCI
group had significantly greater reaction times than HC at each block. Standard errors (+2SE) of
the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 18. NM mean accuracy (proportion correct) across blocks for the AC MCI outcome. The
MCI and HC groups did not significantly differ in accuracy at any block. Standard errors (+2SE)
of the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 19. NM mean reaction time (ms) across blocks for the EAS MCI3 outcome. The naMCI
group had significantly greater reaction times than HC at each block. Standard errors (+2SE) of
the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 20. NM mean accuracy (proportion correct) across blocks for the EAS MCI3 outcome.
The naMCI group had significantly poorer accuracy than HC only at block 2. Standard errors
(+2SE) of the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 21. TMT-A mean (time in sec) for the EAS MCI outcome. The MCI and HC groups did
not significantly differ in the time it took to complete the task. Standard errors (+2SE) of the
mean are represented in the figure by error bars attached at each box.
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______________________________________________________________________________
Figure 22. TMT-A mean (time in sec) for the AC MCI outcome. The MCI and HC groups did
not significantly differ in the time it took to complete the task. Standard errors (+2SE) of the
mean are represented in the figure by error bars attached at each box.
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______________________________________________________________________________
Figure 23. TMT-A mean (time in sec) for the EAS MCI3 outcome. Groups did not significantly
differ in the time it took to complete the task. Standard errors (+2SE) of the mean are
represented in the figure by error bars attached at each box.
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______________________________________________________________________________
Figure 24. NB2 mean reaction time (ms) across blocks for the EAS MCI outcome. The MCI
group had significantly greater reaction time than HC only at block 1. Standard errors (+2SE) of
the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 25. NB2 mean accuracy (proportion correct) across blocks for the EAS MCI outcome.
The MCI group had significantly poorer accuracy than HC only at block 1. Standard errors
(+2SE) of the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 26. NB2 mean reaction time (ms) across blocks for the AC MCI outcome. The MCI
group had significantly greater reaction time than HC only at block 1. Standard errors (+2SE) of
the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 27. NB2 mean accuracy (proportion correct) across blocks for the AC MCI outcome.
The MCI group had significantly poorer accuracy than HC at block 1 and block 3. Standard
errors (+2SE) of the mean are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 28. NB2 mean reaction time (ms) across blocks for the EAS MCI3 outcome. Groups did
not significantly differ in reaction time at any block. Standard errors (+2SE) of the mean are
represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 29. NB2 mean accuracy (proportion correct) across blocks for the EAS MCI3 outcome.
Groups did not significantly differ in accuracy at any block. Standard errors (+2SE) of the mean
are represented in the figure by error bars at each block.
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______________________________________________________________________________
Figure 30. TMT-B mean (time in sec) for the EAS MCI outcome. The MCI and HC groups did
not significantly differ in the time it took to complete the task. Standard errors (+2SE) of the
mean are represented in the figure by error bars attached at each box.
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______________________________________________________________________________
Figure 31. TMT-B mean (time in sec) for the AC MCI outcome. The MCI and HC groups did
not significantly differ in the time it took to complete the task. Standard errors (+2SE) of the
mean are represented in the figure by error bars attached at each box.
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______________________________________________________________________________
Figure 32. TMT-B mean (time in sec) for the EAS MCI3 outcome. Groups did not significantly
differ in the time it took to complete the task. Standard errors (+2SE) of the mean are
represented in the figure by error bars attached at each box.
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______________________________________________________________________________
Figure 33. Across-domain PCA plot.
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______________________________________________________________________________
Figure 34. PCA bootstrap ratio for component 1.
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______________________________________________________________________________
Figure 35. PCA bootstrap ratio for component 2.
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______________________________________________________________________________
Figure 36. PCA bootstrap ratio for component 3.
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